References for Mushroom Powder and Extract Blend for Disease Prevention - m.protect product - Hekma Center

References for Mushroom Powder and Extract Blend for Disease Prevention – m.protect product

References for Mushroom Powder and Extract Blend for Disease Prevention – m.protect product

References for Lentinus Edodes

– Aalto-Korte K, Susitaival P, Kaminska R, Mäkinen-Kiljunen S. Occupational protein contact dermatitis from shiitake mushroom and demonstration of shiitake-specific immunoglobulin E. Contact Dermatitis. 2005;53:211–213.

– Adriano AR, Acosta ML, Azulay DR, Quiroz CD, Talarico SR. Shiitake dermatitis: the first case reported in Brazil. An Bras Dermatol. 2013;88:417–419.

– Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high-fat diets lower circulating leptin concentrations in rats. American Journal of Clinical Nutrition. 2000;71(2):438–442.

– Ampere A, Delhaes L, Soots J, Bart F, Wallaert B. Hypersensitivity pneumonitis induced by shiitake mushroom spores. Med Mycol. 2012;50:654–657.

– Arthur TM, Bosilevac JM, Nou X, et al. Escherichia coli O157 prevalence and enumeration of aerobic bacteria, Enterobacteriaceae, and Escherichia coli O157 at various steps in commercial beef processing plants. J Food Prot. 2004; 67: 658–665.

– Bae, J.S., Jang, K.H., Jin, H.K. Effects of natural polysaccharides on the growth and peritoneal carcinomatosis of human gastric adenocarcinoma in a nude mouse model. Cancer Lett. 2006;235:60–68.

– Bae, J.S., Jang, K.H., Yim, H., Park, S.C., Jin, H.K. Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice. World J Gastroenterol. 2005;11:577–579.

– Barkocy-Gallagher GA, Arthur TM, Rivera-Betancourt M, et al. Seasonal prevalence of Shiga toxin-producing Escherichia coli, including O157:H7 and non-O157 serotypes, and Salmonella in commercial beef processing plants. J Food Prot. 2003; 66: 1978–1986.

– Beelman RB, Gutjrie BD, Royse DJ. Influence of bacterial populations on postharvest deterioration of fresh mushrooms. In: Proceedings of the Twelfth International Congress on the Science and Cultivation of Edible Fungi, Braunschweig, Germany, 1989; 655–665.

– Bobek, P., Galbavy, S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci. 2001;58:164–168.

– Bobek, P., Galbavy, S., Ozdin, L. Effect of oyster mushroom (Pleurotus ostreatus) on pathological changes in dimethylhydrazine-induced rat colon cancer. Oncol Rep. 1998;5:727–730.

– Boels, D., Landreau, A., Bruneau, C., Garnier, R., Pulce, C., Labadie, M. et al, Shiitake dermatitis recorded by French Poison Control Centers – new case series with clinical observations. Clin Toxicol (Phila). 2014;52:625–628.

– Borchers, A.T., Keen, C.L., Gershwin, M.E. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood). 2004;229:393–406.

– Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology. 2006;36(3):485–501.

– Buettner R, Schölmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity. 2007;15(4):798–808.

– Cevallos M. Meat contaminated with resistant bacteria. Available at: http://articles.latimes.com/2011/apr/15/news/laheb-meat-bacteria-20110415.htm. Accessed September 14, 2014.

– Chang, R. Functional properties of edible mushrooms. Nutr Rev. 1996;54:S91–S93.

– Chang ST. The world mushroom industry: trends and technological development. International Journal of Medicinal Mushrooms. 2006;8(4):297–314.

– Chapman PA, Cerdán Malo AT, Ellin M, Ashton R, Harkin. Escherichia coli O157 in cattle and sheep at slaughter, on beef and lamb carcasses and in raw beef and lamb products in South Yorkshire, UK. Int. J Food Microbiol. 2001; 64: 139–150.

– Chen J, Huang XF. The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. Journal of Clinical Lipidology. 2009;3(3):154–158.

– Chen J, Seviour R. Medicinal importance of fungal β-(1→3), (1→6)-glucans. Mycological Research. 2007;111(6):635–652.

– Cheung PCK. Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. Journal of Nutrition. 1998;128(9):1512–1516.

– Chihara, G. Experimental studies on growth inhibition and regression of cancer metastases. Gan To Kagaku Ryoho. 1985;12:1196–1209.

– Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F. Inhibition ol mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature. 1969;222:687–688.

– Chu, E.Y., Anand, D., Dawn, A., Elenitsas, R., Adler, D.J. Shiitake dermatitis: a report of 3 cases and review of the literature. Cutis. 2013;91:287–290.

– Coleman, L.J., Landstrom, E.K., Royle, P.J., Bird, A.R., McIntosh, G.H. A diet containing α-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats. J Nutr. 2002;132:2312–2318.

– Curnow P, Tam M. Contact dermatitis to shiitake mushroom. Australas J Dermatol. 2003;44:155–157.

– Czarnecka, A.B., Kreft, B., Marsch, W.C. Flagellate dermatitis after consumption of Shiitake mushrooms. Postepy Dermatol Alergol. 2014;31:187–190.

– Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) mushrooms daily improves human immunity: A randomized dietary intervention in healthy young adults. J Am Coll Nutr. 2015; 34: 478–487.

– de Lima, P.L., Delmanto, R.D., Sugui, M.M., da Eira, A.F., Salvadori, D.M., Speit, G. et al, Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res. 2001;496:23–32.

– Díaz-Corpas, T., Mateu-Puchades, A., Coll-Puigserver, M.N., Marquina-Vila, A. Flagellate dermatitis after eating shiitake mushrooms. Actas Dermosifiliogr. 2011;102:830–832.

– Eisel WG, Linton RH, Muriana PM. A survey of microbial levels for incoming raw beef, environmental sources, and ground beef in a red meat processing plant. Food Microbiol. 1997; 14: 273–282.

– Elder RO, Keen JE, Siragusa GR, Barkocy-Gallagher GA, Koohmaraie M, Laegreid WW. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc Natl Acad Sci. 2000; 97: 2999–3003.

– Enman J, Rova U, Berglund KA. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes) Journal of Agricultural and Food Chemistry. 2007;55(4):1177–1180.

– Fang, N., Li, Q., Yu, S., Zhang, J., He, L., Ronis, M.J.J. et al, Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from Shiitake mushrooms. J Altern Complement Med. 2006;12:125–132.

– Feeney MJ, Dwyer J, Hasler-Lewis CM, et al. Mushrooms and health summit proceedings. J Nutr. 2014; 144: 1128S–1136S.

– Foti C, Nettis E, Damiani E, Bellino M, Cassano N, Ferannini A, et al. Occupational respiratory allergy due to Boletus edulis powder. Ann Allergy Asthma Immunol. 2008;101: 552–553.

– Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K. Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. Journal of Nutrition. 2000;130(9):2151–2156.

– Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Experimental Biology and Medicine. 2001;226(8):758–765.

– Ghirardi, M., Nascimbeni, R., Villanacci, V., Fontana, M.G., Di Betta, E., Salerni, B. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth. Eur Surg Res. 1999;31:272–280.

– Gold MA, Cernusca MM, Godsey LD. A competitive market analysis of the United States shiitake mushroom marketplace. Hort Technol. 2008; 18: 489–499. 22. Anonymous http://fsi.colostate.edu/mushrooms. Accessed March 10, 2016.

– Hakkak, R., Korourian, S., Ronis, M.J., Johnston, J.M., Badger, T.M. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male ratsCancer Lett. 2001;166:27–32.

– Hara, M., Hanaoka, T., Kobayashi, M., Otani, T., Adachi, H.Y., Montani, A. et al, Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer. 2003;46:138–147.

– Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, et al. GA2LEN skin test study I: GA2LEN harmonization of skin prick testing: Novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009;64: 1498–1506.

– Heisick JE, Rosas-Marty LI, Tatini SR. Enumeration of viable Listeria species and Listeria monocytogenes in foods. J Food Prot. 1995; 58: 733–736.

– Helbling A, Bonadies N, Brander KA, Pichler WJ. Boletus edulis: A digestion-resistant allergen may be relevant for food allergy. Clin Exp Allergy. 2002;32:771–775.

– Holt, P.R., Mokuolu, A.O., Distler, P., Liu, T., Reddy, B.S. Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutr Cancer. 1996;25:129–135.

– Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obesity Reviews. 2009;10(6):610–616.

– Ikekawa, T., Uehara, N., Maeda, Y., Nakanishi, M., Fukuoka, F. Antitumor activity of aqueous extracts of edible mushrooms. Cancer Res. 1969;29:734–735.

– International Commission on Microbiological Specification for Foods Microorganisms in foods 2. Sampling for microbiological analysis: principles and specific applications, 2nd ed. University of Toronto Press, Toronto. 1986; 199.

– Jeannin, J.F., Lagadec, P., Pelletier, H., Reisser, D., Olsson, N.O., Chihara, G. et al, Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat. Int J Immunopharmacol. 1988;10:855–861.

– Jenkins AL, Jenkins DJA, Zdravkovic U, Würsch P, Vuksan V. Depression of the glycemic index by high levels of β-glucan fiber in two functional foods tested in type 2 diabetes. European Journal of Clinical Nutrition. 2002;56(7):622–628.

– Jensen DR, Schlaepfer IR, Morin CL, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. American Journal of Physiology. 1997;273:R683–R689.

– Jeong SC, Jeong YT, Yang BK, et al. White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutrition Research. 2010;30(1):49–56.

– Juvonen KR, Purhonen AK, Salmenkallio-Marttila M, et al. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans. Journal of Nutrition. 2009;139(3):461–466.

– Kaaks, R., Toniolo, P., Akhmedkhanov, A., Lukanova, A., Biessy, C., Dechaud, H. et al, Serum C-peptide, insulin-like growth factor (IGF)–I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000;92:1592–1600.

– Kabir M, Oppert JM, Vidal H, et al. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism: Clinical and Experimental. 2002;51(7):819–826.

– Kabir Y, Kimura S. Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR) Journal of Nutritional Science and Vitaminology. 1989;35(1):91–94.

– Kim C, Stein RA, Pao S. Comparison of the microbial quality of lamb and goat meat acquired from internet and local retail markets. J Food Prot. 2015; 78: 1980–1987.

– Kim YW, Kim KH, Choi HJ, Lee DS. Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnology Letters. 2005;27(7):483–487.

– Kubo, K., Aoki, H., Nanba, H. Anti-diabetic activity present in the fruit body of Grifola frondosa(Maitake). Biol Pharm Bull. 1994;17:1106–1110.

– Kubo K, Nanba H. The effect of maitake mushrooms on liver and serum lipids. Alternative Therapies in Health and Medicine. 1996;2(5):62–66.

– Kurashige, S., Akuzawa, Y., Endo, F. Effects of Lentinus edodesGrifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol. 1997;19:175–183.

– Lewis J. Can Shiitake Mushrooms Be Eaten Raw? Available at: http://www.livestrong.com/article/441739-canshiitake-mushrooms-be-eaten-raw. Accessed March 7, 2015.

– Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57B1/6J mice. International Journal of Obesity. 2000;24(5):639–646.

– Linz, A.L., Xiao, R., Parker, J.G., Simpson, P.M., Badger, T.M., Simmen, F.A. Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny’s colons: interaction of diet with fetal alcohol exposure. J Carcinog. 2004;3:14.

– Loo HV, Oon HH. Flagelatte dermatitis following consumption of shiitake mushroom. Dermatology Reports. 2011;3.

– Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J.M. et al, A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004;96:546–553.

– Mak RKH, Wakelin SH. Shiitake dermatitis: The first case reported from a European country. Brit J Dermatol. 2006;154:774–807.

– Manohar, V., Talpur, N.A., Echard, B.W., Lieberman, S., Preuss, H.G. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab. 2002;4:43–48.

– McLauchlin J. The identification of Listeria species. Int. J. Food Microbiol. 1997; 38: 77–81.

– Mendonça, C.N., Silva, P.M., Avelleira, J.C., Nishimori, F.S., Cassia, F.F. Shiitake dermatitis. An Bras Dermatol. 2015;90:276–278.

– Mercola J. What are shiitake mushrooms good for? Available at: http://foodfacts.mercola.com/shiitakemushrooms.html.

– Mitamura, T., Sakamoto, S., Suzuki, S., Yoshimura, S., Maemura, M., Kudo, H. Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis. Oncol Rep. 2000;7:599–601.

– Moore JE, Convery RP, Millar BC, Rao JR, Elborn JS. Hypersensitivity pneumonititis associated with mushroom worker’s lung: An update on the clinical significance of the importation of exotic mushroom varieties. Int Arch Allergy Immunol. 2005;136:98–102.

– Mori K, Kobayashi C, Tomita T, Inatomi S, Ikeda M. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutrition Research. 2008;28(5):335–342.

– Murray K, Wu F, Aktar R, Namvar A, Warriner K. Comparative study on the efficacy of bacteriophages, sanitizers, and UV light treatments to control Listeria monocytogenes on sliced mushrooms (Agricus bisporus). J Food Prot. 2015; 78: 1147–1153.

– Nakaji, S., Ishiguro, S., Iwane, S., Ohta, M., Sugawara, K., Sakamoto, J. et al, The prevention of colon carcinogenesis in rats by dietary cellulose is greater than the promotive effect of dietary lard as assessed by repeated endoscopic observation. J Nutr. 2004;134:935–939.

– Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis. 1992;27:65–70.

– Nakamura T. Shiitake dermatitis. Japan Medical Journal. 1986;3237:48–50.

– Nanba, H., Kuroda, H. Antitumor mechanisms of orally administered Shiitake fruit bodies. Chem Pharm Bull (Tokyo). 1987;35:2459–2464.

– Nanba, H., Mori, K., Toyomasu, T., Kuroda, H. Antitumor action of Shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull (Tokyo). 1987;35:2453–2458.

– Neves CFQ, Graciolli LA. Caracterização da produção em toros do cogumelo comestível Lentinula edodes (Berk.) Pegler na região oeste do Estado de São Paulo. Acta Sci. Agron. 2008;30:487–494.

– Ng, M.L., Yap, A.T. Inhibition of human colon carcinoma development by lentinan from Shiitake mushrooms (Lentinus edodes). J Altern Complement Med. 2002;8:581–589.

– Nightingale KK, Schukken YH, Nightingale CR, et al. Ecology and transmission of Listeria monocytogenes infecting ruminants and in the farm environment. Appl Environ Microbiol. 2004; 70: 4458–4467.

– Okamoto, T., Kodoi, R., Nonaka, Y., Fukuda, I., Hashimoto, T., Kanazawa, K. et al, Lentinan from Shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors. 2004;21:407–409.

– Okenu D. Retail food safety forum: World health day shines spotlight on food safety. Available at: http://www.foodsafetytech.com/FoodSafetyTech/FSTBlogs2/Retail-Food-Safety-Forum-World-Health-Day-Shines-S- 897.aspx.

– Pao S, Davis CL. Transfer of natural and artificially inoculated microorganisms from orange fruit to fresh juice during extraction. LWT-Food Sci Technol. 2001; 34: 113–117.

– Pao S, Ettinger MR. Comparison of the microbial quality of ground beef and ground beef patties from internet and local retail markets. J Food Prot. 2009; 72: 1722–1726.

– Pao S, Ettinger MR, Khalid MF, Reid AO, Nerrie BL. Microbial quality of raw aquacultured fish fillets procured from Internet and local retail markets. J Food Prot. 2008; 71: 1544–1549.

– Pao S, Kelsey DF. Food Safety Programs. In: W.F. Wardowkski, W.M. Miller, D.J. Hall and W. Grierson (eds.), Fresh citrus fruits, 2nd ed., Florida Science Source, Van Nostrand Reinhold Co., Inc. NY. 2006; 105–127.

– Pao S, Khalid MF, Kalantari A. Microbial profiles of on-line—procured sprouting seeds and potential hazards associated with enterotoxigenic Bacillus spp. in homegrown sprouts. J Food Prot. 2005; 68: 1648–1653.

– Pao S, Long W, Kim C, et al. Chap. 5. Produce Washers in Decontamination of Fresh and Minimally Processed Produce. In Decontamination of Fresh and Minimally Processed Produce. Vicente M. Gómez-López, ed. John Wiley & Sons, Inc. NJ. 2012; 87–101.

– Park, H.S., Goodlad, R.A., Wright, N.A. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res. 1997;57:4507–4510.

– Pastorello EA, Pravettoni V, Farioli L, Ispano M, Fortunato D, Monza M, et al. Clinical role of a lipid transfer protein that acts as a new apple-specific allergen. J Allergy Clin Immunol. 1999;104:1099–1106.

– Poppe, L.M., Anders, D., Kneitz, H., Bröcker, E.B., Benoit, S. Flagellate dermatitis caused by shiitake mushrooms. An Bras Dermatol. 2012;87:463–465.

– Pravettoni V, Incorvaia C, Frati F. Role of measurement of nitric oxide in respiratory diseases. Recent Prog Med. 2008;99:258–262.

– Qi, H.L., Zhang, Y., Ma, J., Guo, P., Zhang, X.Y., Chen, H.L. Insulin/protein kinase B signalling pathway upregulates metastasis-related phenotypes and molecules in H7721 human hepatocarcinoma cell line. Eur J Biochem. 2003;270:3795–3805.

– Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. Journal of Nutrition. 1997;127(5):838S–841S.

– Ribeiro, L.R., Salvadori, D.M. Dietary components may prevent mutation-related diseases in humans. Mutat Res. 2003;544:195–201.

– Roberfroid MB. A European consensus of scientific concepts of functional foods. Nutrition. 2000;16(7-8):689–691.

– Roels TH, Frazak PA, Kazmierczak JJ, et al. Incomplete sanitation of a meat grinder and ingestion of raw ground beef: contributing factors to a large outbreak of Salmonella typhimurium infection. Epidemiol Infect. 1997; 119: 127– 134.

– Roupas P, Keogh J, Noakes M, et al. The role of edible mushrooms in health: Evaluation of the evidence. J Func Foods. 2012; 4: 687–709.

– Royse DJ. Cultivation of shiitake on natural and synthetic logs. Available at: http://extension.psu.edu/publications/xl0083. 2009.

– Samadpour M, Barbour MW, Nguyen T, et al. Incidence of enterohemorrhagic Escherichia coli, Escherichia coli O157, Salmonella, and Listeria monocytogenes in retail fresh ground beef, sprouts, and mushrooms. J Food Prot. 2006; 69: 441–443.

– Schneider I, Kressel G, Meyer A, Krings U, Berger RG, Hahn A. Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans. Journal of Functional Foods. 2011;3(1):17–24.

– Senti G, Leser C, Lundberg M, Wüthrich B. Allergic asthma to shiitake and oyster mushroom. Allergy. 2000;55:975–987.

– Shamtsyan, M., Konusova, V., Maksimova, Y., Goloshchev, A., Panchenko, A., Simbirtsev, A. et al,Immunomodulating and anti-tumor action of extracts of several mushrooms. J Biotechnol. 2004;113:77–83.

– Shimada Y, Morita T, Sugiyama K. Eritadenine-induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterol-free and cholesterol-enriched diets. Bioscience, Biotechnology and Biochemistry. 2003;67(5):996–1006.

– Shin D. The effect of seamustard on blood lipid profiles and glucose level of rats fed diet with different energy composition. Nutrition Research and Practice. 2009;3:31–37.

– Shpitz, B., Bomstein, Y., Kariv, N., Shalev, M., Buklan, G., Bernheim, J. Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. Int J Colorectal Dis. 1998;13:169–172.

– Sjoblom L, Eklund A. Determination of HDL2 cholesterol by precipitation with dextran sulfate and magnesium chloride: establishing optimal conditions for rat plasma. Lipids. 1989;24(6):532–534.

– Suga, T., Shiio, T., Maeda, Y.Y., Chihara, G. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene–induced carcinogenesis. Cancer Res. 1984;44:5132–5137.

– Sugiyama K, Akachi T, Yamakawa A. Eritadenine-induced alteration of hepatic phospholipid metabolism in relation to its hypochlelsterolemic action in rats. Journal of Nutritional Biochemistry. 1995;6(2):80–87.

– Sugiyama K, Yamakawa A, Kawagishi H, Saeki S. Dietary eritadenine modifies plasma phosphatidylcholine molecular species profile in rats fed different types of fat. Journal of Nutrition. 1997;127(4):593–599.

– Sugui, M.M., Alves de Lima, P.L., Delmanto, R.D., da Eira, A.F., Salvadori, D.M., Ribeiro, L.R.Antimutagenic effect of Lentinula edodes (Berk.) Pegler mushroom and possible variation among lineagesFood Chem Toxicol. 2003;41:555–560.

– Taguchi, T. Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer. Gan To Kagaku Ryoho. 1983;10:387–393.

– Takashima K, Sato C, Sasaki Y. Effect of eritadenine on cholesterol metabolism in the rat. Biochemical Pharmacology. 1974;23(2):433–438.

– Takimoto, H., Wakita, D., Kawaguchi, K., Kumazawa, Y. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biol Pharm Bull. 2004;27:404–406.

– Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG. Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Molecular and Cellular Biochemistry. 2002;237(1-2):129–136.

– Tecra. Methods manual: Listeria visual immunoassay. Tecra International Pty Ltd., Frenchs Forest, Australia. 2004.

– Tecra. Methods manual: Salmonella visual immunoassay. Tecra International Pty Ltd., Frenchs Forest, Australia. 2005.

– Toth, B., Patil, K., Pyysalo, H., Stessman, C., Gannett, P. Cancer induction in mice by feeding the raw false morel mushroom Gyromitra esculenta. Cancer Res. 1992;52:2279–2284.

– Tran, T.T., Medline, A., Bruce, W.R. Insulin promotion of colon tumors in ratsCancer Epidemiol Biomarkers Prev. 1996;5:1013–1015.

– United States Department of Agriculture, National Agricultural Statistics Service Mushrooms. Available at: http://www.nass.usda.gov/Publications/Todays_Reports/reports/mush0814.pdf.

– United States Food and Drug Administration United Salad Co. recalls champ’s sliced crimini mushrooms because of possible health risk. Available at: http://www.fda.gov/Safety/Recalls/ucm452008.htm? source=govdelivery&utm_medium=email&utm_source=govdelivery.

– Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. Journal of Clinical Investigation. 1997;99(3):385–390.

– Venturini ME, Reyes JE, Rivera CS, Oria R, Blanco D. Microbiological quality and safety of fresh cultivated and wild mushrooms commercialized in Spain. Food Microbiol. 2011; 28: 1492–1498.

– Voshol PJ, Rensen PCN, van Dijk KW, Romijn JA, Havekes LM. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models. Biochimica et Biophysica Acta. 2009;1791(6):479–485.

– Wang H, Storlien LH, Huang X-F. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. American Journal of Physiology. 2002;282:E1352–E1359.

– WHO. Media centre obesity and overweight. WHO, 2006.

– Wilkin E, Brouillette R, Carver J, et al. Control of Listeria monocytogenes: guidance for the U.S. dairy industry. Innovation Center for U.S. Dairy. 2015; 7.

– Xiao, R., Carter, J.A., Linz, A.L., Ferguson, M., Badger, T.M., Simmen, F.A. Dietary whey protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in azoxymethane-treated male rats. J Nutr Biochem. 2006.

– Xu C, HaiYan Z, JianHong Z, Jing G. The pharmacological effect of polysaccharides from Lentinus edodes on the oxidative status and expression of VCAM-1mRNA of thoracic aorta endothelial cell in high-fat-diet rats. Carbohydrate Polymers. 2008;74(3):445–450.

– Xue CY, Kageyama H, Kashiba M, et al. Different origin of hypertriglyceridemia induced by a high-fat and a high-sucrose diet in ventromedial hypothalamic-lesioned obese and normal rats. International Journal of Obesity. 2001;25(3):434–438.

– Yan, J., Zong, H., Shen, A., Chen, S., Yin, X., Shen, X. et al, The beta-(1→6)-branched beta-(1→3) glucohexaose and its analogues containing an alpha-(1→3)-linked bond have similar stimulatory effects on the mouse spleen as lentinan. Int Immunopharmacol. 2003;3:1861–1871.

– Yang, B.K., Kim, D.H., Jeong, S.C., Das, S., Choi, Y.S., Shin, J.S. et al, Hypoglycemic effect of aLentinus edodes exo-polymer produced from a submerged mycelial culture. Biosci Biotechnol Biochem. 2002;66:937–942.

– Yu, L., Fernig, D.G., Smith, J.A., Milton, J.D., Rhodes, J.M. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res. 1993;53:4627–4632.

– Zaidman, B.Z., Yassin, M., Mahajna, J., Wasser, S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67:453–468.

References for Grifola Frondosa

– A. Synytsya, K. Míčková, I. Jablonský et al., “Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: structure and potential prebiotic activity,” Carbohydrate Polymers, vol. 76, no. 4, pp. 548–556, 2009.

– A. A. J. Carneiro, I. C. F. R. Ferreira, M. Dueñas et al., “Chemical composition and antioxidant activity of dried powder formulations of Agaricus blazei and Lentinus edodes,” Food Chemistry, vol. 138, no. 4, pp. 2168–2173, 2013.

– A. C. Brown and C. I. Waslien, “Stress and nutrition,” in Encyclopedia of Food Sciences and Nutrition, L. Trugo and P. M. Finglas, Eds., Academic Press, London, UK, 2003.

– A. E. S. S. Carvajal, E. A. Koehnlein, A. A. Soares et al., “Bioactives of fruiting bodies and submerged culture mycelia of Agaricus brasiliensis (A.blazei) and their antioxidant properties,” LWT: Food Science and Technology, vol. 46, no. 2, pp. 493–499, 2012.

– A. Jedinak and D. Sliva, “Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway,” International Journal of Oncology, vol. 33, no. 6, pp. 1307–1313, 2008.

– A. Jedinak, S. Dudhgaonkar, Q.-L. Wu, J. Simon, and D. Sliva, “Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling,” Nutrition Journal, vol. 10, article 52, 2011.

– A. M. Al-Dbass, S. K. Al- Daihan, and R. S. Bhat, “Agaricus blazei Murill as an efficient hepatoprotective and antioxidant agent against CCl4-induced liver injury in rats,” Saudi Journal of Biological Sciences, vol. 19, no. 3, pp. 303–309, 2012.

– A. S. Daba and O. U. Ezeronye, “Minireview. Anti-cancer effect of polysaccharides isolated from higher basidiomycetes mushrooms,” African Journal of Biotechnology, vol. 2, pp. 272–278, 2003.

– Abdullah MM, Riediger NN, Chen Q, Zhao Z, Azordegan N, Xu Z, Fischer G, Othman RA, Pierce GN, Tappia PS, Zou J, Moghadasian MH. Effects of long-term consumption of a high-fructose diet on conventional cardiovascular risk factors in Sprague-Dawley rats. Mol Cell Biochem. 2009;327:247-256.

– Adachi K, Nanba H, Otsuka M, Kuroda H. Blood pressure-lowering activity present in the fruit body of Grifola fondosa (Maitake). I Chem Pharm Bull. 1988;36:1000-1006.

– Adachi Y, Okazaki M, Ohno N, et al. Enhancement of cytokine production by macrophages stimulated with (1–>3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull1994;17:1554-60.

– Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001;158:195-198.

– B. Boh, “Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs,” Recent Patents on Anti-Cancer Drug Discovery, vol. 8, no. 3, pp. 255–287, 2013.

– B. H. Falch, T. Espevik, L. Ryan, and B. T. Stokke, “The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation,” Carbohydrate Research, vol. 329, no. 3, pp. 587–596, 2000.

– B. J. Shi, X. H. Nie, L. Z. Chen, Y. L. Liu, and W. Y. Tao, “Anticancer activities of a chemically sulfated polysaccharide obtained from Grifola frondosa and its combination with 5-fluorouracil against human gastric carcinoma cells,” Carbohydrate Polymers, vol. 68, no. 4, pp. 687–692, 2007.

– B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993.

– B. Ribeiro, P. G. de Pinho, P. B. Andrade, P. Baptista, and P. Valentão, “Fatty acid composition of wild edible mushrooms species: a comparative study,” Microchemical Journal, vol. 93, no. 1, pp. 29–35, 2009.

– B. S. Sanodiya, G. S. Thakur, R. K. Baghel, G. B. K. S. Prasad, and P. S. Bisen, “Ganoderma lucidum: a potent pharmacological macrofungus,” Current Pharmaceutical Biotechnology, vol. 10, no. 8, pp. 717–742, 2009.

– B.Z. Zaidman, M. Yassin, J. Mahajna, and S. P. Wasser, “Medicinal mushroom modulators of molecular targets as cancer therapeutics,” Applied Microbiology and Biotechnology, vol. 67, no. 4, pp. 453–468, 2005.

– Bray GA. Soft drink consumption and obesity: it is all about a fructose. Curr Opin Lipidol. 2010;21:51-57.

– Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med. 2002;196(3):407–412.

– Bunag RD. Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol. 1973;34:279-282.

– C. Sarikurkcu, B. Tepe, and M. Yamac, “Evaluation of the antioxidant activity of four edible mushrooms from the Central Anatolia, Eskisehir—Turkey: Lactarius deterrimus, Suillus collitinus, Boletus edulis, Xerocomus chrysenteron,” Bioresource Technology, vol. 99, no. 14, pp. 6651–6655, 2008.

– C.H. Lin, G.-T. Sheu, Y.-W. Lin et al., “A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells,” Process Biochemistry, vol. 45, no. 9, pp. 1537–1542, 2010.

– C. J. Weng and G.-C. Yen, “The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis,” Clinical and Experimental Metastasis, vol. 27, no. 5, pp. 361–369, 2010.

– C. S. G. Kitzberger, A. Smânia Jr., R. C. Pedrosa, and S. R. S. Ferreira, “Antioxidant and antimicrobial activities of shiitake (Lentinula edodes) extracts obtained by organic solvents and supercritical fluids,” Journal of Food Engineering, vol. 80, no. 2, pp. 631–638, 2007.

– C. Thetsrimuang, S. Khammuang, and R. Sarnthima, “Antioxidant activity of crude polysaccharides from edible fresh and dry mushroom fruiting bodies of Lentinus sp. strain RJ-2,” International Journal of Pharmacology, vol. 7, no. 1, pp. 58–65, 2011.

– C. Thetsrimuang, S. Khammuang, K. Chiablaem, C. Srisomsap, and R. Sarnthima, “Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév,” Food Chemistry, vol. 128, no. 3, pp. 634–639, 2011.

– C. U. J. O. Lima, C. O. D. A. Cordova, O. D. T. Nóbrega, S. S. Funghetto, and M. G. D. O. Karnikowski, “Does the Agaricus blazei Murill mushroom have properties that affect the immune system? An integrative review,” Journal of Medicinal Food, vol. 14, no. 1-2, pp. 2–8, 2011.

– C. W. Phan, W.-L. Wong, P. David, M. Naidu, and V. Sabaratnam, “Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde: nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells,” BMC Complementary and Alternative Medicine, vol. 12, article 102, 2012.

Chen, J.T., Tominaga, K., Sato, Y., Anzai, H., Matsuoka, R. 2010. “Maitake Mushroom (Grifola frondosa) Extract Induces Ovulation in Patients with Polycystic Ovary Syndrome: A Possible Monotherapy and a Combination Therapy After Failure with First-Line Clomiphene Citrate.” The Journal of Alternative and Complementary Medicine. Vol. 16, No. 12, p. 1-5. Mary Ann Liebert, Inc. DOI: 10.1089/acm.2009.0696.

– Chen JT, Tominaga K, Sato Y, Anzai H, Matsuoka R. Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: a possible monotherapy and a combination therapy after failure with first-line clomiphene citrate. J Altern Complement Med. 2010;16(12):1295-1299.

– Cheung NK, Modak S, Vickers A, Knuckles B. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother. 2002;51(10):557–564.

– Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–5777.

– D. Sliva, “Ganoderma lucidum (Reishi) in cancer treatment,” Integrative Cancer Therapies, vol. 2, no. 4, pp. 358–364, 2003.

– Daddaoua A, Martínez-Plata E, Ortega-González M, et al. The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation. Food Chem 2013;136:1288-95.

– De Silva, D., Rapior, S., Hyde, K., Bahkali, A. 2012. “Medicinal mushrooms in prevention and control of diabetes mellitus.” Fungal Diversity 56:1-29. DOI 10.1007/s13225-012-0187-42012.

– Deng G., Lim H., Seidman A., Fornier M., D’Andrea G., Wesa K., Yeung, S., Cunningham-Rundles, S., Vickers, AJ, Cassileth, B. 2009. “A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol 135:1215-1221.

– Dunnett C. A multiple comparison procedure for comparing several treatments with control. J Am Statis Assoc. 1955;50:1096-1121.

– E. Guillamón, A. García-Lafuente, M. Lozano et al., “Edible mushrooms: role in the prevention of cardiovascular diseases,” Fitoterapia, vol. 81, no. 7, pp. 715–723, 2010.

– E. Pereira, L. Barros, A. Martins, and I. C. F. R. Ferreira, “Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats,” Food Chemistry, vol. 130, no. 2, pp. 394–403, 2012.

– F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008.

– F. H. Gruen and M. W. Wong, “Distribution of cellular amino acids, proteins and total nitrogen during fruit body development in Flammuling velutipes,” Canadian Journal of Botany, vol. 160, pp. 1339–1341, 1982.

– F. M. Klis, P. De Groot, and K. Hellingwerf, “Molecular organization of the cell wall of Candida albicans,” Medical Mycology, vol. 39, no. 1, pp. 1–8, 2001.

– F. M. N. A. Aida, M. Shuhaimi, M. Yazid, and A. G. Maaruf, “Mushroom as a potential source of prebiotics: a review,” Trends in Food Science & Technology, vol. 20, no. 11-12, pp. 567–575, 2009.

– F. R. Smiderle, L. M. Olsen, E. R. Carbonero et al., “Anti-inflammatory and analgesic properties in a rodent model of a (1→3),(1→6)-linked β-glucan isolated from Pleurotus pulmonarius,” European Journal of Pharmacology, vol. 597, no. 1–3, pp. 86–91, 2008.

– F. S. Reis, L. Barros, A. Martins, and I. C. F. R. Ferreira, “Chemical composition and nutritional value of the most widely appreciated cultivated mushrooms: an inter-species comparative study,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 191–197, 2012.

– F. Schmid, B. A. Stone, B. M. McDougall et al., “Structure of epiglucan, a highly side-chain/branched (1/3;1/6)-β-glucan from the micro fungus Epicoccum nigrum Ehrenb. ex Schlecht,” Carbohydrate Research, vol. 331, no. 2, pp. 163–171, 2001.

– Finimundy TC, Gambato G, Fontana R, et al. Aqueous extracts of Lentinula edodes and Pleurotus sajor-caju exhibit high antioxidant capability and promising in vitro antitumor activity. Nutr Res2013;33:76-84.

– Fournier RD, Chiueh CC, Kopin IJ, Knapka JJ, DiPette D, Preuss HG. The interrelationship between excess CHO ingestion, blood pressure and catecholamine excretion in SHR and WKY. Am J Physiol. 1986;250:E381-385.

– Freireich E.J, Gehan E.A, Rall D.P, Schmidt L.H, Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Reports. 1966;50:219-244.

– G. Kanagasabapathy, S. N. A. Malek, U. R. Kuppusamy, and S. Vikineswary, “Chemical composition and antioxidant properties of extracts of fresh fruiting bodies of Pleurotus sajor-caju (Fr.) singer,” Journal of Agricultural and Food Chemistry, vol. 59, no. 6, pp. 2618–2626, 2011.

– G. Q. Liu and K.-C. Zhang, “Mechanisms of the anticancer action of Ganoderma lucidum (Leyss. ex Fr.) Karst.: a new understanding,” Journal of Integrative Plant Biology, vol. 47, no. 2, pp. 129–135, 2005.

– G. Q. Zhang, J. Sun, H. X. Wang, and T. B. Ng, “A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa,” Acta Biochimica Polonica, vol. 56, no. 3, pp. 415–421, 2009.

– G. Stanley, K. Harvey, V. Slivova, J. Jiang, and D. Sliva, “Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 330, no. 1, pp. 46–52, 2005.

– H. Chen, Y. Ju, J. Li, and M. Yu, “Antioxidant activities of polysaccharides from Lentinus edodes and their significance for disease prevention,” International Journal of Biological Macromolecules, vol. 50, no. 1, pp. 214–218, 2012.

– H. G. Kim, D. H. Yoon, W. H. Lee et al., “Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 307–315, 2007.

– H.H. Chang, P.-J. Chien, M.-H. Tong, and F. Sheu, “Mushroom immunomodulatory proteins possess potential thermal/freezing resistance, acid/alkali tolerance and dehydration stability,” Food Chemistry, vol. 105, no. 2, pp. 597–605, 2007.

– H. Tong, F. Xia, K. Feng et al., “Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus,” Bioresource Technology, vol. 100, no. 4, pp. 1682–1686, 2009.

– H.Y. Kim, J.-H. Kim, S.-B. Yang et al., “A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects,” Journal of Medicinal Food, vol. 10, no. 1, pp. 25–31, 2007.

– Harada N, Kodama N, Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett. 2003;192(2):181–187.

– Hawrylowicz CM. Regulatory T cells and IL-10 in allergic inflammation. J Exp Med. 2005;202(11):1459–1463.

– Hazama S, Watanabe S, Ohashi M, et al. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res 2009;29:2611-7.

– Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol. 2004;40(12):869–876.

– Hirata N, Tsuzuki A, Ohno N, et al. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1–>3)-beta-D-glucan preparation, sonifilan. Zentralbl Bakteriol1998;288:403-13.

– I. C. F. R. Ferreira, J. A. Vaz, M. H. Vasconcelos, and A. Martins, “Compounds from wild mushrooms with antitumor potential,” Anti-Cancer Agents in Medicinal Chemistry, vol. 10, no. 5, pp. 424–436, 2010.

– I. C. F. R. Ferreira, L. Barros, and R. M. V. Abreu, “Antioxidants in wild mushrooms,” Current Medicinal Chemistry, vol. 16, no. 12, pp. 1543–1560, 2009.

– I. Lavi, D. Friesem, S. Geresh, Y. Hadar, and B. Schwartz, “An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells,” Cancer Letters, vol. 244, no. 1, pp. 61–70, 2006.

– I. Palacios, M. Lozano, C. Moro et al., “Antioxidant properties of phenolic compounds occurring in edible mushrooms,” Food Chemistry, vol. 128, no. 3, pp. 674–678, 2011.

– Ina K, Kataoka T, Ando T. The use of lentinan for treating gastric cancer. Anticancer Agents Med Chem 2013;13:681-8.

– J. A. Vaz, S. A. Heleno, A. Martins, G. M. Almeida, M. H. Vasconcelos, and I. C. F. R. Ferreira, “Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2881–2884, 2010.

– J.C. Wang, S.-H. Hu, Z.-C. Liang, and C.-J. Yeh, “Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus in submerged culture and its antitumor effect,” Applied Microbiology and Biotechnology, vol. 67, no. 6, pp. 759–766, 2005.

– J. Chen and R. Seviour, “Medicinal importance of fungal β-(1→3), (1→6)-glucans,” Mycological Research, vol. 111, no. 6, pp. 635–652, 2007.

– J. Erjavec, J. Kos, M. Ravnikar, T. Dreo, and J. Sabotič, “Proteins of higher fungi—from forest to application,” Trends in Biotechnology, vol. 30, no. 5, pp. 259–273, 2012.

– J. Lee, J.-H. Hong, J.-D. Kim et al., “The antioxidant properties of solid-culture extracts of basidiomycetous fungi,” Journal of General and Applied Microbiology, vol. 59, no. 4, pp. 279–285, 2013.

– J. Mahajna, N. Dotan, B.-Z. Zaidman, R. D. Petrova, and S. P. Wasser, “Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum,” Nutrition and Cancer, vol. 61, no. 1, pp. 16–26, 2009.

– J. T. Xie, C. Z. Wang, S. Wicks et al., “Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells,” Experimental Oncology, vol. 28, no. 1, pp. 25–29, 2006.

– J. Yu, R. Sun, Z. Zhao, and Y. Wang, “Auricularia polytricha polysaccharides induce cell cycle arrest and apoptosis in human lung cancer A549 cells,” International Journal of Biological Macromolecules, vol. 68, pp. 67–71, 2014.

– K. Hensley, E. J. Benaksas, R. Bolli et al., “New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine,” Free Radical Biology and Medicine, vol. 36, no. 1, pp. 1–15, 2004.

– K.I. Ishibashi, N. N. Miura, Y. Adachi, N. Ohno, and T. Yadomae, “Relationship between solubility of grifolan, a Fungal 1,3-β-D-glucan, and production of tumor necrosis factor by macrophages in vitro,” Bioscience, Biotechnology and Biochemistry, vol. 65, no. 9, pp. 1993–2000, 2001.

– K. K. Mishra, R. S. Pal, R. Arunkumar, C. Chandrashekara, S. K. Jain, and J. C. Bhatt, “Antioxidant properties of different edible mushroom species and increased bioconversion efficiency of Pleurotus eryngii using locally available casing materials,” Food Chemistry, vol. 138, no. 2-3, pp. 1557–1563, 2013.

– K. K. Maity, S. Patra, B. Dey et al., “A heteropolysaccharide from aqueous extract of an edible mushroom, Pleurotus ostreatus cultivar: structural and biological studies,” Carbohydrate Research, vol. 346, no. 2, pp. 366–372, 2011.

– K. K. W. Chu, S. S. S. Ho, and A. H. L. Chow, “Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values,” Journal of Clinical Pharmacology, vol. 42, no. 9, pp. 976–984, 2002.

– K. Kataoka, T. Muta, S. Yamazaki, and K. Takeshige, “Activation of macrophages by linear (1→3)-β-D-glucans. Implications for the recognition of fungi by innate immunity,” Journal of Biological Chemistry, vol. 277, no. 39, pp. 36825–36831, 2002.

– K. Mori, C. Kobayashi, T. Tomita, S. Inatomi, and M. Ikeda, “Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus(Bunashimeji) in apolipoprotein E-deficient mice,” Nutrition Research, vol. 28, no. 5, pp. 335–342, 2008.

– K. Wisitrassameewong, S. C. Karunarathna, N. Thongklang et al., “Agaricus subrufescens: a review,” Saudi Journal of Biological Sciences, vol. 19, no. 2, pp. 131–146, 2012.

– Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol. 2007;37(2):467–478.

– Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol. 2002b;90(4):357–360.

– Kodama N, Komuta K, Nanba H. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. J Med Food. 2003;6(4):371–377.

– Kodama N, Komuta K, Sakai N, Nanba H. Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull. 2002a;25(12):1647–1650.

– Kodama, N., Mizuno, S., Asakawa, A., Inui, A., Nanba, H. 2010. “Effect of a hot water-soluble extraction from Grifola frondosa on the viability of a human monocyte cell line exposed
to mitomycin C.” Mycoscience (2010) 51:134-138. DOI: 10.1007/s10267-009-0016-0.

– Kodama N, Murata Y, Asakawa A, Inui A, Hayashi M, Sakai N, et al. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition. 2005;21(5):624–629.

– Kodama N, Yamada M, Nanba H. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol 2001;87:327-32.

– Konno, S., D. G. Tortorelis, S. A. Fullerton, A. A. Samadi, J. Hettiarachchi and H. Tazaki, 2001. “A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients” Diabetic Medicine, 18, 1007-1010. Department of Urology, New York Medical College, Valhalla, NY, USA.

– Kubo K, Aoki H, Nanba H. Anti-diabetic activity in the fruit body of Grifola frondosa (Maitake). Biol Pharm Bull. 1994;17:1106-1110.

– L. Barros, D. M. Correia, I. C. F. R. Ferreira, P. Baptista, and C. Santos-Buelga, “Optimization of the determination of tocopherols in Agaricus sp. edible mushrooms by a normal phase liquid chromatographic method,” Food Chemistry, vol. 110, no. 4, pp. 1046–1050, 2008.

– L. Barros, P. Baptista, D. M. Correia, S. Casal, B. Oliveira, and I. C. F. R. Ferreira, “Fatty acid and sugar compositions, and nutritional value of five wild edible mushrooms from Northeast Portugal,” Food Chemistry, vol. 105, no. 1, pp. 140–145, 2007.

– L. J. Standish, C. A. Wenner, E. S. Sweet et al., “Trametes versicolor mushroom immune therapy in breast cancer,” Journal of the Society for Integrative Oncology, vol. 6, no. 3, pp. 122–128, 2008.

– L. K. Jagadish, R. Shenbhagaraman, V. Venkatakrishnan, and V. Kaviyarasan, “Studies on the phytochemical, antioxidant and antimicrobial properties of three indigenous Pleurotus species,” Journal of Molecular Biology and Biotechnology, vol. 1, pp. 20–29, 2008.

– L. K. Lai, N. Z. Abidin, N. Abdullah, and V. Sabaratnam, “Anti-human papillomavirus (HPV) 16 E6 activity of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) extracts,” International Journal of Medicinal Mushrooms, vol. 12, no. 3, pp. 279–286, 2010.

– L. S. Adams, S. Phung, X. Wu, L. Ki, and S. Chen, “White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice,” Nutrition and Cancer, vol. 60, no. 6, pp. 744–756, 2008.

– L. Ye, J. Zhang, S. Zhou, S. Wang, D. Wu, and Y. Pan, “Preparation of a novel sulfated glycopeptide complex and inhibiting L1210 cell lines property in vitro,” Carbohydrate Polymers, vol. 77, no. 2, pp. 276–279, 2009.

– L. Zhang, C. Fan, S. Liu, Z. Zang, and L. Jiao, “Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus,” Journal of Medicinal Plants Research, vol. 5, no. 7, pp. 1251–1260, 2011.

– Lavi I, Levinson D, Peri I, et al. Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis. Br J Nutr2010;103:393-402.

– Li, William, MD. “Can we eat to starve cancer?” TED, 2010. Long Beach, California. Angiogenesis Institute, Cambridge, Massachusetts.

– Lin, En-Shyh, 2011. “Production of exopolysaccharides by submerged mycelial culture of Grifola frondosa TFRI1073 and their antioxidant and antiproliferative activities.” World Journal of Microbiology and Biotechnology, Vol. 27, No. 3, p. 555-561(7).

– Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol. 2004;4(1):91–99.

– Lo, H-C, Hsu, T-H, Chen, C-Y. 2008. “Submerged Culture Mycelium and Broth of Grifola frondosa Improve Glycemic Responses in Diabetic Rats.” The American Journal of Chinese Medicine, Vol. 36, No. 2, p. 265-285.

– M. A. Khan, M. Tania, R. Liu, and M. M. Rahman, “Hericium erinaceus: an edible mushroom with medicinal values,” Journal of Complementary and Integrative Medicine, vol. 10, no. 1, pp. 253–258, 2013.

– M. A. Reza, M. A. Hossain, S. J. Lee et al., “Dichlormethane extract of the jelly ear mushroom Auricularia auricula-judae (higher Basidiomycetes) inhibits tumor cell growth in vitro,” International Journal of Medicinal Mushrooms, vol. 16, no. 1, pp. 37–47, 2014.

– M. Alves, I. F. R. Ferreira, J. Dias, V. Teixeira, A. Martins, and M. Pintado, “A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds,” Planta Medica, vol. 78, no. 16, pp. 1707–1718, 2012.

– M. E. Valverde and O. Paredes Lopez, “Production and evaluation of some food properties of huitlacoche (Ustilago maydis),” Food Biotechnology, vol. 7, no. 3, pp. 207–220, 1993.

– M. E. Valverde, T. Hernandez-Perez, and O. Paredes-Lopez, “Huitlacoche—a 21st century culinary delight originated in the Aztec times,” in Hispanic Foods: Chemistry and Bioactive Compounds, M. H. Tunick and E. González de Mejía, Eds., vol. 1109, American Chemical Society, Washington, DC, USA, 2012.

– M. Makropoulou, N. Aligiannis, Z. Gonou-Zagou, H. Pratsinis, A.-L. Skaltsounis, and N. Fokialakis, “Antioxidant and cytotoxic activity of the wild edible mushroom Gomphus clavatus,” Journal of Medicinal Food, vol. 15, no. 2, pp. 216–221, 2012.

– M. Mayell, “Maitake extracts and their therapeutic potential—a review,” Alternative Medicine Review, vol. 6, no. 1, pp. 48–60, 2001.

– M. McIntosh, B. A. Stone, and V. A. Stanisich, “Curdlan and other bacterial (1→3)-β-D-glucans,” Applied Microbiology and Biotechnology, vol. 68, no. 2, pp. 163–173, 2005.

– M. S. Shiao, “Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions,” Chemical Record, vol. 3, no. 3, pp. 172–180, 2003.

– M. Valdez-Morales, K. Barry, G. C. Fahey Jr. et al., “Effect of maize genotype, developmental stage, and cooking process on the nutraceutical potential of huitlacoche (Ustilago maydis),” Food Chemistry, vol. 119, no. 2, pp. 689–697, 2010.

– M. Y. Yeh, W.-C. Ko, and L.-Y. Lin, “Hypolipidemic and antioxidant activity of enoki mushrooms (Flammulina velutipes),” BioMed Research International, vol. 2014, Article ID 352385, 6 pages, 2014.

– M. Zhang, S. W. Cui, P. C. K. Cheung, and Q. Wang, “Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity,” Trends in Food Science & Technology, vol. 18, no. 1, pp. 4–19, 2007.

– Manohar V, Talpur N, Echard BW, Lieberman S, Preuss HG. Effects of a water soluble extract of a mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes, Obesity and Metabolism. 2002;4:43-48.

– Matsuur H., Asakawa C., Kurimoto M., Mizutani, J. 2002. “Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa.” Bioscience, Biotechnology, and Biochemistry 66 (7): 1576-8.

– Mayell M. Maitake extracts and their therapeutic potential. Altern Med Rev. 2001;6(1):48–60.

– Mizuno T, Zhuang C. Maitake, Grifola frondosa, pharmacological effects. Food Rev Int 1995;11:135-49.

– Mohamadi A, Jarrell ST, Dadgar-Dehkordi A, Bushehri N, Shi S-J, Andrawis NS, Myers A, Clouatre D, Preuss HG. Effects of wild garlic on blood pressure and other parameters of hypertensive rats: Comparison with cultivated garlics. Heart Disease. 2000;2:3-9.

– More NS, Rao NA, Preuss HG. Early sucrose-induced retinal vascular lesions in SHR and WKY rats. Ann Lab Clin Sci. 1986;16:419-426.

– N. Armassa, O. Poungchompu, S. Rayan, S. Leethong, N. Weerapreeyakul, and S. Machana, “Antioxidant activity and cytotoxicity in breast cancer cells line of mushrooms extracts; Lentinus polychrous Lev. compared to Ganoderma lucidum (Fr.) Karst,” Isan Journal of Pharmaceutical Sciences, vol. 5, pp. 243–250, 2009.

– N. Balasundram, K. Sundram, and S. Samman, “Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses,” Food Chemistry, vol. 99, no. 1, pp. 191–203, 2006.

– N. Fangkrathok, B. Sripanidkulchai, K. Umehara, and H. Noguchi, “Bioactive ergostanoids and a new polyhydroxyoctane from Lentinus polychrous mycelia and their inhibitory effects on E2-enhanced cell proliferation of T47D cells,” Natural Product Research, vol. 27, no. 18, pp. 1611–1619, 2013.

– N. H. Chen and J.-J. Zhong, “p53 is important for the anti-invasion of ganoderic acid T in human carcinoma cells,” Phytomedicine, vol. 18, no. 8-9, pp. 719–725, 2011.

– N. Inoue, M. Inafuku, B. Shirouchi, K. Nagao, and T. Yanagita, “Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice,” Lipids in Health and Disease, vol. 12, no. 1, article 18, 2013.

– Nanba H, Hamaguchi A, Kuroda H. The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake) Chem Pharm Bull (Tokyo) 1987;35(3):1162–1168.

– Novak M, Vetvicka V. Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 2008;5:47-57.

– Novak M, Vetvicka V. Glucans as biological response modifiers. Endocr Metab Immune Disord Drug Targets 2009;9:67-75.

– O. Olaku and J. D. White, “Herbal therapy use by cancer patients: a literature review on case reports,” European Journal of Cancer, vol. 47, no. 4, pp. 508–514, 2011.

– O’Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest. 2004;114(10):1372–1378.

– Ohtskuru M, Horio H, Masui H. Angiotensin-I-converting enzylme inhibitory peptides from pepsin digest of Maitake (Grifola frondosa). Food Sci Technol Res. 2000;6:9-11.

– P. B. Flegg and G. Maw, “Mushrooms and their possible contribution to the world,” Mushroom Journal, vol. 48, pp. 395–403, 1997.

– P. Bobek, L. Ozdín, and Š. Galbavý, “Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats,” Nutrition, vol. 14, no. 3, pp. 282–286, 1998.

– P. E. Vanegas, M. E. Valverde, O. Paredes-Lopez, and J. K. Pataky, “Production of the edible fungus huitlacoche (Ustilago maydis): effect of maize genotype on chemical composition,” Journal of Fermentation and Bioengineering, vol. 80, no. 1, pp. 104–106, 1995.

– P. H. K. Ngai and T. B. Ng, “A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju,” Peptides, vol. 25, no. 1, pp. 11–17, 2004.

– P. G. Ergönül, I. Akata, F. Kalyoncu, and B. Ergönül, “Fatty acid compositions of six wild edible mushroom species,” The Scientific World Journal, vol. 2013, Article ID 163964, 4 pages, 2013.

– P. K. Ouzouni, D. Petridis, W.-D. Koller, and K. A. Riganakos, “Nutritional value and metal content of wild edible mushrooms collected from West Macedonia and Epirus, Greece,” Food Chemistry, vol. 115, no. 4, pp. 1575–1580, 2009.

– P. Kalač, “A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms,” Journal of the Science of Food and Agriculture, vol. 93, no. 2, pp. 209–218, 2013.

– P. Manzi and L. Pizzoferrato, “Beta-glucans in edible mushrooms,” Food Chemistry, vol. 68, no. 3, pp. 315–318, 2000.

– P. Mattila, K. Könkö, M. Eurola et al., “Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms,” Journal of Agricultural and Food Chemistry, vol. 49, no. 5, pp. 2343–2348, 2001.

– P. Mattila, P. Salo-Väänänen, K. Könkö, H. Aro, and T. Jalava, “Basic composition and amino acid contents of mushrooms cultivated in Finland,” Journal of Agricultural and Food Chemistry, vol. 50, no. 22, pp. 6419–6422, 2002.

– P. S. Bisen, R. K. Baghel, B. S. Sanodiya, G. S. Thakur, and G. B. K. S. Prasad, “Lentinus edodes: a macrofungus with pharmacological activities,” Current Medicinal Chemistry, vol. 17, no. 22, pp. 2419–2430, 2010.

– P. V. Hung and N. N. Y. Nhi, “Nutritional composition and antioxidant capacity of several edible mushrooms grown in the Southern Vietnam,” International Food Research Journal, vol. 19, no. 2, pp. 611–615, 2012.

– Patel, S., Goyal, A. 2012. “Recent developments in mushrooms as anti-cancer therapeutics: a review.” 3 Biotech (2012) 2:1-15. DOI 10.1007/s13205-011-0036-2.
Preuss, H., Echard, B., Bagchi, D., Perricone, N.V., Zhuang, C. 2007. “Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom.” Mol Cell Biochem (2007) 306:105-113. DOI 10.1007/s11010-007-9559-6.

– Penna C, Dean PA, Nelson H. Pulmonary metastases neutralization and tumor rejection by in vivo administration of beta glucan and bispecific antibody. Int J Cancer. 1996;65(3):377–382.

– Perricone NV, Echard B, Preuss HG. Blood pressure lowering effects of niacin-bound chromium in sucrose-fed rats: renin-angiotensin system. J Inorg Bio. 2008;102:1541-1548.

– Preuss H, Konno S. Maitake Magic. USA: Freedom Press. 2002:1-160.

– Preuss HG, Echard B, Bagchi D, et al. Enhanced insulin hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom. Mol Cell Biochem. 2007;306:105-113.

– Preuss HG, Zein M, MacArthy P, Dipette D, Sabnis S, Knapka J. Sugar-induced blood pressure elevations over the lifespan of three substrains of Wistar rats. J Amer Coll Nutr. 1998;17:36-47.

– Preuss MB, Preuss HG. Effects of sucrose on the blood pressure of various strains of Wistar rats. Lab Invest. 1980;43:101-107.

– R. A. Hakime-Silva, J. C. R. Vellosa, N. M. Khalil, O. A. K. Khalil, I. L. Brunetti, and O. M. M. F. Oliveira, “Chemical, enzymatic and cellular antioxidant activity studies of Agaricus blazei Murrill,” Anais da Academia Brasileira de Ciencias, vol. 85, no. 3, pp. 1073–1081, 2013.

– R. D. Delmanto, P. L. A. de Lima, M. M. Sugui et al., “Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide,” Mutation Research, vol. 496, no. 1-2, pp. 15–21, 2001.

– R. J. Nijveldt, E. van Nood, D. E. C. van Hoorn, P. G. Boelens, K. van Norren, and P. A. M. van Leeuwen, “Flavonoids: a review of probable mechanisms of action and potential applications,” The American Journal of Clinical Nutrition, vol. 74, no. 4, pp. 418–425, 2001.

– R. Kaneno, L. M. Fontanari, S. A. Santos, L. C. Di Stasi, E. Rodrigues Filho, and A. F. Eira, “Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice,” Food and Chemical Toxicology, vol. 42, no. 6, pp. 909–916, 2004.

– R. R. M. Paterson, “Ganoderma—a therapeutic fungal biofactory,” Phytochemistry, vol. 67, no. 18, pp. 1985–2001, 2006.

– R. S. Singh, R. Bhari, and H. P. Kaur, “Mushroom lectins: current status and future perspectives,” Critical Reviews in Biotechnology, vol. 30, no. 2, pp. 99–126, 2010.

– Rahar S, Swami G, Nagpal N, et al. Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res 2011;2:94-103.

– Reaven GM, Ho H, Hoffman BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension. 1989;14:117-120.

– Rincão VP, Yamamoto KA, Ricardo NM, et al. Polysaccharide and extracts from Lentinula edodes: structural features and antiviral activity. Virol J 2012;9:37.

– Roman BE, Beli E, Duriancik DM, et al. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res 2013;33:12-7.

– Ross GD, Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999;42(1–3):61–74.

– S. A. Heleno, L. Barros, A. Martins, M. J. R. P. Queiroz, C. Santos-Buelga, and I. C. F. R. Ferreira, “Portugal: chemical compounds with antioxidant properties,” Journal of Agricultural and Food Chemistry, vol. 60, no. 18, pp. 4634–4640, 2012.

– S. A. Heleno, L. Barros, M. J. Sousa, A. Martins, and I. C. F. R. Ferreira, “Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity,” Food Chemistry, vol. 119, no. 4, pp. 1443–1450, 2010.

– S. B. Han, C. W. Lee, J. S. Kang et al., “Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion,” International Immunopharmacology, vol. 6, no. 4, pp. 697–702, 2006.

– S. C. Hsu, C. C. Ou, J.-W. Li et al., “Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest,” Journal of Ethnopharmacology, vol. 120, no. 3, pp. 394–401, 2008.

– S. J. M. Mdachi, M. H. H. Nkunya, V. A. Nyigo, and I. T. Urasa, “Amino acid composition of some Tanzanian wild mushrooms,” Food Chemistry, vol. 86, no. 2, pp. 179–182, 2004.

– S. K. Das, M. Masuda, A. Sakurai, and M. Sakakibara, “Medicinal uses of the mushroom Cordyceps militaris: current state and prospects,” Fitoterapia, vol. 81, no. 8, pp. 961–968, 2010.

– S. M. Wong, K.-K. Wong, L. C.-M. Chiu, and P. C.-K. Cheung, “Non-starch polysaccharides from different developmental stages of Pleurotus tuber-regium inhibited the growth of human acute promyelocytic leukemia HL-60 cells by cell-cycle arrest and/or apoptotic induction,” Carbohydrate Polymers, vol. 68, no. 2, pp. 206–217, 2007.

– S. P. Wasser, “Current findings, future trends, and unsolved problems in studies of medicinal mushrooms,” Applied Microbiology and Biotechnology, vol. 89, no. 5, pp. 1323–1332, 2011.

– S. Patel and A. Goyal, “Recent developments in mushrooms as anticancer therapeutics: a review,” 3 Biotech, vol. 2, no. 1, pp. 1–15, 2012.

– S. T. Chang and P. G. Miles, Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact, CRC Press, Boca Raton, Fla, USA, 2nd edition, 2008.

– S. T. Chang and S. P. Wasser, “The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health,” International Journal of Medicinal Mushrooms, vol. 14, no. 2, pp. 95–134, 2012.

– S. Wasser, “Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides,” Applied Microbiology and Biotechnology, vol. 60, no. 3, pp. 258–274, 2002.

– S. Yu, V. Weaver, K. Martin, and M. T. Cantorna, “The effects of whole mushrooms during inflammation,” BMC Immunology, vol. 10, article 12, 2009.

– Shigama K, Nakaya A, Wakame K, et al. Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice. J Exp Ther Oncol 2009;8:43-51.

– Stamets, P. 2000. Growing Gourmet & Medicinal Mushrooms. Ten Speed Press, Berkeley, Ca.

– Stamets, P. 2005. “Notes on nutritional properties of culinary-medicinal mushrooms.” International Journal of Medicinal Mushrooms, vol. 7, p. 109-116.

– Stamets, P. 2003. “Potentiation of cell-mediated host defense using fruitbodies and mycelia of medicinal mushrooms.” International Journal of Medicinal Mushroom, vol. 5, no. 2,
p. 179-192.

– Suzuki I, Itani T, Ohno N, Oikawa S, Sato K, Miyazaki T, et al. Effect of a polysaccharide fraction from Grifola frondosa on immune response in mice. J Pharmacobiodyn. 1985;8(3):217–226.

– Suzuki I, Hashimoto K, Oikawa S, Sato K, Osawa M, Yadomae T. Antitumor and immunomodulating activities of a beta-glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull (Tokyo) 1989;37(2):410–413.

– T. B. Ng and H. X. Wang, “Pharmacological actions of Cordyceps, a prized folk medicine,” Journal of Pharmacy and Pharmacology, vol. 57, no. 12, pp. 1509–1519, 2005.

– T. C. Finimundy, G. Gambato, R. Fontana et al., “Aqueous extracts of Lentinula edodes and Pleurotus sajor-caju exhibit high antioxidant capability and promising in vitro antitumor activity,” Nutrition Research, vol. 33, no. 1, pp. 76–84, 2013.

– T. G. Pillai, C. K. K. Nair, and K. K. Janardhanan, “Enhancement of repair of radiation induced DNA strand breaks in human cells by Ganoderma mushroom polysaccharides,” Food Chemistry, vol. 119, no. 3, pp. 1040–1043, 2010.

– T. Jayakumar, M. Sakthivel, P. A. Thomas, and P. Geraldine, “Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain,” Chemico-Biological Interactions, vol. 176, no. 2-3, pp. 108–120, 2008.

– T. Takaku, Y. Kimura, and H. Okuda, “Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action,” Journal of Nutrition, vol. 131, no. 5, pp. 1409–1413, 2001.

-Takeyama T, Suzuki I, Ohno N, Oikawa S, Sato K, Ohsawa M, et al. Host-mediated antitumor effect of grifolan NMF-5N, a polysaccharide obtained from Grifola frondosa. J Pharmacobiodyn. 1987;10(11):644–651.

– Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D, Preuss HG. Effects of maitake mushroom fractions on blood pressure of Zucker Fatty Rats. Res Comm Molec Pathol Pharmacol. 2002;112:68-82.

– Talpur N, Echard B, Yasmin T, et al. Effects of niacin-bound chromium, Maitake mushroom fraction SX and hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol Cell Biochem. 2003; 252:369-377.

– Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG. Antihypertensive and antidiabetic effects of whole maitake mushroom powder and its fractions in two rat strains. Molec Pharmacol and Biol.2002;237:129-136.

– Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8(1):31–38.

– Ulbricht C, Brigham A, Bryan JK, et al. An evidence-based systematic review of active hexose correlated compound (AHCC) by the Natural Standard Research Collaboration. J Diet Suppl 2013;10:264-308.

– Ulbricht, C., Weissner, W., Basch, E., Giese, N., Hammerness, P., Rusie-Seamon, E., Varghese, M., Woods, J. “Maitake Mushroom (Grifóla frondosa): Systematic Review by the Natural Standard Research Collaboration.” Journal of the Society for Integrative Oncology, Vol. 7, No. 2, p. 66-72.

– V. Vetvicka and J.-C. Yvin, “Effects of marine β-1,3 glucan on immune reactions,” International Immunopharmacology, vol. 4, no. 6, pp. 721–730, 2004.

– Vĕtvicka V, Fornůsek L, Kopecek J, et al. Phagocytosis of human blood leukocytes: a simple micromethod. Immunol Lett 1982;5:97-100.

– Vĕtvicka V, Fornůsek L. Polymer microbeads in immunology. Biomaterials 1987;8:341-5.

– Vĕtvicka V, Holub M, Kovárů H, et al. Alpha-fetoprotein and phagocytosis in athymic nude mice. Immunol Lett 1988;19:95-8.

– Vetvicka V, Novak M. eds. Biology and Chemistry of Beta Glucan, Vol. 2, Beta-glucan, Structure, Chemistry and Specific Application. Oak Park: Bentham Science Publ., 2013.

– Vetvicka V, Sima P. β-Glucan in invertebrates. Inv Surv J 2004;1:60-5.

– Vetvicka V, Vetvickova J. An evaluation of the immunological activities of commercially available β-1,3-glucans. J Am Nutr Assoc 2007;10:25-31.

– Vetvicka V, Vetvickova J. Immune enhancing effects of WB365, a novel combination of Ashwagandha (Withania somnifera) and Maitake (Grifola frondosa) extracts. N Am J Med Sci 2011;3:320-4.

– Vetvicka V, Vetvickova J. Immunostimulating properties of two different)-β-glucans isolated from Maitake mushrooms (Grifola frondosa). JANA 2005;8:33-9.

– Vetvicka V, Vetvickova J. Physiological effects of different types of beta-glucan. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:225-31.

– Vetvicka V, Vetvickova J. β-1,3-Glucan: silver bullet or hot air? Open Glycoscience 2010;3:1-6.

– Vickers AJ. How to design a phase I trial of an anticancer botanical. J Soc Integr Oncol. 2006;4(1):46–51.

– W. L. Wong, M. A. Abdulla, K.-H. Chua, U. R. Kuppusamy, Y.-S. Tan, and V. Sabaratnam, “Hepatoprotective effects of Panus giganteus (Berk.) corner against thioacetamide-(TAA-) induced liver injury in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 170303, 10 pages, 2012.

– Williams DE, Prevost AT, Whichelow MJ, Cox BD, Day NE, Wareham NJ. A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr. 2000;83:257-266.

– Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol. 2005;35(5):1539–1547.

– Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, Rosner B, Hennekens CH. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989;80:1320-1327.

– Wong PC, Price WA Jr, Chiu AT, Ducia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB. In vivo pharmacology of DuP 753. Am J Hypertens. 1991;4:288S-298S.

– Wotecki CE, Welsh SO, Raper N, Marston RW. Recent trends and levels of dietary sugar and other caloric sweeteners. In: (ed.) Reiser S. Metabolic effects of utilizable dietary CHO. New York NY: Dekkar. 1982:1-27.

– Wu K, Bi Y, Sun K, Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol. 2007;4(4):269–275.

– Wu, M-J., Cheng, T-L., Cheng, S-Y., Lian, T-W., Wang, L., Chiou, S.Y. 2006. “Immunomodulatory Properties of Grifola frondosa in Submerged Culture.” Journal of Agricultural and Food Chemistry. 54(8):2906-14. DOI:10.1021/jf052893q.

– X.M. Wang, J. Zhang, L.-H. Wu et al., “A mini-review of chemical composition and nutritional value of edible wild-grown mushroom from China,” Food Chemistry, vol. 151, pp. 279–285, 2014.

– X. W. Zhou, K. Q. Su, and Y. M. Zhang, “Applied modern biotechnology for cultivation of Ganodermaand development of their products,” Applied Microbiology and Biotechnology, vol. 93, no. 3, pp. 941–963, 2012.

– X. W. Zhou, J. Lin, Q. Z. Li, Y. Z. Yin, X. F. Sun, and K. X. Tang, “Study progress on bioactive proteins from Ganoderma spp,” Natural Products Research Development, vol. 19, pp. 916–924, 2007.

– X. Xu, H. Yan, J. Chen, and X. Zhang, “Bioactive proteins from mushrooms,” Biotechnology Advances, vol. 29, no. 6, pp. 667–674, 2011.

– X. Zhou, J. Lin, Y. Yin, J. Zhao, X. Sun, and K. Tang, “Ganodermataceae: natural products and their related pharmacological functions,” The American Journal of Chinese Medicine, vol. 35, no. 4, pp. 559–574, 2007.

– X. Zhou, Z. Gong, Y. Su, J. Lin, and K. Tang, “Cordyceps fungi: natural products, pharmacological functions and developmental products,” Journal of Pharmacy and Pharmacology, vol. 61, no. 3, pp. 279–291, 2009.

– Y. F. Chen, W.-L. Lu, M.-D. Wu, and G.-F. Yuan, “Analysis of Taiwan patents for the medicinal mushroom “niu-Chang-Chih”,” Recent Patents on Food, Nutrition and Agriculture, vol. 5, no. 1, pp. 62–69, 2013.

– Y. K. Rao, S.-H. Fang, W.-S. Wu, and Y.-M. Tzeng, “Constituents isolated from Cordyceps militarissuppress enhanced inflammatory mediator’s production and human cancer cell proliferation,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 363–367, 2010.

– Y. Masuda, M. Inoue, A. Miyata, S. Mizuno, and H. Nanba, “Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice,” International Immunopharmacology, vol. 9, no. 5, pp. 620–626, 2009.

– Y. R. Li, Q. H. Liu, H. X. Wang, and T. B. Ng, “A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus,” Biochimica et Biophysica Acta, vol. 1780, no. 1, pp. 51–57, 2008.

– Y. Yamaguchi, E. Miyahara, and J. Hihara, “Efficacy and safety of orally administered Lentinula edodesmycelia extract for patients undergoing cancer chemotherapy: a pilot study,” American Journal of Chinese Medicine, vol. 39, no. 3, pp. 451–459, 2011.

– Young VR. Diet as a modulator of aging and longevity. Fed Proc. 1979;38:1994-2000.

– Z. B. Lin and H.-N. Zhang, “Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms,” Acta Pharmacologica Sinica, vol. 25, no. 11, pp. 1387–1395, 2004.

– Z. Wang, D. Luo, and Z. Liang, “Structure of polysaccharides from the fruiting body of Hericium erinaceus Pers,” Carbohydrate Polymers, vol. 57, no. 3, pp. 241–247, 2004.

References for Reishi Ganoderma Lucidum

– Agarwala, S. S., Glaspy, J., O’Day, S. J., Mitchell, M., Gutheil, J., Whitman, E., Gonzalez, R., Hersh, E., Feun, L., Belt, R., Meyskens, F., Hellstrand, K., Wood, D., 212 Gao et al.

– Akihisa T, Nakamura Y, Tagata M, editors. et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers. 2007;4:224–31.

– Argiles, J. M., Lopez-Soriano, F. J. (1999). The role of cytokines in cancer cachexia. Med. Res. Rev. 19:223–248.

– Aromaa M, Sillanpaa ML, Rantava P. Neurology, 1998; 50(6):1729-36.

– Bao X, Liu C, Fang J, Li X. Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum. Carbohydr Res. 2001;332:67–74.

– Bao X, Wang X, Dong Q, Fang J, Li X. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 2002;59:175–81.

– Batra P, Sharma AK, Khajuria R. Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. Int J Med Mushrooms. 2013;15(2):127–43.

– Battle, J., Ha, T. Z., Li, C. F., Dellabeffa, V., Rice, P., Kalbfleisch, J., Browder, W., Williams, D. (1998). Ligand binding to the (1-]3)-beta-D-glucan receptor stimulates NF-kappa B activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun. 249:499–504.

– Becker WJ et al. Can J Neurol Sci 2007; 34(4):S3-S9.

– Benzie I. F. F, Wachtel-Galor S. Biomarkers of long-term vegetarian diets. Adv Clin Chem. 2009;47:169–220.

– Blau JN. Lancet, 1992; 339: 1202-7.

– Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review 2007;13:265-301.

– Borchers A. T, Krishnamurthy A, Keen C. L, Meyers F. J, Gershwin M. E. The immunobiology of mushrooms. Exp Biol Med. 2008;233:259–76.

– Borchers A. T, Stern J. S, Hackman R. M, Keen C. L, Gershwin M. E. Minireview: Mushrooms, tumors and immunity. Proc Soc Exp Biol Med. 1999;221:281–93.

– Brittenden, J, Heys, S. D, Ross, J, Eremin, O. Natural killer cells and cancer. Cancer 1996;77:1226–1243.

– Brown GD. Dectin-1: a signalling non-TLR pattern recognition receptor. Nature Reviews Immunology 2006;6(1):33-43.

– Budavari S. The Merck Index. elevan. New Jersey: Merck & Co., INC; 1989. p. 845.

– Burnet, F. M. (1971). Immunological surveillance in neoplasia. Transplant. Rev. 7:3–13.

– Cady RK, Schreiber CP. Neurology, 2002; 58(6): S10-S14.

– Cao L. Z, Lin Z. B. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002;83:163–9.

– Cao Q. Z, Lin Z. B. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin. 2004;25:833–8.

– Cao Q. Z, Lin Z. B. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci. 2006;78:1457–63.

– Cao Q. Z, Lin S. Q, Wang S. Z. Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro. Beijing Da Xue Xue Bao. 2007;39:653–6.

– Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol. 1999;40:862–5.

– Chan WK, Lam DT, Law HK, Wong WT, Koo MV, Lau AS, et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. Journal of Alternative and Complementary Medicine 2005;11(6):1047-57.

– Chan WK, Law HK, Lin ZB, Lau YL, Chan GC. Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. International Immunology 2007;19(7):891-9.

– Chang, R. (1994). Effective dose of Ganoderma in humans. In: Buchanan, P. K., Hseu, R. S., Moncalvo, J. M., eds. Proc 5th Int Mycol Congr. 5th International Mycology Congress Organizing Committee. pp. 117–121. Vancouver.

– Chang, R. (1996). The central importance of the beta-glucan receptor as the basis of immunologic bioactivity of Ganoderma polysaccharides. In: Mizuno, T., Kim, B. K., eds. Seoul: II Yang Press, pp. 177 –179.

– Chang ST, Buswell JA. Int. J. Med. Mushrooms, 1999; 1 (2):139–46.

– Chang S. T, Buswell J. A. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae): A mushrooming medicinal mushroom. Int J Med Mushrooms. 1999;1:139–46.

– Chang S. T, Buswell J. A. Mushroom nutriceuticals. World J Microbiol Biotechnol. 1996;12:473–6.

– Chang S. T, Buswell J. A. Safety, quality control and regulational aspects relating to mushroom nutriceuticals. Proc. 6th Intl. Conf. Mushroom Biology and Mushroom Products. 2008:188–95. GAMU Gmbh, Krefeld, Germany.

– Chang Y. H, Yang J. S, Yang J. L, editors. et al. Ganoderma lucidum extract promotes immune responses in normal BALB/c mice in vivo. Vivo. 2009;23:755–9.

– Chen D. H, Shiou W. Y, Wang K. C, editors. et al. Chemotaxonomy of triterpenoid pattern of HPLC of Ganoderma lucidum and Ganoderma tsugae. J Chin Chem Soc. 1999;46:47–51.

– Chen HS, Tsai YF, Lin S, et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. 2004;12:5595–601.

– Chen, S. (2001). In vitro mechanism of PC-SPES. Urology 58:28– 35.

– Chen, S. et al. 2012. “Genome sequence of the model medicinal mushroom Ganoderma lucidum.” Nat. Commun. 3:913 doi: 10.1038 / ncomms1923.

– Chen T. Q, Li K. B, He X. J, Zhu P. G, Xu J. Micro-morphology, chemical components and identification of log-cultivated Ganoderma lucidum spore. Lu M, Gao K, Si H. -F, Chen M. -J. Proc ’98 Nanjing Intl Symp Science & Cultivation of Mushrooms. 1998 214. Nanjing, China. JSTC-ISMS.

– Chen Y, Bicker W, Wu J, Xie M. Y, Lindner W. Ganoderma species discrimination by dual-mode chromatographic fingerprinting: A study on stationary phase effects in hydrophilic interaction chromatography and reduction of sample misclassification rate by additional use of reversed-phase chromatography. J Chromatogr. 2010;1217(8):1255–65.

– Chen Y, Zhu S. B, Xie M. Y, editors. et al. Quality control and original discrimination of Ganoderma lucidum based on high-performance liquid chromatographic fingerprints and combined chemometrics methods. Anal Chim Acta. 2008;623:146–56.

-Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, et al. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. International Immunopharmacology 2006;6(3):499-508.

– Cheuk W, Chan JK, Nuovo G, et al. Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int J Surg Pathol 2007 Apr;15(2):180-6.

– Chien C. M, Cheng J. L, Chang W. T, editors. et al. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood. Bioorg Med Chem. 2004;12:5603–9.

– Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Statistics in Medicine 2000;19(22):3127-31.

– Chiu S. W, Wang Z. M, Leung T. M, Moore D. Nutritional value of Ganoderma extract and assessmentof its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem Toxicol. 2000;38:173–8.

– Chu TT, Benzie IF, Lam CW, et al. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br.J.Nutr. 2012;107(7):1017-1027.

– Chung W. T, Lee S. H, Kim J. D. et al. Effect of mycelial culture broth of Ganoderma lucidum on the growth characteristics of human cell lines. J Biosci Bioeng. 2001;92:550–5.

– Collins A. R. Antioxidant intervention as a route to cancer prevention. Eur J Cancer. 2005;41:1923–30.

– Cooper, M. A., Fehniger, T. A., Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. Trend Immunol. 22:633–640.

– Czop, J. K., Austen, K. F. (1985). A beta-glucan inhibitable receptor on human mono- cytes. J. Immunol. 134:2588–2593.

– Davidoff R.A. Migraine: Manifestations, Pathogenesis, and Management. 2nd Ed. Oxford University Press:1994.

– Diamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L., Springer, T. A. (1993). The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/ CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031–1043.

– Donk M. A. A conspectus of the families of Aphyllophorales. Persoonia. 1964;3:19–24.

– Du M, Wang C, Hu X. C, Zhao G. Positive effect of selenium on the immune regulation activity of lingzhi or reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae), proteins in vitro. Int J Med Mushrooms. 2008;10:337–44.

– El-Mekkawy S, Meselhy M. R, Nakamura N, editors. et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998;49:1651–7.

– Eo S. K, Kim Y. S, Lee C. K, Han S. S. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol. 1999;68:129–36.

– Eo SK, Kim YS, Lee CK, Han SS. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 2000;72:475–81.

– Evans S, Dizeyi N, Abrahamsson P. A, Persson J. The effect of novel botanical agent TBS-101 on invasive prostate cancer in animal models. Anticancer Res. 2009;29:3917–24.

– Falandysz J. Selenium in edible mushrooms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008;26(3):256–99.

– Fang Q. H, Zhong J. J. Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnol Prog. 2002;18:51–4.

– Fenichel GM. Clinical Pediatric Neurology, 1997; 3: 79-82.

– Ferrari MD. Lancet, 1998; 351: 1043-51.

– Flanagan JC. Measurement of quality of life: current state of the art. Archives of Physical Medicine and Rehabilitation 1982;63:56-9.

– Fukuzawa M, Yamaguchi R, Hide I, editors. et al. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008;31:1933–7.

– Furusawa E, Chou S. C, Furusawa S, Hirazumi A, Dang Y. Antitumour activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice. Phytother Res. 1992;6:300–4.

– Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. The Journal of Experimental Medicine 2003;197(9):1107-17.

– Gao J. J, Min B. S, Ahn E. M, Nakamura N, Lee H. K, Hattori M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull. 2002;50:837–40.

– Gao Y, Dai X, Chen G, Ye J, Zhou S. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (w.curt.:fr.) Lloyd (aphyllophoromycetideae) polysaccharides (ganopoly) in patients with advanced lung cancer. International Journal of Medicinal Mushrooms 2003;5(4):369-81.

– Gao Y, Gao H, Chan E, editors. et al. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol Invest. 2005;34:171–98.

– Gao Y. H, Sai X. H, Chen G. L, Ye J. X, Zhou S. F. A randomized, placebo-controlled, multi-center study of Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly) in patients with advanced lung cancer. Int J Med Mushrooms. 2003;5:368–81.

– Gao Y. H, Zhou S. F, Chen G. L, Dai X. H, Ye J. X. A phase I/II study of a Ganoderma lucidum (Curr.: Fr.) P. Karst. Extract (Ganopoly) in patients with advanced cancer. Int J Med Mushrooms. 2002;4:207–14.

– Gao Y. H, Zhou S. F, Jiang W. Q, Huang M, Sai X. H. Effects of Ganopoly (a Ganoderma lucidum polysaccharide extract) on immune functions in advanced-stage cancer patients. Immunol Invest. 2003;32:201–15.

– Gao Y, Lan J, Dai X, Ye J, Zhou S. A phase I/II study of Lingzhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int J Med Mushrooms. 2004;6:33–40.

– Gao Y, Tang W, Dai X, Gao H, Chen G, Ye J, et al. Effects of water-soluble Ganoderma lucidumpolysaccharides on the immune functions of patients with advanced lung cancer. Journal of Medicinal Food 2005;8(2):159-68.

– Gao Y, Tang W, Dai X, Gao H, Chen G, Ye J, et al. Immune responses to water-soluble Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) P. Karst. Polysaccharides in patients with advanced colorectal cancer. International Journal of Medicinal Mushrooms 2005;7(4):525-37.

– Gao Y, Tang W, Gao H, Chan E, Lan J, Zhou S. Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats. J Med Food. 2004;7(4):417–21.

– Gao Y, Tank W, Gao H, Lan J, Zhou S. Chemopreventive, and tumoricidal properties of Ling Zhi mushroom Ganoderma lucidum (w. Curt.:fr.) Lloyd (aphyllophoromycetideae). Part i. Preclinical and clinical studies. International Journal of Medicinal Mushrooms 2004;6(2):95-106.

– Gao Y, Zhou S. Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties. Food Rev Int. 2009;19:275–325.

– Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidumpolysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunological Investigations 2003;32(3):201-15.

– Gibbs, J. B. (2000). Mechanism-based target identification and drug discovery in cancer research. Science 287:1969– 1973.

– Gill SK. Rieder MJ. Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer. Canadian Journal of Clinical Pharmacology 2008;15(2):e275-85.

– Gilmour H, Wilkins K. Migraine. Health Reports (Statistics Canada, Catalogue 82-003), 2001; 12(2): 23- 40.

– Gonzalez A. G, Leon F, Rivera A, Munoz C. M, Bermejo J. Lanostanoid triterpenes from Ganoderma lucidum. J Nat Prod. 1999;62:1700–1.

– Gordan JD, Chay WY, Kelley RK, et al. “And what other medications are you taking?”. J.Clin.Oncol. 4-10-2011;29(11):e288-e291.

– Goto, S., Sato, M., Kaneko, R., Itoh, M., Sato, S., Takeuchi, S. (1999). Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol. Immunother. 48:435– 442.

– Gottlieb A. M, Ferref E, Wright J. E. rDNA analyses as an aid to the taxonomy of species of Ganoderma. Mycol Res. 2000;104:1033–45.

– Gottlieb A. M, Saidman B. O, Wright J. E. Isoenzymes of Ganoderma species from southern South America. Mycol Res. 1998;102:415–26.

– Grunfeld E, Gresty MA. Brain Res Bull, 1998; 47(5): 433-6.

– Habijanic J, Berovic M. The relevance of solid-state substrate moisturing on Ganoderma lucidum biomass cultivation. Food Technol Biotechnol. 2000;38:225–8.

– Haniadka R, Popouri S, Palatty PL, et al. Medicinal plants as antiemetics in the treatment of cancer: a review. Integr.Cancer Ther. 2012;11(1):18-28.

– Haralampidis K, Trojanowska M, Osbourn A. E. Biosynthesis of triterpenoid saponins in plants. Adv Biochem Eng Biotechnol. 2002;75:31–49.

– Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2005;25:3443-57.

– Harhaji Trajkovic LM, Mijatovic SA, Maksimovic-Ivanic DD, et al. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo. Nutr Cancer. 2009;61:696–707.

– Haslett, P. A. J. (1998). Anticytokine approaches to the treatment of anorexia and cachexia. Semin. Oncol. 25:53–57.

– He W, Yi J. Study of clinical efficacy of Lingzhi spore capsule on tumour patients with chemotherapy/radiotherapy. Clinical Journal of Traditional Chinese Medicine 1997;9(6):292-3.

– Headache Classification Committee of the International Headache Society. Cephalalgia, 1988; 8 (Suppl 7): 1-96.

– Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011.

– Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring Inconsistency in meta analyses. BMJ2003;327:557-60.

– Hijikata Y, Yamada S. Effect of Ganoderma lucidum on postherpetic neuralgia. Am J Chin Med. 1998;26:375–81.

– Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med. 2007;13:985–7.

– Hikino H, Ishiyama M, Suzuki Y, Konno C. Mechanisms of hypoglycemic activity of ganoderan B: A glycan of Ganoderma lucidum fruit body. Planta Med. 1989;55:423–8.

– Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planata Med. 1985;4:339–40.

– Ho Y. W, Yeung J. S, Chiu P. K, Tang W. M, Lin Z. B, Man R. Y, Lau C. S. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast. Mol Cell Biochem. 2007;301:173–9.

– Hobbs Ch. Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture, 2nd Ed.; Botanica Press, Inc; Santa Cruz, CA, USA:1995.

– Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, et al. Mechanism by which orally administered beta-1-3-glucans enhance the tumoricidal activity of antitumour monoclonal antibodies in murine tumour models. The Journal of Immunology 2004;173(2):797-806.

– Hong K. J, Dunn D. M, Shen C. L, Pence B. C. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res. 2004;18:768–70.

– Hseu R. S, Wang H. H, Wang H. F, Moncalvo J. M. Differentiation and grouping of isolates of Ganoderma lucidum complex by random amplified polymorphic DNA-PCR compared with grouping on the basis of internal transcribed spacer sequences. Appl Environ Microbiol. 1996;62:1354–63.

– Hsiao W. L, Li Y. Q, Lee T. L, Li N, You M. M, Chang S. T. Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis. 2004;25:1177–83.

– Hu H, Ahn N. S, Yang X, Lee Y. S, Kang K. S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 2002;102:250–3.

– Huang J, Zhong X, Li G. Therapeutic effect of mixture Lingzhi with CD3/NK cell on lung cancer. Modern Journal of Integrated Traditional Chinese and Western Medicine 2001;10(8):704-5.

– Hwang, S. F., Liu, K. J., Kuan, Y. H., Tung, K. S., Su, C. H., Tung, T. C. (1989). The inhibitory effect on artificial pulmonary metastasis of murine S-180 sarcoma cells by orally administered Ganoderma lucidum culture broth. J. Chin. Oncol. Soc. 5:10–15.

– Hyun J. W, Choi E. C, Kim B. K. Studies on constituents of higher fungi of Korea (LXVII), antitumor components of the basidiocarp of Ganoderma lucidum. Korean J Mycol. 1990;18:58–69.

– Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol. 2007;112:445–50.

– Jia HQ, Wu SH, Wu J. Clinical analysis of Lingzhi spore in prostate cancer treatment. Andrology2005;9(4):18-9.

– Jia J, Zhang X, Hu Y. S, editors. et al. Evaluation of in vivo antioxidant activities of Ganoderma lucidum poly- saccharides in STZ-diabetic rats. Food Chem. 2009;115:32–6.

– Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med. 2008;21:577–84.

– Jiang J, Slivova V, Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol. 2006;29:695–703.

– Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 2004;24:1093–9.

– Jing J, Zhu X, Li B, Jie Y. Clinical comparative investigation of Bailong capsule and liquid in combination with chemotherapy for digestive tumor. Shanxi Medical Journal 2007;36(7):631-3.

– Jin X, Ruiz Beguerie J, Sze DM, et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane. Database. Syst. Rev. 2012;6:CD007731.

– Johnston N. Medicinal mushroom cuts off prostate cancer cells’ blood supply. Drug Discov Today. 2005;10:1584.

– Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Advances in Applied Microbiology 1992;37:101-34.

– Jovic, V., Konjevic, G., Radulovic, S., Jelic, S., Spuzic, I. (2001). Impaired perforin- dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma. Tumori 87:324–329.

– Kabir Y, Kimura S, Tamura T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats. J Nutr Sci Vitaminol. 1988;34:433–8.

– Kawagishi H, Mitsunaga S. I, Yamawaki M, editors. et al. A lectin from mycelia of the fungus Ganoderma lucidum. Phytochemistry. 1997;44:7–10.

– Kelman L. Cephalalgia, 2007; 27(5): 394-402.

– Kempf, R. A., Mitchell, M. S. (1985). Effects of chemotherapeutic agents on the immune response. II. Cancer Investig. 3:23–33.

– Kenneth F Schulz, Douglas G Altman, David Moher. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine. 15-Feb-2011;154(4):290-1.

– Keypour S, Riahi H, Moradali M. F, Rafati H. Investigation of the antibacterial activity of a chloroformextract of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) Int J Med Mushrooms. 2008;10(4):345–9.

– Kim B. K, Chung H. S, Chung K. S, Yang M. S. Studies on the antineoplastic components of Korean basidiomycetes. Korean J Mycol. 1980;8:107–13.

– Kim D. H, Shim S. B, Kim N. J, Jang I. S. β-Glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull. 1999;22:162–4.

– Kim H. M, Park M. K, Yun J. W. Culture pH affects exopolysaccharide production in submerged mycelial culture of Ganoderma lucidum. Appl Biochem Biotechnol. 2006;134:249–62.

– Kim HW, Kim BK. Int. J. Med. Mushrooms, 1999; 1 (2): 121–38.

– Kim K. C, Kim J. S, Son J. K, Kim I. G. Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts. Cancer Lett. 2007;246:210–17.

– Kim S. D, Nho H. J. Isolation and characterization of alpha-glucosidase inhibitor from the fungus Ganoderma lucidum. J Microbiol. 2004;42:223–7.

– Kim Y. S, Eo S. K, Oh K. W, Lee C. K, Han S. S. Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with interferons. J Ethnopharmacol. 2000;72:451–8.

– Kimura Y, Taniguchi M, Baba K. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: Mechanism of action and isolation of an active substance. Anticancer Res. 2002;22:3309–18.

– Kirkwood, J. M., Gehlsen, K. R., Naredi, P. (2002). Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J. Clin. Oncol. 20:125–133.

– Kishida, E., Okuda, R., Sone, Y., Misaki, A. (1988). Fractionation structures and antitumor activities of the polysaccharides of Reishi, the fruiting body of Ganoderma lucidum. Osaka Shiritsu Daigaku Seikatsu Kagakubu Kiyo 35:1–10.

– Kolesnikova O. P, Tuzova M. N, Kozlov V. A. Screening of immunoactive properties of alkanecarbonic acid derivatives and germanium-organic compounds in vivo. Immunologiya. 1997;10:36–8.

– Konopski, Z., Smedsrod, B., Seljelid, R., Eskeland, T. (1994). A novel immunomodulator soluble aminated b-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages. Biochim. Biophys. Acta, Mol. Cell Res. 1221:61 –65.

– Krasowska D, Schwartz RA, Wojnowska D, Maćkiewicz B, Czelej D. Polymorphous cutaneous and chronic multisystem sarcoidosis. Acta Dermatovenerol Alp Pannonica Adriat. 2008;17:26–30.

– Kuang J, Wang J, Kuang J. Investigation of effectiveness of Sporoderm-Broken Lingzhi spore powder in conjunction with chemotherapy on malignant tumour. Shangdong Medical Journal2007;47(21):59-60.

– Kubota T, Asaka Y, Miura I, Mori H. Structures of ganoderic acids A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv Chim Acta. 1982;65:611–9.

– Kuo M. C, Weng C. Y, Ha C. L, Wu M. J. Ganoderma lucidum mycelia enhance innate immunity by activating NF-kappaB. J Ethnopharmacol. 2006;103:217–22.

– Kwong WJ, Pathak DS. Cephalalgia, 2007; 27(4): 336-42.

– Lakshmi B, Ajith T. A, Jose N, Janardhanan K. K. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol. 2006;107(2):297–303.

– Lambert J, Carides GW, Meloche JP, et al. Can J Clin Pharmacol, 2002; 9(3): 158-64.

– Lanzi G, Balottin U, Ottolini A, Rosano Burgio F, et al. Cephalalgia, 1983; 3(2):115-8.

– Lauerova, L., Dusek, L., Simickova, M., Kocak, I., Vagundova, M., Zaloudik, J., Kovarik, J. (2002). Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response. Neoplasma 49:159–166.

– Lee J. M, Kwon H, Jeong H, editors. et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 2001;15:245–9.

– Lee, J. O., Rieu, P., Arnaout, M. A., Liddington, R. (1995a). Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80:631–638.

– Lee K. M, Lee S. Y, Lee H. Y. Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. J Biosci Bioeng. 1999;88:646–50.

– Lee S, Park S, Oh JW, Yang C. Natural inhibitors for protein prenyl transferase. Planta Medica1998;64:303-8.

– Lee S. S, Wei Y. H, Chen C. F, Wang S. Y, Chen K. Y. Antitumor effects of Ganoderma lucidum. J Chin Med. 1995;6:1–12.

– Leng K, Lu M. Investigation of ZhengQing Lingzhi liquid as adjuvant treatment on patients with colon cancer. Journal of Guiyang Medical College 2003;28(5):1.

– Li C. H, Chen P. Y, Chang U. M, editors. et al. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 2005;77:252–65.

– Li EK, Tam LS, Wong CK et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis Rheum 2007 Oct 15;57(7):1143-50.

– Li G, Cheng H. A Clinical Study on Immunity Regulation Function of Shenqi Lingzhi Regimen on Tumour Patients. Forum On Traditional Chinese Medicine 2000;15(6):29-30.

– Li Y. Clinical investigation of immunological indications of hematological malignancy. Journal of Guangxi Medical College 2000;17(2):54-6.

– Li Y. Q, Wang S. F. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 2006;28(11):837–41.

– Li Z, Liu J, Zhao Y. Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Biochem Mol Biol. 2005;38(1):34–40.

– Liang J, Li Y, Wang S. Effect of radiotherapy combined with a medicine Lingzhi-912 on treatment of esophageal cancer. Journal of The Forth Military Medical University 2002;23(3):278-80.

– Lin J. M, Lin C. C, Chen M. F, Ujiie T, Takada A. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganodermalucidum and Ganoderma neo-japonicum. J Ethnopharmacol. 1995;47:33–41.

– Lin S. B, Li C. H, Lee S. S, Kan L. S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing proteinkinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci. 2003;72:2381–90.

– Lin S. C. Beijing, China: Chinese Agricultural Press; Medicinal Fungi of China-Production and Products Development. 2000

– Lindequist U, Niedermeyer T. H, Jülich W. D. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285–99.

– Lindequist U, Rausch R, Fussel A, et al. [Higher fungi in traditional and modern medicine]. Med.Monatsschr.Pharm. 2010;33(2):40-48.

– Lipton RB, Silberstein SD, Stewart WF. Headache, 1994; 34: 319–28.

– Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Headache, 2001; 41: 646–57.

– Liu J, Shimizu K, Konishi F, editors. et al. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum. Food Chem. 2007a;100:1691–6.

– Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorg Med Chem. 2007b;15:4966–72.

– Liu J, Shiono J, Shimizu K, et al. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg.Med.Chem.Lett. 4-15-2009;19(8):2154-2157.

– Liu J, Yang F, Ye L. B, Yang X. J, Timani K. A, Zheng Y, Wang Y. H. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Ethnopharmacol. 2004;95:265–72.

– Liu K. C, Phounsavan S. F, Huang R. L, Liao C, Hsu S. Y, Wang K. J. Pharmacological and liver functional studies on mycelium of Ganoderma lucidum. Chin Pharm J. 1998;40:21–9.

– Liu X, Yuan J. P, Chung C. K, Chen X. J. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett. 2002;182:155–61.

– Liu Y. W, Gao J. L, Guan J, Qian Z. M, Feng K, Li S. P. Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem. 2009;57:3087–93.

– Lu Q. Y, Jin Y. S, Zhang Q, editors. et al. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 2004;216:9–20.

– Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep. 2003;10:375–9.

– Lu H, Uesaka T, Katoh O, Kyo E. Watanabe H. Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep. 2001;8:1341–5.

– Ma C, Guan S. H, Yang M, Liu X, Guo D. A. Differential protein expression in mouse splenic mononuclear cells treated with polysaccharides from spores of Ganoderma lucidum. Phytomedicine. 2008;15:268–76.

– Ma J, Ye Q, Hua Y, editors. et al. New lanostanoids from the mushroom Ganoderma lucidum. J Nat Prod. 2002;65:72–5.

– Ma MQ. Immunomodulatory effects of Chen-Ling anti-tumour capsule on tumour patients. China’s Naturopathy 2003;11(8):38-9.

– Mahajna J, Dotan N, Zaidman BZ, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutrition & Cancer61;1:16-26.

– Mahato S. B, Sen S. Advances in triterpenoid research, 1990-1994. Phytochemistry. 1997;44:1185–236.

– Mao T, Van de Water J, Keen C. L, Stem J. S, Hackman R, Gershwin M. E. Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int J Immunother. 1999;15:13–22.

– Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ et al. Headache, 2000; 40: 204– 15.

– Mashour N. K, Lin G. I, Frishman W. H. Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Arch Intern Med. 1998;158:2225–34.

– Mathew NT. Neurol Clin, 1997; 15(1): 167-86.

– Matthews WB. Br Med J, 1972; 2:326-7.

– Mau J. L, Lin H. C, Chen C. C. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem. 2002;50:6072–7.

– Mau J. L, Lin H. C, Chen C. C. Non-volatile components of several medicinal mushrooms. Food Res Int. 2001;34:521–6.

– Mayzumi F, Okamoto H, Mizuno T. Cultivation of Reishi. Food Rev Int. 1997;13:365–73.

– McKenna DJ, Jones K, Hughes K. Reishi Botanical Medicines. The Desk reference for Major Herbal Supplements. 2nd Ed., New York, London, Oxford; The Haworth Herbal Press: 2002; 825–55.

– McMeekin D. The perception of Ganoderma lucidum in Chinese and Western culture. Mycologist. 2005;18:165–9.

– Mihich, E., Fefer, A. (1983). Biological response modifiers: subcommittee report. NCI Monogr. 63.

– Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer1981;47:207-14.

– Min B. S, Gao J. J, Nakamura N, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull. 2000;48:1026–33.

– Min B. S, Nakamura N, Miyashiro H, Bae K. W, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. 1998;46:1607–12.

– Mino Y, Ota N, Sakao S, Shi momura S. Determination of germanium in medicinal plants by atomic absorption spectrometry with electrothermal atomization. Chem Pharm Bull. 1980;28:2687–91.

– Miura T, Yuan L, Sun B, editors. et al. Isoflavone aglycon produced by culture of soybean extracts with basidiomycetes and its anti-angiogenic activity. Biosci Biotechnol Biochem. 2002;66:2626–31.

– Miyazaki T, Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull. 1981;29:3611–16.

– Mizuno, T. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev. Int. 1995, 11 (1), 151–66.

– Mo H, Hong M, Zhang J. Effect of Wuse – Lingzhi – Jiaonang on reducing side-effects of radiotherapy and improving immune function in patients with nasopharyngeal cancer. Chinese Journal of Clinical Oncology 1999;26(3):216-8.

– Moche MJ, Glassman SJ, Modi D, Grayson W. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature. Clin Exp Dermatol. 2010;35:399–402.

– Moncalvo JM., Ryvarden LA. Nomenclatural study of the Ganodermataceae Donk; Synopsis Fungorum 11; Fungiflora: Oslo, Norway, 1997; 114.

– Moncalvo J. M. Systematics of Ganoderma. In: Ganoderma Diseases of Perennial Crops. Wallingford, UK: CAB International; 2000. pp. 23–45.

– Moncalvo, J.M., Wang, H.F., and Hseu, R.S. 1995. Gene phylogeny of the Ganoderma lucidum complex. Comparison with traditional taxonomic characters. Mycological Research 99:1489-1499.

– Moncalvo J. M, Wang H. F, Wang H. H, Hseu R. S. The use of rDNA nucleotide sequence data for species identification and phylogeny in the Ganodermataceae. In: Ganoderma: Systematics. Phytopathology and Pharmacology. Taipei: Department of Agricultural Chemistry, National Taiwan University; 1995.

– Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R., Moretta, A. (2002). Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 32:1205–1211.

– Mueller, A., Raptis, J., Rice, P. J., Kalbfleisch, J. H., Stout, R. D., Ensley, H. E., Browder, W., Williams, D. L. (2000). The influence of glucan polymer structure and solution conformation on binding to (1- > 3)-beta-D-glucan receptors in a human monocyte-like cell line. Glycobiology 10:339–346.

– Muller, A., Rice, P. J., Ensley, H., Coogan, P. S., Kalbfleisch, J. H., Kelley, J. L., Love, E. J., Portera, C. A., Ha, T. Z., Browder, I. W., Williams, D. L. (1996). Receptor binding and internalization of a water-soluble (1-]3)-beta-D-glucan biologic response modifier in two monocyte macrophage cell lines. J. Immunol. 156:3418–3425.

– Muller C. I, Kumagai T, O’Kelly J, Seeram N. P, Heber D, Koeffler H. P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res. 2006;30:841–8.

– Nishitoba T, Sato H, Kasai T, Kawagishi H, Sakamura S. New bitter C27 and C30 terpenoids from fungus Ganoderma lucidum (Reishi) Agric Biol Chem. 1984;48:2905–7.

– Niu Z. Observation of 30 cases of advanced malignant tumours treated by Zhonghua Lingzhi Bao. Shanxi Oncology Medicine 2002;10(3):225-6.

– Nonaka Y, Shibata H, Nakai M, editors. et al. Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci Biotechnol Biochem. 2006;70:2028–34.

– Oh K. W, Lee C. K, Kim Y. S, Eo S. K, Han S. S. Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and incombination with Acyclovir and Vidarabine. J Ethnopharmacol. 2000;72:221–7.

– Ohno N, Miura N. N, Sugawara N, Tokunaka K, Kirigaya N, Yadomae T. Immunomodulation by hot water and ethanol extracts of Ganoderma lucidum. Pharm Pharmacol Lett. 1998;4:174–7.

– Olaku O and White JD. Herbal therapy use by cancer patients: a literature review on case reports. Eur.J.Cancer 2011;47(4):508-514.

– Oncology Nursing Society (ONS). Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. Oncology Nursing Society, 2005.

– Ooi V. E, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000;7:715–29.

– Pan S, Sun W. The clinical efficacy study of ginseng and Ganoderma lucidum essence – reinforcing pills combine with chemotherapy for malignant tumours. Liaoning Journal of Traditional Chinese Medicine 2007;34(10):1411-3.

– Park E. J, Ko G, Kim J, Dong H. S. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, Glycyrrhizin, and Pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull. 1997;20:417–20.

– Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Japanese Journal of Clinical Oncology 2003;33(10):533-7.

– Paterson R. R. Ganoderma-a therapeutic fungal biofactory. Phytochemistry. 2006;67(18):1985–2001.

– Patrick T, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute2000;92:205-16.

– Paulsen, B. S. (2001). Plant polysaccharides with immunostimulatory activities. Curr. Org. Chem. 5:939–950.

– Pryse-Phillips WEM, Dodick DW, Edmeads JG, Gawel MJ, Nelson R F, Purdy RA, Robinson G, Stirling D, Worthington I. CMAJ, 1997;156:1273-87.

– Pryse-Phillips WEM, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, Robinson G, Stirling D, Worthington I. CMAJ ,1998;159:47-54.

– Qi Y, Li X, Yan M, Liu A, Jiao Z, Liu H. Clinical investigation of Lingzhi spore powder in adjuvant treatment of digestive tumours. Chinese Journal of Integrated Traditional and Western Medicine1999;19(9):554-5.

– Raskin NH. Headache, (2nd Edition). New York: Churchill-Livingstone:1988

– Ratain, M. J. (1997). Pharmacology of cancer chemotherapy. In: DeVita, V. T., Hellman, S., Rosenberg, S. A., eds. Philadelphia: Lippincott-Raven Publishers, pp. 375–509.

– Ratain, M. J., Relling, M. V. (2001). Gazing into a crystal ball—cancer therapy in the post-genomic era. Nat. Med. 7:283–285.

– Riu H, Roig G, Sancho J. Production of carpophores of Lentinus edodes and Ganoderma lucidum grown on cork residues. Microbiologia SEM. 1997;13:185–92.

– Robertson, M. J., Ritz, J. (1990). Biology and clinical relevance of human natural killer cells. Blood 12:2421–2438.

– Ryvarden L. Can we trust morphology in Ganoderma? Buchanan P. K, Hseu R. S, Moncalvo J. M. Ganoderma: Systematics, Phytopathology and Pharmacology. Proceedings of Contributed Symposium. 1994:19–24. 59A, B 5th International Mycological Congress August 14-21 1994.

– Sadava D, Still D. W, Mudry R. R, Kane S. E. Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Lett. 2009;277:182–9.

– Saltarelli R, Ceccaroli P, Iotti M, editors. et al. Biochemical characterisation and antioxidant activity of mycelium of Ganoderma lucidum from Central Italy. Food Chem. 2009;116:143–51.

– Sanodiya B. S, Thakur G. S, Baghel R. K, Prasad G. B, Bisen P. S. Ganoderma lucidum: A potent pharmacological macrofungus. Curr Pharm Biotechnology. 2009;10(8):717–42.

– Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Roman, J., Pecorelli, S., Cannon, M., Parham, G. P. (2000). Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 48:997–1006.

– Sato H, Nishitoba T, Shirasu S, Oda K, Sakamura S. Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi) Agric Biol Chem. 1986;50:2887–90.

– Schoch, C.L., Seifert, K.A., Huhndorf, S., Robert, V., Spouge, J.L., André Levesque, C., Chen, W., and Fungal Barcoding Consortium. 2012. “Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi.” Proc Natl Acad Sci. 109(16): 6241-6246.

– See, D., Mason, S., Roshan, R. (2002). Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol. Invest. 31:137–153.

– Seto SW, Lam TY, Tam HL, et al. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009;16:426–36.

– Shang D, Zhang J, Wen L, Li Y, Cui Q. Preparation, characterization, and antiproliferative activities of the Se-containing polysaccharide SeGLP-2B-1 from Se-enriched Ganoderma lucidum. J Agric Food Chem. 2009;57:7737–42.

– Sheena M, Ajith A, Janardhanan K. Prevention of nephrotoxicity induced by the anticancer drug Cisplatin, using Ganoderma lucidum, a medicinal mushroom occuring in South India. Curr Sci. 2003;85:478–82.

– Sheftell FD. Neurol Clin, 1997; 15(1):187-97.

– Sheng Zheng, Yanping Jia, Jun Zhao, Qun Wei, Yuehua Liu. Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells. Oncology Letters December 6, 2011;3(3):613-616.

– Shi X. M, Zhang J. S, Tang Q. J, Yang Y, Hao R. X, Pan Y. J. Fingerprint analysisof lingzhi (Ganoderma) strains by high-performance liquid chromatography coupled with chemometric methods. World J Microbiol Biotechnol. 2008;24:2443–50.

– Shi Y. L, James A. E, Benzie I. F, Buswell J. A. Mushroom-derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA. Teratog Carcinog Mutagen. 2002;22:103–11.

– Shi Y, Sun J, He H, Guo H, Zhang S. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. J Ethnopharmacol. 2008;117:415–19.

– Shieh Y. H, Liu C. F, Huang Y. K, Yang J. Y, Wu I. L, Lin C. H, Lin S. C. Evaluation of the hepatic and renal protective effects of Ganoderma lucidum in mice. Am J Chin Med. 2001;29:501–7.

– Silberstein SD. Neurology, 2000; 55: 754–62.

– Sillanpaa M. Headache, 1976; 15: 288–90.

– Simone C.B., Simone N.L., Simone V., Simone C.B. 2007. “Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2.” Altern Ther Health Med. 13(2):40-47.

– Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi) Mini Rev Med Chem. 2004;4:873–9.

– Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integrative Cancer Therapies2003;2(4):358-64.

– Sliva D. Ganoderma lucidum in cancer research. Leukemia Research 2006;30(7):767-8.

– Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd F. P Jr, Ho N. W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun. 2002;298:603–12.

– Sliva D, Loganathan J, Jiang J, et al. Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS.One. 2012;7(10):e47873.

– Small, E. J., Frohlich, M. W., Bok, R., Shinohara, K., Grossfeld, G., Rozenblat, Z., Kelly, W. K., Corry, M., Reese, D. M. (2000). Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J. Clin. Oncol. 18:3595 –3603.

– Solomon PW. Reishi or Ling Zhi (Ganoderma lucidum). Encyclopedia of Dietary Supplements DOI: 10.1081/E-EDS-120022119, Marcel Dekker: 2005

– Solomon S. Headache, 1998; 38:772-8.

– Sone, Y., Okuda, R., Wada, N., Kishida, E., Misaki, A. (1985). Structural and anti-tumor activities of polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agr. Biol. Chem. 49:2641–2653.

– Song C. H, Yang B. K, Ra K. S, Shon D. H, Park E. J, Go G. I, Kim Y. H. Hepatoprotective effect of extracellular polymer produced by submerged culture of Ganoderma lucidum WK-003. J Microbiol Biotechnol. 1998;8:277–9.

– Song Y. S, Kim S. H, Sa J. H, Jin C, Lim C. J, Park E. H. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol. 2004;90:17–20.

– Song Z, Cong Z, Wei J. Clinical investigation of Bozhi glycopeptide injection combined with chemotherapy for advanced-stage malignancy. Journal of Nantong University (Medical Sciences)2006;26(6):474-5.

– Stamets. P., 1993. Growing Gourmet & Medicinal Mushrooms. Ten Speed Press, Berkeley, Ca.

– Stamets, P. 2008. U.S. Patent Application # 12/284,646. “Antiviral and Antibacterial Activity from Medicinal Mushrooms.” Filed September 24.

– Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun. 2005;330:46–52.

– Steward BW, Kleihues P, World Health Organization. World Cancer Report 2003. IARC Press, 2003.

– Su C. H, Yang Y. Z, Ho H, Hu C. H, Sheu M. T. High-performance liquid chromatographic analysis for the characterization of triterpenoids from Ganoderma. J Chromatogr Sci. 2001;39:93–100.

– Suay, I., F. Arenal, F. Asenio, A. Basilio, M. Cabello, M. T. Diez, J. B. Garcia, A. Gonzalez del Val, J. Gorrochategui, P. Hernandez, F. Pelaez, and M. F. Vicente. 2000. “Screening of basidiomycetes for antimicrobial activities.” Antonie van Leeuwenhoek 78:129-139.

– Sun J, He H, Xie B. J. Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem. 2004;52:6646–52.

– Sun S. J, Gao W, Lin S. Q, Zhu J, Xie B. G, Lin Z. B. Analysis of genetic diversity in Ganoderma populations with a novel molecular marker SRAP. Appl Microbiol Biotechnol. 2006;72:537–43.

– Tang W, Liu J. W, Zhao W. M, Wei D. Z, Zhong J. J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006;80:205–11.

– Teow Sun Soo. Mushroom Biology and mushroom products, Royse (ed.). 1996. Penn State Univ. ISBN 1- 883956-01-3: 1996

– Tepper SJ, Dahlof CG, Dowson A, et al. Headache, 2004; 44(9): 856-64.

– Thakur A, Rana M, Lakhanpal T. N, Ahmad A, Khan M. I. Purification and characterization of lectin from fruiting body of Ganoderma lucidum: Lectin from Ganoderma lucidum. Biochim Biophys Acta. 2007;1770:1404–12.

– The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004; 24 (1): 1-152.

– The State Pharmacopoeia Commission of P. R. China. State Pharmacopoeia Commission of the People’s Republic of China. Beijing, China: Chemical Industry Press; 2000.

– Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., Ross, G. D. (1996). Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site

of complement receptor type 3 (CD11b/CD18). J. Immunol. 156:1235–1246.

– Tomasi S, Lohezic-Le D. F, Sauleau P, Bezivin C, Boustie J. Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie. 2004;59:290–3.

– Tomoda M, Gonda R, Kasahara Y, Hikino H. Glycan structures of ganoderans B and C, hypoglycemic glycans of Ganoderma lucidum fruit bodies. Phytochemistry. 1986;25:2817–20.

– Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. (2002). Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer. 87:21 –27.

– Upton R. American Herbal Pharmacopeia and Therapeutic Compendium: Reishi Mushroom, Ganoderma lucidum. Standards of Analysis, Quality Control, and Therapeutics. U.S.A. Canada: Santa Cruz; 2000.

– Usui, T., Iwasaki, Y., Hayashi, K., Mizuno, T., Tanaki, M., Shinkai, K., Arakawa, M. (1981). Antitumor activity of water-soluble beta-D-glucan elaborated by Gano- derma applanatum. Agr. Biol. Chem. 45:323–326.

– Usui, T., Iwasaki, Y., Mizuno, T., Tanaki, M., Shinkai, K., Arakawa, M. (1983). Isolation and characterization of antitumor active beta-D-glucans from the fruit bodies of Ganoderma applanatum. Carbohyd. Res. 115:273–280.

– Van Der Hem L, Van Der Vliet A, Bocken C. F. M, Kino K, Hoitsma A. J, Tax W. J. M. Lingzhi-8: Studies of a new immunomodulating agent. Transplantation. 1995;60:438–43.

– Vickers, A. (2000). Recent advances: complementary medicine. Br. Med. J. 321:683 –686.

– Villegas, F. R., Coca, S., Villarrubia, V. G., Jimenez, R., Chillon, M. J., Jareno, J., Zuil, M., Callol, L. (2002). Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 35:23 –28.

– Wachtel-Galor S, Buswell J. A, Tomlinson B, Benzie I. F. F. Lingzhi polyphorous fungus. In: Herbal and Traditional Medicine: Molecular Aspects of Health. New York: Marcel Dekker Inc; 2004. pp. 179–228.

– Wachtel-Galor S, Choi S. W, Benzie I. F. F. Effect of Ganoderma lucidum on human DNA is dose dependent and mediated by hydrogen peroxide. Redox Rep. 2005;10(3):145–9.

– Wachtel-Galor S, Szeto Y. T, Tomlinson B, Benzie. F I. F. Ganoderma lucidum (Lingzhi): Acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. 2004;1:75–83.

– Wang G, Zhao J, Liu J, Huang Y, Zhong J. J, Tang W. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol. 2007;7:864–70.

– Wang H, Ng T. B. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides. 2006;27:27–30.

– Wang H, Ng T. B, Ooi V. E. C. Lectins from mushrooms. Mycol Res. 1998;102:897–906.

– Wang HJ, Zhang H. Clinical research of Lingzhi in cancer treatment. Journal of Dalian Medical College 1999;21(1):29-31.

– Wang JW. Observation on the side effect of “Gloosy Ganoderma Spores Powder” combined with Qining injection in the treatment of 28 patients with malignant tumor and nursing care. Journal of Qilu Nursing 2005;13(17):1-2.

– Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S., Ho, C. K. (1997). The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 70:699 –705.

– Wang Y. Y, Khoo K. H, Chen S. T, Lin C. C, Wong C. H, Lin C. H. Studies on the immunomodulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: Functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem. 2002;10:1057–62.

– Wanmuang H, Leopairut J, Kositchaiwat C, et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai 2007 Jan;90(1):179-81.

– Wasser S. P, Coates P, Blackman M, Cragg G, Levine M, Moss J, White J. Encyclopedia of Dietary Supplements. New York: Marcel Dekker; 2005. Reishi or Lingzhi (Ganoderma lucidum) pp. 680–90.

– Wasser SP, Weis AL. Medicinal Mushrooms. Ganoderma lucidum, (Curtis: Fr.), P. Karst; Nevo, E., Eds.; Peledfus Publ House: Haifa, Israel, 1997; 39.

– Wasser S. P, Weis A. L. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: Current perspectives. Int J Med Mushrooms. 1999;1:31–62.

– Wasser, S. P., Weis, A. L. (1999). Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol. 19:65 –96.

– Wasson, R.G. 1968 Soma: Divine Mushroom of Immortality, Harcourt Brace Jovanovich Inc.; Los Angeles, USA, pp. 80-92.

– Wen H, Kang S, Song Y, Song Y, Sung S. H, Park S. Differentiation of cultivation sources of Ganoderma lucidum by a NMR-based metabolomics approach. Phytochem Anal. 2010;21:73–9.

– Weng C. J, Chau C. F, Yen G. C, Liao J. W, Chen D. H, Chen K. D. Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem. 2009;57:5049–57.

– Werner, G. H., Jolles, P. (1996). Immunostimulating agents—what next—a review of their present and potential medical applications. Eur. J. Biochem. 242:1–19.

– WHO (World Health Organization). Mortality Statistics. 2008. World Health Report.

– Wicks SM, Tong R, Wang CZ, et al. Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med 2007;35(3):407-14.

– Woo Y. A, Kim H. J, Cho J. H, Chung H. Discrimination of herbal medicines according to geographical origin with near infrared reflectance spectroscopy and pattern recognition techniques. J Pharm BiomedAnal. 1999;21:407–13.

– World Health Organization. WHO handbook for reporting results of cancer treatment; Offset Publication No. 48. Geneva (Switzerland): Would Health Organization Offset Publication, 1979.

– Wu Q. P, Xie Y. Z, Li S. Z, editors. et al. Tumour cell adhesion and integrin expression affected by Ganoderma lucidum. Enzyme Microb Technol. 2006;40:32–41.

– Wu Y. W, Fang H. L, Lin W. C. Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice. PhytotherRes. 2010;24(4):494–9.

– Wu Y, Wang D. A new class of natural glycopeptides with sugar moiety-dependent antioxidant activities derived from Ganoderma lucidum fruiting bodies. J Proteome Res. 2009;8:436–42.

– Xie J. T, Wang C. Z, Wicks S, editors. et al. Ganoderma lucidum extracts inhibits proliferation of SW 480 human colorectal cancer cells. Exp Oncol. 2006;28:25–9.

– Xie Y. Z, Li S. Z, Yee A, editors. et al. Ganoderma lucidum inhibits tumour cell proliferation and induces tumour cell death. Enzyme Microb Technol. 2009;40:177–85.

– Xu Z, Chen X, Zhong Z, et al. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am.J.Chin Med. 2011;39(1):15-27.

– Xu Z, Zhou R, Wei H. Clinical observation of Tian-an Lingzhi capsule in 120 patients with malignant tumours. The Journal of Pharmaceutical Practice 2000;18(4):197-9.

– Yan B, Wei Y, Li Y. Effect of Laojunxian Lingzhi oral liquid combined with chemotherapy on non-parvicellular lung cancer at stage II and III. Traditional Chinese Drug Research & Clinical Pharmacology 1998;9(2):78-80.

– Yang F. C, Liau C. B. The influence of environmental conditions on polysaccharide formation by Ganoderma lucidum in submerged cultures. Process Biochem. 1998;33:547–53.

– Yoon S. Y, Eo S. K, Kim Y. S, Lee C. K, Han S. S. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res. 1994;17:438–42.

– Yue Q. X, Xie F. B, Guan S. H, editors. et al. Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci. 2008;99:1461–70.

– Yuen J. W, Gohel M. D. Anticancer effects of Ganoderma lucidum: A review of scientific evidence. Nutrition & Cancer. 2005;53:11–7.

– Yuen J. W, Gohel M. D, Au D. W. Telomerase-associated apoptotic events by mushroom Ganoderma lucidum on premalignant human urothelial cells. Nutr Cancer. 2008;60:109–9.

– Yuen J. W, Gohel M. D. The dual roles of Ganoderma antioxidants on urothelial cell DNA under carcinogenic attack. J Ethnopharmacol. 2008;118:324–30.

– Yun T. K. Update from Asia: Asian studies on cancer chemoprevention. Ann N Y Acad Sci. 1999;889:157–92.

– Zaidman B. Z, Yassin M, Mahajna J, Wasser S. P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67:453–68.

– Zhang, J. S., Tang, Q. J., Zimmerman-Kordmann, M., Reutter, W., Fan, H. (2002). Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci. 71:623–638.

– Zhang L, Zhang M, Chen J. Solution properties of antitumor carboxymethylated derivatives of a-(1→3)-D-Glucan from Ganoderma lucidum. Chin J Polym Sci. 2001;19:283–9.

– Zhang Q. H, Lin Z. B. Antitumor activity of Ganoderma lucidum (Curt.: Tr.) P.Karst. (Lingzhi) (Aphyllophoromycetideae) polysaccharides is related to tumor necrosis factor-alpha and interferongamma. Int J Med Mushrooms. 1999;1:207–15.

– Zhang W, Sun D, Li W, Wei X. Clinical observation of efficacy of Ganoderm Lucidum capsule on induced toxicity of radiotherapy/chemotherapy. Journal of Binzhou Medical College1999;22(2):141-2.

– Zhang W, Tang Y. J. A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharides. Biotechnol Prog. 2008;24:1249–61.

– Zhang X, Jia Y, Li Q, Niu S, Zhu S, Shen C. Clinical curative effect investigation of Lingzhi tablet on lung cancer. Chinese Traditional Patent Medicine 2000;22(7):486-8.

– Zhao J. D, Zhang X. Q. Importance, distribution and taxonomy of Ganodermataceae in China. Proceedings of Contributed Symposium, B 5th International Mycological Congress, Vancouver. 1994 1994 August 14-21.

– Zhao L, Dong Y, Chen G, Hu H. Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr Polym. 2010;80(3):783–9.

– Zheng L, Jia D, Fei X, Luo X, Yang Z. An assessment of the genetic diversity within Ganoderma strains with AFLP and ITS PCR-RFLP. Microbiol Res. 2009;164:312–21.

– Zhong J. J, Xiao J. H. Secondary metabolites from higher fungi: Discovery, bioactivity and biopro-duction. Adv Biochem Eng Biotechnol. 2009;113:79–150.

– Zhou J, Zou XX, Zhou JC. Clinical investigation of Lingzhi infusion in adjuvant treatment of tumour. Jiangxi Journal of Traditional Chinese Medicine 2001;32(3):30-1.

– Zhou, S. F., Gao, Y. H. (2002). The immunomodulating effects of Ganoderma lucidum (Curt.: Fr) P. Karst (Ling Zhi Reishi mushroom) (Aphyllophoromycetideae). Int. J. Med. Mushroom 4:1–11.

– Zhou, S. F., Kestell, P., Baguley, B. C., Paxton, J. W. (2002). 5,6-Dimethylxanthenone-4- acetic acid: a novel biological response modifier for cancer therapy. Invest. New Drugs 20:281–295.

– Zhou S, Gao Y, Chan E. Clinical trials for medicinal mushrooms: experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi mushroom). International Journal of Medicinal Mushrooms2005;7(1-2):111-7.

– Zhou X, Lin J, Yin Y, Zhao J, Sun X, Tang K. Ganodermataceae: Natural products and their related pharmacological functions. Am J Chin Med. 2007;35:559–74.

– Zhu X. L, Chen A. F, Lin Z. B. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol. 2007;111:219–26.

– Zhu X, Lin Z. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydr Polym. 2006;63:188–97.

– Zhu Y. P. Chinese Materia Medica. Singapore: Harwood Academic Publishers; 1998.

– Zhuang SR, Chen SL, Tsai JH, Huang CC, Wu TC, Liu WS, et al. Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytotherapy Research 2009;23(6):785-90.

References for Cordyceps Sinensis

– Adhikari MK. Chyau: Ayurvediya vishleshan ek vivechana (Mushrooms: An Ayurvedic concepts) J Nep Pharm Asso. 1981;9:17–21.

– Adhikari MK, Devkota S, Tiwari RD. Ethnomycolgical Knowledge on Uses of Wild Mushrooms in Western and Central Nepal. Our Nat. 2005;3:13–9.

– Ali S, Ren S, Huang Z, Wu J (2010) Purification of enzymes related to host penetration and pathogenesis from entomopathogenic fungi. In: Mendez-Vilas A (ed) Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology, Formatex Research Center, Spain, pp 15–22.

– Arora, R.K. 2008. Collection, Isolation and Characterization of Caterpillar Mushroom-Cordyceps sinensis (Berk.)Sacc. Of Uttarakhand. PhD Thesis, Govind Ballabh Pant University of Agriculture and Technology, Uttarakhand, India.160pp.

– Arora R.K., Singh, N. and Singh, R.P. 2013. Characterization of an entomophagous medicinal fungus Cordyceps sinensis (Berk.) Sacc. of Uttarakhand, India. The Bioscan. 8(1):195-200.

– Arora, R.K. and Singh, R.P. 2009a. Biochemical characterization of caterpillar mushroom(Cordyceps sinensis). Mushroom Research, 18(1):39-41.

– Arora, R.K. and Singh, R.P. 2009b. Effect of nutritional sources on mycelial growth of Caterpillar mushroom Cordyceps sinensis(Berk.) Sacc. Journal of Mycology and Plant Pathology, 39(1): 114-117.

– Arora, R.K., Singh, R.P. and Guru, S.K. 2008. Determination of bio-active compounds in medicinal mushroom, Cordyceps sinensis. Mushroom Research, 17(2):61-66.

– Baik JS, Kwon HY, Kim KS, Jeong YK, Cho YS, Lee YC. Cordycepin induces apoptosis in human neuroblastoma SK-N-BE(2)-C and melanoma SK-MEL-2 cells. Indian J Biochem Biophys. 2012;49:86–91.

– Balon, T.W., Jasman, A.P. and Zhu, J.S. 2002. A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats. Journal of Alternate and Complementary Medicine, 8:315-323.

– Bao TT. Further study of pharmacological functions on Jin Shui Bao. J Admin Trad Chinese Med 1995;5(suppl6).

– Bao ZD, Wu ZG, Zheng F. Amelioration of aminoglycoside nephrotoxicity by Cordyceps sinensis in old patients. Chin J Integr Med1994;14(259):271–273.

– Berne, R.M.1980. The role of adenosine in the regulation of coronary blood flow. Circular Research, 47:807-813.

– Bhattarai NK. Folk herbal medicines of Dolakha district, Nepal. Fitoterapia. 1993;66:387-395.

– Bhattarai S, Chaudhary RP, Taylor R. Ethnomedicinal plants used by the people of Manang district, central Nepal. J Ethnobio Ethnomed. 2006;2(41):1-8.

– Bod ljongs rgyun spyod krung dbyi’i sman rigs. Bod ljongs mi dmangs dpe skrun khang. 1973: 579. [A List of Chinese Traditional Medicines of Tibetan Everyday UseLhasa: Tibetan People Press; 1973.]

– Boesi A. The dbyar rtswa dgun ‘bu (Cordyceps sinensis Berk.): an important trade item for the Tibetan population of the Lithang County, Sichuan Province, China. The Tibet Journal. 2003;27(3):29-42.

– Bok, J.W., Lermer, L., Chilton, J., Klingeman, H.G. and Towers, G.H.1999. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry, 51(7): 891-898.

– Borchers AT, Keen CL, Gershwin ME. Mushroom, tumor, and immunity: an update. Exp Biol Med. 2004;229:393–406.

– Braith RW, Graves JE, Leggett SH, Pollock ML. Effect of training on the relationship between maximal and submaximal strength. Med Sci Sports Exerc 1993;25:132–138.

– Brownell S. Beijing’s Games: What the Olympics Mean to China. Rownam & Littlefield, 2008.

– Buchfuhrer MJ, Hansen JE, Robinson TE, et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983;55:1558–1564.

– Buenz, E.J., Weaver, J.C., Bauer, B.A., Chalpin, S.D. and Badley, A.D. 2004.Cordyceps sinensis extracts do not prevent Fas-receptor and hydrogen peroxide-induced Tcell apoptosis. Journal of Ethnopharmacology, 90(1):57- 62.

– Byams pa ‘phrin las. Bod lugs gso rig tshig mdzod chen mo. Beijing: Mi rigs dpe skrun khang; 2006:707. [Champa Trinle. Great dictionary of the Tibetan medical tradition. Beijing: Nationalities Languages Press; 2006:707.]

– Chatterjee R, Srinivasan KS, Maiti PC. Cordyceps sinensis (Berkeley) saccardo: structure of cordycepic acid. J Am Pharm Assoc. 1957;46:114–122.

– Chen DG. Effects of Jing Shui Bao capsule on quality of life of patients with chronic heart failure. J Admin Traditional Chin Med 1995;5:40–43.

– Chen, K. and Zhang, W. 1987. Advances on anti-aging herbal medicines in China. Abstracts of Chinese Medicines, 1: 309-330.

– Chen K, Li C. Recent advances in studies on traditional Chinese anti-aging materia medica. J Tradit Chin Med 1993;13:223–226.

– Chen LS, Stellrecht CM, Gandhi V. RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Brit J Haematol. 2008;140:391–682.

– Chen, S.J., Yin, D.H., Zhong, G.Y. and Huang, T.F. 2002b. Study on the biology of adult parasite of Cordyceps sinensis, Hepialus biruensis. In: Zhongguo Zhong Yao Za Zhi. 27(12): 893-895.

– Chen SZ, Chu JZ. NMR and IR studies on the characterization of cordycepin and [email protected] Zhong Guo Kangshengsu Zazhi 1996;21:9–12.

– Chen, Y.C. and Huang, B.M. 2010. Regulatory mechanisms of Cordyceps sinensis on steroidogenesis in MA-10 mouse Leydig tumor cells. Bioscience, Biotechnology and Biochemistry, 74(9):1855-1859.

– Chen, Y.J., Shiao, M.S., Lee, S.S. and Wang, S.Y. 1997. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sciences, 60:2349-2359.

– Chen, Y.Q., Wang, N., Zhou, H. and Qu, L.H.2002a.Differentiation of medicinal Cordyceps species by rDNA 18S sequence analysis. Planta Medica, 68(7): 635-639.

– Cheng, Q. 1992.Effect of Cordyceps sinensis on cellular immunity in rats with chronic renal insufficiency, Chung Hua I. Hsueh Tsa Chih.(Taipei). 72: 27-29.

– Chiou, W.F., Chang, P.C., Chou, C.J. and Chen, C.F.2000. Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci., 66(14):1369-1376.

– Choi S, Lim MH, Kim KM, Jeon BH, Song WO, Kim TW. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of estrogen receptor. Toxicol Appl Pharmacol. 2011;257:165–173.

– Chu HL, Chien JC, Duh PD. Protective effect of Cordyceps militaris against high glucose-induced oxidative stress in human umbilical vein endothelial cells. Food Chem. 2011;129:871–876.

– Cooper CB, Storer TW. Exercise Testing and Interpretation: A Practical Approach. New York: Cambridge University Press, 2001.

– Cordyceps. In: Commission CP, ed. Pharmacopoeia of the People’s Republic of China. Beijing: People’s Medical Publishing House, 2005:36.

– Cordyceps. In: Division HMS, ed. The Korean Herbal Pharmacopoeia (KHP). Seoul, Korea: Korea Food and Drug Administration, 2002:59.

– Cunnigham, K.G., Hutchinson, S.A., Manson, W. and Spring, F.S. 1951.Cordycepin-A metabolic product from cultures of Cordyceps militaris (Linn.). Part 1, Isolation and characterization. J. Chem. Soc., pp.2299-3000.

– Cunningham KG, Manson W, Spring FS, Hutchinson SA. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (L.) Link. Nature. 1950;166:949–954.

– Dai G, Bao T, Xu C, Cooper R, Zhu JX. CordyMax™ Cs-4 improves steady-state bioenergy status in mouse liver. J Altern Complement Med. 2001;7:231–240.

– Das SK, Masuda M, Hatashita M, Sakurai A, Sakakibara M. A new approach for improving cordycepin productivity in surface liquid culture of Cordyceps militaris using high-energy ion beam irradiation. Lett Appl Microbiol. 2008;47:534–538.

– Das SK, Masuda M, Hatashita M, Sakurai A, Sakakibara M. Effect of inoculation on production of anti-cancer drug-cordycepin in surface liquid culture using Cordyceps militaris mutant: a minor factor may greatly affect the result. Indian J Biotechnol. 2010;9:427–430.

– Das SK, Masuda M, Sakurai A, Sakakibara M. Medicinal uses of the mushroom Cordyceps militaris: current state and prospects. Fitoterapia. 2010;81:961–968.

– De’u dmar dge shes bstan ‘dzin phun tshogs. Shel gong shel phrengDharamsala: Tibetan Medical and Astro Institute; 1994. [Deumar Geshe Tenzin Phuntsok. The Crystal Block, The Crystal Rosary. Dharamsala: Tibetan Medical and Astro Institute; 1994.]

– Devkota S. Yarsagumba (Cordyceps sinensis): Reflection on Historical Perspectives. Soc Life. 2007;13:40–1.

– Devkota S. Yarsagumba [Cordyceps sinensis (Berk.) Sacc.]; traditional utilization in Dolpa district, western Nepal. Our Nat. 2006;4:48–55.

– dGa’ ba’i rdo rje. Khrungs dpe dri med shel gyi me long. Beijing: Mi rigs dpe skrun khang; 1998. [Gawe Dorje. The Immaculate Crystal Mirror of Source and IdentificationBeijing: Nationalities Languages Press; 1998.]

– Diggin FE. The true history of discovery of penicillin. Br J Biomed Sci. 1999;25:2–3.

– Ding, G.1987. Anti-arrhythmia agents in traditional Chinese medicines. Abstracts of Chinese Medicines, I:287-308.

– Dong, C.H. and Yao, Y.J.2008. In vitro evaluation of antioxidant activities of aqueous extracts from natural and cultured mycelia of Cordyceps sinensis. LWT Food Science and Technology, 41(4):669-677.

– Effect of Cs-4® (Cordyceps sinensis) on Exercise Performance in Healthy Older Subjects: A Double-Blind, Placebo-Controlled Trial (2010).

– Francia, C., Rapior, S., Courte cecuisse, R. and Siroux, Y.1999. Current research findings on the effects of selected mushrooms on cardiovascular diseases. International Journal of Medicinal Mushrooms, 1:169- 172.

– Gangs ljongs sman pa’i grong khyer lcags ri bai durya gling gi sngo’i sman gyi ‘khrungs dpe1971. Bod gzhung sman rtsi khang, Dharamsala. [Materia Medica of Herbal Medicines of the Country of Beryl: The Iron Mountain City of the Doctors in the Land of SnowDharamsala: Medical and Astro Institute of the Tibetan Government; 1971.]

– Garbyal, S.S., Aggarwal, K.K. and Babu, C.R.2004. Impact of Cordyceps sinensis in the rural economy of interior villages of Dharchula sub-division of Kumaon Himalayas and its implications in the society. Indian Journal of Traditional Knowledge, 3(2):182-186.

– Geng, S.1985.Treatment of Hyperlipidemia with Cultivated Cordyceps-A Double Blind, Randomized Placebo Control Trial. Chinese Journal of Internal Medicine, 5:652.

– Ghimire SK, Lama YC, Thomas YA. Medicinal Plant Management and Health Care Development in Shey Phoksumdo National Park, Dolpa. Kathmandu: People and Plants Initiative, WWF Nepal Program, 2000.

– Gi-Ho Sung, Nigel L, Hywel-Jones, et al. Spatafora1 phylogenetic classification of Cordyceps and the clavicipitaceous fungi. Studies in Mycology. 2007;57:5–59.

– Gist, G.N.1918. Notes on Cordyceps sinensis. Mycology Notes. 54:767-768.

– Gong Z, Su Y, Huang L, Lin J, Tang K, Zhou X. Cloning and analysis of glyceraldehyde-3-phosphate dehydrogenase gene from Cordyceps militaris. Afr J Agr Res. 2009;4:402–408.

– Gu YX, Wang ZS, Li SX. Effect of multiple factors on accumulation of nucleosides and bases in Cordyceps militaris. Food Chem. 2007;102:1304–1309.

– Guan, J. and Li, S.P.2010.Discrimination of polysaccharides from traditional Chinese medicines using saccharide mapping – enzymatic digestion followed by chromatographic analysis. Journal of Pharmaceutical and Biomedical Analysis, 51(3):590-598.

– Guan, Y.J., Hu, G., Hou, M.., Jiang, H., Wang, X. and Zhang,C. 1992.Effect of Cordyceps sinensis on Tlymphocyte subsets in Chronic renal failure, Chinese Journal of Integrated Medicine, 323(12):338-339.

– Guo C, Zhu J, Zhang C, Zhang L. Determination of adenosine and 3′-deoxyadenosine in Cordyceps militaris (L.) Link by HPLC. Chin J Chinese Materia Medica. 1998;23:236–243.

– Guo, J.Y., Han, C.C. and Liu, Y.M.2010. A contemporary treatment approach to both diabetes and depression by Cordyceps sinensis, rich in vanadium. Evidence based Complementary and Alternative Medicine, 7(3): 387-389.

– Guo YZ. Medicinal chemistry, pharmacology and clinical applications of fermented mycelia of Cordyceps sinensis and JinShuBao capsule. J Modern Diagnostics Therapeutics. 1986;1:60–65.

– Gwangpo, K.2000a. Characteristics of Cordyceps species. hits: 539. www.mushworld.com. Halpern, G.M.1999. Cordyceps-China’s Healing Mushroom. Avery Publishing Group. NewYork, USA.pp.16.

– Hajek AE, Leger RJS. Interactions between fungal pathogens and insects hosts. Annu Rev Entomol. 1994;39:293–322.

– Harsahay, M., Mohsin, M., Pandey, H.K., Negi, P.S. and Ahmed, Z.2010. Estimation of cordycepin by improved HPLC method in the natural and cultured mycelia of high medicinal value Himalayan entomogenous fungus Cordyceps sinensis, Electronic Journal of Environmental, Agricultural and Food Chemistry, 9(10): 1598-1603.

– Hattori M, Isomura S, Yokoyama E, Ujita M, Hara A. Extracellular trypsin-like protease produced by Cordyceps militaris. J Biosci Bioeng. 2005;100:631–636.

– He W, Zhang MF, Ye J, Jiang TT, Fang X, Song Y. Cordycepin induces apoptosis by enhancing JNK and p38 kinase activity and increasing the protein expression of Bcl-2 pro-apoptotic molecules. J Zhejiang Univ Sci B. 2010;11:654–660.

– Ho JM, Seo MJ, Park JU, Kang BW, Kim KS, Lee JY, Kim GY, Kim JI, Choi YH, Kim KH, Jeong YK. Effect of cordycepin purified from Cordyceps militaris on Th1 and Th2 cytokines in mouse splenocytes. J Microbiol Biotechnol. 2012;22:1161–1164.

– Hobbs, C.L.1986. Medicinal Mushrooms. An exploration of tradition, healing and culture.pp. 81-86.

– Hodge KT, Humber RA, Wozniak CA. Cordycepsvariabilis and the genus Syngliocladium. Mycologia. 1998;90:743–753.

– Hofmann A. Switzerland: J.B. Lippincott Company; 1970. The Discovery of LSD and Subsequent Investigations on Naturally Occurring Hallucinogens in Discoveries in Biological Psychiatry. Chapter -7; pp. 34–7.

– Holbein S, Wengi A, Decourty L, Freimoser FM, Jacquier A, DichtlrnaI B. Cordycepin interferes with 3′ end formation in yeast independently of its potential to terminate RNA chain elongation. RNA. 2009;15:837–849.

– Holliday J, Cleaver M. Medicinal value of the caterpillar fungi species of the genus Cordyceps (Fr.) Link (Ascomycetes): a review. Int J Med Mushrooms. 2008;10:219–234.

– Holliday J, Cleaver P, Powers ML, Patel D. Analysis of quality and techniques for hybridization of medicinal fungus Cordyceps sinensis. Int J Med Mushrooms. 2004;6:147–160.

– Hong, Z. and Li, Y.1990. Immuno-pharmacological functions of Cordyceps. Chinese Journal of International Trade and Western Medicine, 10:570-571.

– Hsu, T.H.1999. Health benefits of Cordyceps related species. J. Chin. Soc. Tradit. Vet. Soc. 3:48-61.

– Huang BM, Hsua CC, Tsai SJ, Sheu CC, Leu SF. Effects of Cordyceps sinensis on steroidogenesis in normal mouse Leydig cells. Life Sci. 2001;69:2593–2602.

– Huang, K.C.1993.The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, Florida.pp., 207-208.

– Huang LF, Liang YZ, Guo FQ, Zhou ZF, Cheng BM. Simultaneous separation and determination of active components in Cordyceps sinensis and Cordyceps militaris by LC/ESI-MS. J Pharm Biomed Anal. 2003;33:1155–1162.

– Huang Y, Lu J, Zhu B, Wen Q, Jia F, Zeng S, Chen T, Li Y, Cheng G, Yi Z. Toxicity study of fermentation Cordyceps mycelia B414. Chin Tradit Pat Med. 1987;10:24–25.

– Huang YL, Leu SF, Liu BC, Sheu CC, Huang BM. In vivo stimulatory effect of Cordyceps sinensismycelium and its fractions on reproductive functions in male mouse. Life Sci. 2004;75:1051–1062.

– Huber T. Antelope hunting in northern Tibet, cultural adaptation to wildlife ecology. In: Boesi A, Cardi F. Wildlife and plants in traditional and modern Tibet: conceptions, exploitation, and conservation. Memorie della Società Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano. 2005;33(1):5-17.

– Humber RA. Fungal pathogens and parasites of insects. In: Priest F, Goodfellow M, editors. Applied microbial systematics. Dordrecht: Kluwer Academic Publishers; 2000. pp. 203–230.

– Hyun H. Chemical ingredient of Cordyceps militaris. Mycobiology. 2008;36:233–235.

– Hywel NLJ. Multiples of eight in Cordyceps ascospores. Mycol Res. 2002;106:2–3.

– Illana, E.C.2007. Cordyceps sinensis – a fungi used in the Chinese traditional medicine. Revista Iberoamericana de Micologia, 24(4):259-262.

– Isaka M, Kongsaeree P, Thebtaranonth Y. Bioxanthracenes from the insect pathogenic fungus Cordyceps pseudomilitaris BCC 1620. II. Structure elucidation. J Antibiot (Tokyo) 2001;54:36–43.

– Jagger DV, Kredich NM, Guarino AJ. Inhibition of Ehrlich mouse ascites tumor growth by cordycepin. Cancer Res. 1961;21:216–220.

– ‘Jam dpal rdo rje. An Illustrated Tibeto-Mongolian Materia Medica of AyurvedaChandra L, ed. New Delhi: International Academy of Indian Culture; 1971.

– Jason, E.B.2005. Medicinal mushrooms. Alternative and complementary Therapies. 11(3) :141-145.

– Jen CY, Lin CY, Huang BM, Leu SF. Cordycepin induced MA-10 mouse leydig tumor cell apoptosis through Caspase-9 Pathway. Evid Based Complement Alternat Med. 2008;2011:1–11.

– Jeong JW, Jin CY, Park C, Hong SH, Kim GY, Jeong YK, Lee JD, Yoo YH, Choi YH. Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol In Vitro. 2011;25:817–824.

– Ji DB, Ye J, Li CL. Antiaging effect of Cordyceps sinensis extract. Phytother Res. 2009;23(1):116-22.

– Jiang JC, Gao YF. Summary of treatment of 37 chronic renal dysfunction patients with Jin Shui Bao. J Admin Traditional Chin Med 1995;5:23–24.

– Jiang, Y. and Yao, Y.J.2002. Names related to Cordyceps Sinensis anamorph. Mycotaxon. October-December. 84: 245-254.

– Jin Yun C, Kim GY, Choi YH. Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 cells. J Microbiol Biotechnol. 2008;18:1997–2003.

– Jing, K.Y., Wenkian, W.Q., Lin L and Jian, Y.W.2011. Physiochemical properties and antitumor activities of two alpha-glucans isolated from hot water and alkaline extracts of Cordyceps (Cs-HK1) fungal mycelia. Carbohydrate Polymers, 85(4): 753-758.

– Jo WS, Choi YJ, Kim HJ, Lee JY, Nam BH, Lee JD, Lee SW, Seo SY, Jeong MH. The anti-inflammatory effects of water extract from Cordyceps militaris in murine macrophage. Mycobiology. 2010;38:46–51.

– Jones.1997. An ancient Chinese secret promotes longevity and endurance. Healthy and Natural Journal, 3(3): 90-93.

– Jung EC, Kim KD, Bai CH, Kim JC, Kim DK, Kim HH. A mushroom lectin from ascomycete Cordyceps militaris. BBA-Gen Subj. 2007;1770:833–841.

– Kaczka EA, Trenner NR, Arison B, et al. Identification of cordycepin, a metabolite of Cordyceps militaris, as 3’- deoxyadenosine. Biochem Biophys Res Commun 1964;14: 456–457.

– Karma chos ‘phel. bDud rtsi sman gyi ‘khrungs dpe legs bshad nor bu’i phreng mdzes. Lhasa: Bod ljongs mi dmangs dpe skrun khang; 1993. [Karma Chopel. Beautiful Rosary of Precious and Elegant Teachings: a Materia Medica on the Medicines which are Elixir of ImmortalityLhasa: Tibetan People Press; 1993.]

– Kawaguchi N, Ohmori T, Takeshita Y, Kawanishi G, Katayama S, Yamada H. Occurrence of Gal beta (1–3) GalNAc-Ser/Thr in the linkage region of polygalactosamine containing fungal glycoprotein from Cordyceps ophioglossoides. Biochem Biophys Res Commun. 1986;140:350–356.

– Kawanishi, T., Ikeda, D.Y. and Nagayama, A.2010. Effects of two basidiomycetes species on interleukin 1 and interleukin 2 production by macrophage and T cell lines. Immunobiology, 215(7):516-520.

– Kiho T, Hui J, Yamane A, Ukai S. Polysaccharides in fungi. XXXII. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull 1993;16:1291– 1293.

– Kim JS, Sapkota K, Park SE, Choi BS, Kim S, Nguyen TH, Kim CS, Choi HS, Kim MK, Chun HS, Park Y, Kim SJ. A fibrinolytic enzyme from the medicinal mushroom Cordyceps militaris. J Microbiol. 2006;44:622–631.

– Kinjo N, Zang M. Morphological and phylogenetic studies on coryceps Sinensis. Mycoscience. 2001;42:567–74.

– Klenow H. Formation of the mono-, di- and triphosphate of cordycepin in Ehrlich ascites-tumor cells in vitro. Biochim Biophys Acta. 1963;76:347–353.

– Kobayasi, Y.1941. The genus Cordyceps and its allies. Sci. Rep. Tokyo Bunrika Daigaku. Section B-5. 53-260.

– Koh, J.H., Yu, K.W., Suh, H.J., Choi, Y.M. and Ahn, T.S.2002. Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis, Biosci. Biotechnol. Biochem., 66(2):407-411.

– Krasnoff SB, Reategui RF, Wagenaar MM, Gloer JB, Gibson DM. Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda. J Nat Prod. 2005;68:50–55.

– Kuo MC, Chang CY, Cheng TL, Wu MJ. Immunomodulatory effect of exo-polysaccharides from submerged cultured Cordyceps sinensis: enhancement of cytokine synthesis, CD11b expression, and phagocytosis. Appl Microbiol Biotechnol. 2007;75:769–775.

– Kuo, Y.C., Lin, C.Y., Tsai, W.J., Wu, C.L., Chen, C.F. and Shiao,M.S.1994.Growth inhibitors against tumor cells in Cordyceps sinensis other than cordycepin and polysaccharides. Cancer Invest. 12:611-615.

– Kuo, Y.C., Tsai, W.J., Shiao, M.S., Chen, C.F. and Lin, Y.C.1996. Cordyceps sinensis, as an immunomodulatory agent. Am. J. Chin. Med., 24:111-125.

– Kuo, Y.C., Tsai, W.J., Wang, J.Y., Chang, S.C., Lin, C.Y.2001.Regulation of bronchoalveolar lavage fluid cell function by the immunomodulatory agents from Cordyceps sinensis. Life Science, 68:1067-1082.

– Lama YC, Ghimire SK, Thomas YA. Amchis’ Knowledge and Conservation. Kathmandu: People and Plants Initiative, WWF Nepal Program; 2001. Medicinal Plants of Dolpo; p. 56.

– Lama, Y.C., Ghimirey, S.K. and Thomas, Y.A.2001. Medicinal plants of Dolpa: Amchis Knowledge and Conservation. WWF Nepal Program, Kathmandu.pp.56. Lei, J.1992. Pharmacological study on Cordyceps sinensis (Berk.) Sacc. and ze-e Cordyceps. Chung Kuo Chung Yao Tsa Chih. 17(6):364-366.

– Lama YC, Ghimire SK, Thomas YA. Medicinal Plants of Dolpo. Amchis’ Knowledge and Conservation. Kathmandu: People and Plants Initiative, WWF Nepal Program; 2001:56.

– Lee B, Park J, Park J, Shin HJ, Kwon S, Yeom M, Sur B, Kim S, Kim M, Lee H, Yoon SH, Hahm DH. Cordyceps militaris improves neurite outgrowth in neuro2A cells and reverses memory impairment in rats. Food Sci Biotechnol. 2011;20:1599–1608.

– Lee EJ, Kim WJ, Moon SW. Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells. Phytother Res. 2010;24:1755–1761.

– Lee JH, Hong SM, Yun JY, Myoung H, Kim MJ. Anti-cancer effects of cordycepin on oral squamous cell carcinoma proliferation and apoptosis in vitro. J Cancer Ther. 2011;2:224–234.

– Lee KH, Min TJ. Purification and characterization of a chitinase in culture media of Cordyceps militaris(L.) Link. Korean J Med Mycol. 2003;31:168–174.

– Lee SJ, Kim SK, Choi WS, Kim WJ, Moon SK. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells. Arch Biochem Biophys. 2009;490:103–109.

– Lee YR, Noh EM, Jeong EY, Yun SK, Jeong YJ, Kim JY, Kwon KB, Kim BS, Lee SH, PPark CS, Kim JS. Cordycepin inhibits UVB-induced matrix metalloproteinase expression by suppressing the NF-κB pathway in human dermal fibroblasts. Exp Mol Med. 2009;41:548–554.

– Leger RJS, Bidochka MJ, Staples RC. Preparation events during infection of host cuticle by Metarhizium anisopliae. J Invertebr Pathol. 1991;58:168–179.

– Lei M, Wang JP. Jin Shui Bao capsule as adjuvant treatment for acute stage pulmonary heart disease: Analysis of therapeutic effect of 50 clinical cases. J Admin Traditional Chin Med 1995;5:28–29.

– Li, L.S., Zheng, F. and Liu, Z.H. 1996. Experimental study on the effect of Cordyceps sinensis in ameliorating aminoglycoside induces nephrotoxicity. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 16:733-737.

– Li QS, Zeng W, Yin DH, et al. A preliminary study on alternation of generations of Cordyceps sinensis [In Chinese, Engl. Abstract]. Zhongguo Zhong Yao Za Zhi [China Jour. Chin. Mat. Med.]. 1999; 23.4:210-2.

– Li S, Li P, Ji H. RP-HPLC determination of ergosterol in natural and cultured Cordyceps. Chin J Mod Appl Pharm. 2011;18:297–299.

– Li SP, Li P, Dong TT, Tsim KW. Anti –oxidant activity of different types of natural Cordyceps sinensis and cultured Cordyceps mycelia. Phytomedicine. 2001;8:207–12.

– Li, S.P., Li, P., Dong, T.T. and Tsim, K.W.K. 2001b. Determination of nucleosides in natural Cordyceps sinensis and cultured Cordyceps mycelia by capillary electrophoresis. Electrophoresis, 22:144-150.

– Li, S.P., Su, Z.R., Dong, T.T.X. and Tsim, K.W.K.2002.The fruiting body and its caterpillar host of Cordyceps sinensis show close resemblance in main constituents and antioxidation activity. Phytomedicine, 9(4):319-324.

– Li SP, Yang FQ, Tsim KW. Quality control of Cordyceps sinensis, a valued traditional Chinese medicine. J Pharm Biomed Anal. 2006;41:1571–1584.

– Li, S.P., Zhao, K.J., Ji, Z.N., Song, Z.H., Dong, T.T.X., Lo, C.K., Cheung, J.K.H., Zhu, S.Q. and Tsim, K.W. 2003. A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury. Life Science, 73:2503- 2513.

– Li T, Li W. Impact of polysaccharides from Cordyceps on antifatigue in mice. Sci Res Essays. 2009;4:705–709.

– Li Y, Chen GZ, Jiang DZ. Effect of Cordyceps sinensis on erythropoiesis in mouse bone marrow. Chinese Med J. 1993;106:313–316.

– Liang, C.H., Huang, S.J., Tsai, S.Y., Lee, Y.L., Kuo, H.C., Wu, T.P., Jian, S.Y., Huang, W.L. and Mau, J.L. 2009. Antioxidant properties of novel solid-state fermented culinary-medicinal mushroom and fungi products. International Journal of Medicinal Mushrooms, 11(3):259-268.

– Lin, C.Y. 1999. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy. J. Lab. Clin. Med., 133:55-63.

– Lin, S., Lo, H. and Lin, C. 2002. Oral administration of Cordyceps does not affect lymphocyte subsets in STZinduced diabetic rats. Journal of Nutritional sciences, 27(2):77-83.

– Lin WH, Tsai MT. Improvement of sperm production in subfertile Boars by Cordyceps militarissupplement. Am J Chinese Med. 2007;35:631–641.

– Lindequist U, Niedermeyer THJ, Julich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2:285–299.

– Ling, J.Y., Sun, Y.J., Zhang, H. and Zhang, C.K. 2002. Measurement of cordycepin and adenosine in stroma of Cordyceps sp. by capillary zone electrophoresis (CZE). J. Biosci. Bioeng., 94:371-374.

– Liu, C., Xue, H.M., Xu, L.M., Zhao, P.Z., Zhang, L.B. and Tang, M.G. 1986. Treatment of 22 patients with post hepatic cirrhosis with a preparation of fermented mycelia of Cordyceps sinensis Shanghai. J. Chinese Materia. Medica, 6:30-31.

– Liu, J., Yang, S., Yang, X., Chen, Z. and Li, J.1997. Anticarcinogenic effect and hormonal effect of Cordyceps militaris Link. Chung Kuo Chung Yao Tsa Chih.(Chinese Journal). 22: 111-113.

– Liu, W.C., Chuang, W.L., Tsai, M.L., Hong, J.H., McBride, W.H. and Chiang,C.S.2008. Cordyceps sinensis health supplement enhances recovery from taxol-induced leucopenia. Experimental Biology and Medicine, 233(4):447-455.

– Lu L. Study on effect of Cordyceps sinensis and artemisinin in preventing recurrence of lupus nephritis. Chin J Integr Med. 2002;22:169–171.

– Lui, J.C.K., Wong, J.W.Y., Suen, Y.K., Kwok, T.T., Fung, K.P and Kong, SK. 2007. Cordycepin induced eryptosis in mouse erythrocytes through a Ca2+-dependent pathway without caspase-3 activation.

– Mains, E.B. 1940. Cordyceps species from Michigan. Papers Michigan Academy of Science. 25:79-84.

– Mains, E.B. 1957. Species of Cordyceps parasitic on Elaphomyces. Bul. Torrey. Bot. Club. 84:243-251.

– Mains, E.B.1947. New and interesting species of Cordyceps. Mycologia, 39: 535-545.

– Mains EB. 1958. North American entomogenous species of Cordyceps. Mycologia. 50:169–222.

– Mains, E.B.1954. Species of Cordyceps on Spiders. Bull. Torrey. Bot. Club. 81: 492-500.

– Manabe N, Azuma Y, Sugimoto M, Uchio K, Miyamoto M, Taketomo N, Tsuchita H, Miyamoto H. Effects of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism and blood flow in dietary hypoferric anaemic mice. Br J Nutr. 2000;83:197–204.

– Manabe N, Sugimoto M, Azuma Y, et al. Effects of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism in the mouse. Jpn J Pharmacol 1996;70:85–88.

– Marchbank, T., Ojobo, E., Playford, C.J. and Playford, R.J. 2011. Reparative properties of the traditional Chinese medicine Cordyceps sinensis (Chinese caterpillar mushroom) using HT29 cell culture and rat gastric damage models of injury. British Journal of Nutrition, 105(9):1303-1310.

– Masuda M, Urabe E, Sakurai A, Sakakibara M. Production of cordycepin by surface culture using the medicinal mushroom Cordyceps militaris. Enzyme Microb Tech. 2006;39:641–646.

– Ministry of Forests and Soil Conservation. Medicinal Plants of Nepal. Kathmandu: 1970:116-117.

– Mizuha Y, Yamamoto H, Sato T, Tsuji M, Masuda M, Uchida M, Sakai K, Taketani Y, Yasutomo K, Sasaki H, Takeda E. Water extract of Cordycepssinensis (WECS) inhibits the RANKL-induced osteoclast differentiation. Biol Factors. 2007;30:105–116.

– Mizuno, T., Saito, H., Nishitoba, T. and Kawagishi, H. 1995. Antitumor active substances from mushrooms. International Journal of Food Reviews, 111: 23-61.

– Mizuno T. Medicinal effects and utilization of Cordyceps (Fr.) Link (Ascomycetes) and Isaria Fr. (Mitosporic fungi) Chinese caterpillar fungi, “Tochukaso” (review) Int J Med Mushrooms. 1999;1:251–262.

– Mollah ML, PPark DK, Park HJ. Cordyceps militaris grown on germinated soybean induces G2/M cell cycle arrest through downregulation of Cyclin B1 and Cdc25c in human colon cancer HT-29 cells. Evid Based Complement Alternat Med. 2012;2012:1–7.

– Muslim N, Rahman H. A possible new record of Cordyceps species from Ginseng Camp, Maliau Basin, Sabah, Malaysia. JTBC. 2010;6:39–41.

– Nakamura. K., Konoha, K., Yamaguchi, Y., Kagota, S., Shinozuka, K. and Kunitomo, M. 2003. Combined effects of Cordyceps sinensis and methotrexate on hematogenic lung metastasis in mice. Receptors Channels, 9(5):329- 334.

– Nakamura K, Yamaguchi Y, Kagota S, Kwon YM, Shinozuka K, Kunitomo M. Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of lewis lung carcinoma and B16 melanoma cells in syngeneic mice. Jpn J Pharmacol. 1999;79:335–341.

– Namgyel P. Household income, property rights and sustainable use of NTFP in subsistence mountain economy: the case of cordyceps and matsutake in Bhutan Himalayas. Paper presented in November at the Regional CBNRM Workshop. 2003.

– Nan JX, Park EJ, Yang BK, Song CH, Ko G, Sohn DH. Anti-fibrotic effect of extracellular biopolymer from submerged mycelial cultures of Cordyceps militaris on liver fibrosis induced by bile duct ligation and scission in rats. Arch Pharm Res. 2001;24:327–332.

– Negi CS, Koranga PR, Ghinga HS, Gumba Yar tsa (Cordyceps sinensis): A call for its sustainable exploitation. Int J Sust Dev World. 2006;13:1–8.

– Negi, C.S. 2007. Changing face of polyculture in the Darma and Johaar valleys, Pithoragarh, Kumaun Himalayas. International Journal of Sustainable Development and World Ecology, 14(4): 428-436.

– Negi, P.S. 2005. Systematics of mushrooms of Almora and Pithoragarh districts. Ph.D. Thesis, Deptt. of Botany, Kumaun University, Almora.(Uttarakhand),India pp.162.

– Ng TB, Wang HX. Pharmacological actions of Cordyceps, a prized folk medicine. J Pharm Pharmacol. 2005;57:1509–1519.

– Ni H, Zhou XH, Li HH, Huang WF. Column chromatographic extraction and preparation of cordycepin from Cordyceps militaris waster medium. J Chromatogr B. 2009;877:2135–2141.

– Norbu N. Journey Among the Tibetan Nomads. An Account of a Remote Civilization. Dharamsala: Library of Tibetan Works & Archives; 1997:68.

– Overgaard KH. The inhibition of 5-phosphoribosyl-1- pyrophosphate formation by Cordycepin triphosphate in extracts of Ehrlich ascites tumor cells. Biochim Biophys Acta. 1964;80:504–507.

– Pan BS, Lin CY, Huang BM. The effect of cordycepin on steroidogenesis and apoptosis in MA-10 mouse leydig tumor cells. Evid Based Complement Alternat Med. 2011;2011:1–14.

– Panda AK, Swain KC. Traditional uses and medicinal potential of Cordyceps sinensis of Sikkim. J Ayurveda Integr Med. 2011;2:9–13.

– Panda AK. Tracing the historical prospective of Cordyceps sinensis –an aphrodisiac in Sikkim Himalya. Ind J Hist Sci. 2010;45:189–98.

– Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G. Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metabol. 2004;14:236–242.

– Park BT, Na KH, Jung EC, Park JW, Kim HH. Anti-fungal and -cancer activities of a protein from the mushroom Cordyceps militaris. Korean J Physiol Pharmacol. 2009;13:49–54.

– Park, D.K., Choi, W.S., Park, P.J., Kim, E.K., Jeong, Y.J., Choi, S.Y., Yamada, K., Kim, J.D. and Lim, B.O. 2008. Immunoglobulin and cytokine production from mesenteric lymph node lymphocytes is regulated by extracts of Cordyceps sinensis in C57Bl/6N mice. Journal of Medicinal Food, 11(4): 784-788.

– Park NS, Lee KS, Sohn HD, Kim DH. Molecular cloning, expression, and characterization of the Cu, Zn superoxide dismutase (SOD1) gene from the entomopathogenic fungus Cordyceps militaris. Mycologia. 2005;97:130–138.

– Park SE, Kim J, Lee YW, Yoo HS, Cho CK. Antitumor activity of water extracts from Cordyceps militarisin NCI-H460 cell xenografted nude mice. J Acupunct Meridian Stud. 2009;2:294–300.

– Park SE, Yoo HS, Jin CY, Hong SH, Lee YW, Kim BW, Lee SH, Kim WJ, Cho CK, Choi YH. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol. 2009;47:1667–1675.

– Patel S, Goyal A. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech. 2012;2:1–15.

– Pelleg, A. and Porter, R.S.1990. The pharmacology of Adenosine. Pharmacotherapy. 10:157-174.

– Petch, T.1921. Fungi parasitic on scale insects. Brit. Myc. Soc. Trans. 7:18-40.

– Polhe P. Useful Plants of Manang District. Stuttgart: Franz Steiner Verlag Wiesbaden GMBH, Nepal Research Centre Publications. 1990;16:37.

– Rao YK, Fang SH, Wu WS, Tzeng YM. Constituents isolated from Cordyceps militaris suppress enhanced inflammatory mediator’s production and human cancer cell proliferation. J Ethnopharmacol. 2010;131:363–367.

– Rao, Y.K., Fang, S.H. and Tzeng, Y.M.2007. Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis and Cinnamomum osmophloeum bark extracts. Journal of Ethnopharmacology, 114(1):78-85.

– Rockhill WW. Diary of a Journey through Mongolia and Tibet in 1891 and 1892. City of Washington: Smithsonian Institute, 1894:361.

– Rogers, D.P.1954. The genus Cordyceps and Friese’s Observation. Mycologia, 46: 248-253.

– Rottman F, Guarino AJ. The inhibition of phosphoribosyl-pyrophosphate amidotransferase activity by cordycepin mono phosphate. Biochim Biophys Acta. 1964;89:465–472.

– Rukachaisirikul V, Chantaruk S, Tansakul C, Saithong S, Chaicharernwimonkoon L, Pakawatchai C, Isaka M, Intereya K. A cyclopeptide from the insect pathogenic fungus Cordyceps sp. BCC 1788. J Nat Prod. 2006;69:305–307.

– Rukachaisirikul V, Pramjit S, Pakawatchai C, Isaka M, Supothina S. 10- membered macrolides from the insect pathogenic fungus Cordyceps militaris BCC 2816. J Nat Prod. 2004;67:1953–1958.

– Russell R, Paterson M. Cordyceps—a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochem. 2008;69:1469–1495.

– Saccardo, P.A.1883. Cordyceps. Syll Fungi., 2:566-578.

– Sacherer J. The high altitude ethnobotany of the Rolwaling Sherpas. Contributions to Nepalese Studies. Kathmandu: CNAS, Tribhuvan University. 1979;6(2):45-64.

– Shao, G.1985. Treatment of Hyperlipidemia with Cultivated Cordyceps-A double blind, randomized placebo control trial. Chung Hsi I Chieh Ho Tsa Chih. 5:652-665.

– Sharma S. Trade of Cordyceps sinensis from high altitudes of the Indian Himalaya: conservation and biotechnological priorities. Curr Sci. 2004;86:1614–1619.

– Shen FR, Yang DR, Yang YX, et al. Observation on the feeding habits of the larvae of Hepialus baimaensis Liang [In Chinese]. Insect Knowledge. 1990;27(1):36-37.

– Sheng, L., Chen, J.P., Li, J. and Zhang, W.Y.2011. An exopolysaccharide from cultivated Cordyceps sinensis and its effects on cytokine expressions of immunocytes, Applied Biochemistry and Biotechnology, 163(5):669-678.

– Shi, Z., Huijuan, P., Leifa, F., Guoying, L., Yongzhi, W., Binod, P., Pandey, A. and Soccol, C.R. 2009. Advances in research of polysaccharides in Cordyceps species. Food Technology and Biotechnology, 47(3): 304-312.

– Shin, K.H., Lim, S.S., Lee, S., Lee, Y.S., Jung, S.H. and Cho, S.Y. 2003. Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res., 17(7): 830-833.

– Shrestha B, Sung JM. Notes on Cordyceps species collected from the central region of Nepal. Mycobiology. 2005;33:235–239.

– Singh N, Pathak R, Singh AK, Rautela D, Dubey A. Collection of Cordyceps sinensis (Berk.) Sacc. in the interior villages of Chamoli district in Garhwal Himalaya (Uttarakhand) and its social impacts. J Am Sci. 2010;6:5–9.

– Singh, R.P., Pachauri, V., Verma, R.C. and Mishra, K.K.2008. Caterpillar fungus (Cordyceps sinensis) – A Review. J. Eco-friendly Agric., 3(1):1-15.

– Singh, R.P., Verma, R.C., Arora, R.K., Mishra. K.K., Bhanu, C. 2007. Medicinal mushrooms of Uttaranchal with particular reference to Ganoderma, Auricularia and Cordyceps sinensis, Mushroom Biology and Biotechnology Proc, ICMBB eds. RD Rai, SK Singh, MC Yadav and RP Tewari. pp.321-324.

– Siu KM, Mak HFD, Chiu PY, Poon KTM, Du Y, Ko KM. Pharmacological basis of ‘Yin-nourishing’ and ‘Yang-invigorating’ actions of Cordyceps, a Chinese tonifying herb. Life Sci. 2004;76:385–395.

– Song, L.Q., Yu, S.M., Ma, X.P. and Jin, L.X. 2010. The protective effects of Cordyceps sinensis extract on extracellular matrix accumulation of glomerular sclerosis in rats. African Journal of Pharmacy and Pharmacology, 4(7):471-478.

– Sprecher, M. and Sprinson, D.B.1963. A reinvestigation of the structure of Cordycepic acid. Journal of Organic Chemistry, 28:2490-2491.

– Steinkraus, D.C. and Whitefield, J.B.1994. Chinese caterpillar fungus and world record runners. Am. Entomol., 40:235- 239.

– Sugar AM, Mccaffrey RP. Antifungal activity of 3′-deoxyadenosine (cordycepin) Antimicrob Agents Chemother. 1998;42:1424–1427.

– Sun, W., Yu, J., Shi, Y.M., Zhang, H., Wang, Y. and Wu, B.B. 2010. Effects of Cordyceps extract on cytokines and transcription factors in peripheral blood mononuclear cells of asthmatic children during remission stage. Journal of Chinese Integrative Medicine, 8(4): 341-346.

– Thakur A, Hui R, Hongyan Z, Tian Y, Tianjun C, Mingwei C. Pro-apoptotic effects of Paecilomyces hepiali, a Cordyceps sinensis extract on human lung adenocarcinoma A549 cells in vitro. J Can Res and Ther. 2011;7:421–426.

– Tiera, M.1998. The Way of Chinese Herbs, (Pocket Books), pp.255.

– Trigg P, Gutteridge WE, Williamson J. The effect of Cordycepin on malarial parasites. T Roy Soc Trop Med H. 1971;65:514–520.

– Tsai, Y.J., Lin, L.C. and Tsai, T.H. 2010. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. Journal of Agricultural and Food Chemistry, 58(8): 4638-4643.

– Tshe ring nor bu. Bod kyi gso ba rig pa’i sman rdzas rnams spyod yul sman sbyor gang du gsal ba btso sbyang zhun thigs. Dharamsala: Bod gzhung sman  rtsi khang; 2004:360. [Tsering Norbu. The Refining Quintessence Elucidating Whichever Medicinal Preparation on the topic of the Medical Substances in  the Tibetan Science of Healing. Dharamsala: Tibetan Government Astro and Medical Institute; 2004:360.]

– Tsuno A, Taketomo N, Hiroyuki I. Healthful composition obtained from the hot water extract of Cordyceps sinensis mycelia. J Lab Clin Med. 1995;8:134–7.

– Ujita M, Katsuno Y, Suzuki K, Sugiyama K, Takeda E, Yokoyama E, Hara A. Molecular cloning and sequence analysis of the beta-1,3-glucan synthase catalytic subunit gene from a medicinal fungus, Cordyceps militaris. Mycoscience. 2006;47:98–105.

– Unagul P, Wongsa P, Kittakoop P, Intamas S, Srikitikulchai P, Tanticharoen M. Production of red pigments by the insect pathogenic fungus Cordyceps unilateralis BCC 1869. J Ind Microbiol Biot. 2005;32:135–140.

– Wang L, Zhang WM, Hu B, Chen YQ, Qu LH. Genetic variation of Cordyceps militaris and its allies based on phylogenetic analysis of rDNA ITS sequence data. Fungal Divers. 2008;31:147–156.

– Wang, S.M., Lee, L.J., Lin, W.W. and Chang, C.M. 1998. Effects of a water-soluble extract of Cordyceps sinensis on steroidogenesis and capsular morphology of lipid droplets in cultured rat adrenocortical cells. Journal of Cell Biochemistry, 69: 483-489.

– Wang, S.Y. and Shiao, M.S. 2000. Pharmacological functions of Chinese Medicinal Fungus Cordyceps sinensis and related species. Journal of Food and Drug Analysis, 8(4).84-88.

– Wang SY, Shiao MS. Pharmacological function of Chinese medicinal fungus Cordyceps sinensis and related species. J Food Drug Anal. 2000;8:248–57.

– Wanga Z, Heb Z, Lib S, Yuanb Q. Purification and partial characterization of Cu, Zn containing superoxide dismutase from entomogenous fungal species Cordyceps militaris. Enzyme Microb Tech. 2005;36:862–869.

– Wang ZM, Peng X, Lee KLD, Tang JCO, Cheung PCK, Wu JY. Structural characterisation and immunomodulatory property of an acidic polysaccharide from mycelial culture of Cordyceps sinensisfungus Cs-HK1. Food Chem. 2011;125:637–643.

– Wang ZX, Wang XM, Wang TZ. Current status of pharmacological studies on Cordyceps sinensis and Cordyceps hyphae. Chung-Kuo Chung His I Chieh ho Tsa Chih. 1995;15:255–6.

– Wasson R. New York: New York Press; 1968. Gordon, Soma: Divine mushroom of immortality; pp. 3–4.

– Wasserman K, Stringer WW, Casaburi R, et al. Determination of the anaerobic threshold by gas exchange: Biochemical considerations, methodology and physiological effects. Z Kardiol 1994;83(suppl 3):1–12.

– Watanabe N, Hattori M, Yokoyama E, Isomura S, Ujita M, Hara A. Entomogenous fungi that produce 2, 6-pyridine dicarboxylic acid (dipicolinic acid) J Biosci Bioeng. 2006;102:365–373.

– Webster J. Introduction to fungi. 2. Cambridge: Cambridge University Press; 1980. p. 355.

– Weckerle, C.S., Yang, Y.P., Huber, F.K. and Li, Q. H. 2010. People, money, and protected areas: the collection of the caterpillar mushroom Ophiocordyceps sinensis in the Baima Xueshan Nature Reserve, Southwest China. Biodiversity and Conservation, 19(9): 2685-2698.

– Wei, Q., Ya, B.Y., Pu,J.W. and Wei, L.2011. The co-effect of Cordyceps sinensis and strontium on osteoporosis in ovariectomized osteopenic rats. Biological Trace Element Research, 141(1-3): 216-223.

– Wild RG, Mutebi J. Conservation through community use of plant resources: establishing collaborative management at Bwindi Impenetrable and Mgahinga Gorilla National Parks, Uganda. In UNESCO, People and Plants Working Paper 5. 1996:1–45.

– Winkler D. Cordyceps sinensis—a precious parasitic fungus infecting Tibet. Field Mycol. 2010;11:60–67.

– Winkler D. Forest Use and Implications of the 1998 Logging Ban in the Tibetan Prefectures of Sichuan: Case Study on Forestry, Reforestation And NTFP in Litang County, Ganzi TAP, China. In: Jiang Z, Centritto M, Liu S, et al. The ecological basis and sustainable management of forest resources. Informatore Botanico Italiano. 2003;35(2):116-125.

– Winkler D. Panel abstracts: Yartsa Gunbu (Cordyceps sinensis): An ancient medicinal fungus transforming rural Tibet. In: Seventh International Congress on Traditional Asian Medicine, 2008. Thimphu, Bhutan: Institute for Traditional Medicine Services, 2008:7–11.

– Winkler D. Present and historic relevance of Yartsa Gunbu (Cordyceps sinensis).An ancient myco-medicinal in Tibet. Fungi. 2008;1:6–7.

– Winkler D. ‘Yartsa Gunbu (Cordyceps sinensis) and the fungal commodification of the rural economy in Tibet AR. Econ Bot. 2008;63:291–305.

– Winkler D. Yartsa gunbu—Cordyceps sinensis: economy, ecology & ethno-mycology of a fungus endemic to the Tibetan plateau. In: Boesi A, Cardi F. Wildlife and plants in traditional and modern Tibet: conceptions, exploitation, and conservation. Memorie della Società Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano2005;33(1):69-85.

– Wong KL, So EC, Chen CC, Wu RS, Huang BM. Regulation of steroidogenesis by Cordyceps sinensismycelium extracted fractions with (hCG) treatment in mouse Leydig cells. Arch Androl. 2007;53:75–77.

– Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, de Moor CH. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem. 2010;285:2610–2621.

– Wonga JH, Nga TB, Wangb H, Szec SCW, Zhangc KY, Lid Q, Lue X. Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris. Phytomedicine. 2011;18:387–392.

– Wu, J.Y., Zhang, Q.X. and Leung, P, H. 2007. Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomedicine, 14(1):43-49.

– Wu, S.H., Zhang, X.J., Zhang, P. and Chen, Z.H. 2010. Antioxidant activities of the methanolic extracts of four species of Ascomycetes. Mycosystema, 29(1):113-118.

– Wu TN, Yang KC, Wang CM, Lai JS, Ko KN, Chang PY, Liou SH. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ. 1996;182:193–195.

– Wu, Y., Ishurd, O., Sun, C.R. and Pan, Y.J. 2005. Structure analysis and antitumor activity of (1->3) – beta-D-glucans (Cordyglucans) from the mycelia of Cordyceps sinensis. Planta Medica, 71(4): 381-384.

– Xiao, G., Miyazato, A., Abe, Y., Zhang, T.T., Nakamura, K. 2010. Activation of myeloid dendritic cells by deoxynucleic acids from Cordyceps sinensis via a Tolllike receptor 9-dependent pathway. Cellular Immunology, 263(2): 241-250.

– Xiao JH, Xiao DM, Xiong Q, Liang ZQ, Zhong JJ. Nutritional requirements for the hyperproduction of bioactive exopolysaccharides by submerged fermentation of the edible medicinal fungus Cordyceps taii. Biochem Eng J. 2010;49:241–249.

– Xiao, J.H. and Zhong, J.J. 2007. Secondary metabolites from Cordyceps species and their antitumor activity studies. Recent Patents on Biotechnology, 1(2):123-137.

– Xiao YQ, Liu JM, Tu YY. Studies on chemical constituents in Cordyceps sinensis. Bull Chin Mater Med. 1983;8:32–3.

– Xu, W.H., Xuc, Z. and Ma, J.M. 1988b. Water-soluble constituents in Cordyceps sinensis. I. Bull. Chin. Mat. Med., 8: 32-33.

– Xu Y. Drug allergy occurred in a patient after orally taken JinShuiBao capsule. Chin J Chinese Materia Medica. 1994;19:503.

– Xun, C.Q., Shen, N.Y., Li, B.L., Zhang, Y.H., Wang, F., Yang, Y.X., Shi, X., Schafermyer, K., Brown, S.A. and Thompson, J.S. 2008. Radiation mitigation effect of cultured mushroom fungus Hirsutella sinensis (Corimmune) isolated from a Chinese/Tibetian herbal preparation Cordyceps sinensis, International Journal of Radiation Biology, 84(2):139-149.

– Yamaguchi, Y., Kagota, S., Nakamura, K., Shinozuka, K. and Kunitomo, M. 2000. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother. Res., 14:647-649.

– Yan JK, Li L, Wang ZM, Wu JY. Structural elucidation of an exopolysaccharide from mycelia fermentation of a Tolypocladium sp. fungus isolated from wild Cordyceps sinensis. Carbohydr Polym. 2010;79:125–130.

– Yang BK, Ha JY, Jeong SC, Das S, Yun JW, Lee YS, Choi JW, Song CH. Production of exo-polymers by submerged mycelial culture of Cordyceps militaris and its hypolipidemic effect. J Microbio Biotechnol. 2000;10:784–788.

– Yang FQ, Feng K, Zhao J, Li SP. Analysis of sterols and fatty acids in natural and cultured Cordyceps by one-step derivatization followed with gas chromatography mass spectrometry. J Pharm Biomed Anal. 2009;49:1172–1178.

– Yang FQ, Li DQ, Feng K, Hu DJ, Li SP. Determination of nucleotides, nucleosides and their transformation products in Cordyceps by ion-pairing reversed-phase liquid chromatography-mass spectrometry. J Chromatogr A. 2010;1217:5501–5510.

– Yang, H.D., Ma, Z.L., Sun, T.Q., Zhang, X.C. and Cai, J.G. 1985. Comparative study on the chemical constituents between xiangbangchongcao (Cordyceps barnessi) and Cordyceps (Cordyceps sinensis).Chinese Traditional Herbal Drugs.16:194-195.

– Yarnell, E. and Abascal, K. 2008. Lupus erythematosus and herbal medicine. Alternative and Complementary Therapies, 14(1): 9-12.

– Ye MQ, Hu Z, Fan Y, He L, Xia FB, Zou GL. Purification and characterization of an acid deoxyribonuclease from the cultured mycelia of Cordyceps sinensis. J Biochem Mol Biol. 2004;37:466–473.

– Yoo HS, Shin JW, Cho JH, Son CG, Lee YW, Park SY, Cho CK. Effects of Cordyceps militaris extract on angiogenesis and tumor growth. Acta Pharm Sinic. 2004;25:657–665.

– You-Ping Zhu. Australia: Harwood Academic Publication; 1998. Chinese Material Medical – Chimistry, Pharmacology and Appilcation; pp. 10–121.

– Yu R, Yin Y, Yang W, Ma W, Yang L, Chen X, Zhang Z, Ye B, Song L. Structural elucidation and biological activity of a novel polysaccharide by alkaline extraction from cultured Cordyceps militaris. Carbohydr Polym. 2009;75:166–171.

– Yu RM, Yang W, Song LY, Yan CY, Zhang Z, Zhao Y. Structural characterization and antioxidant activity of a polysaccharide from the fruiting bodies of cultured Cordyceps militaris. Carbohydr Polym. 2007;70:430–436.

– Yu thog yon tan mgon po. bDud rtsi snying po yan lag brgyad pa gsang ba man ngag gi rgyud. Lhasa: Bod ljongs mi dmangs dpe skrun khang; 1992. [Yuthog Yonten Gonpo. Tantra of Secret Instructions on the Eight Branches, the Essence of the Elixir of Immortality. Lhasa: Tibetan People Press; 1992.]

– Yuan JP, Wang JH, Liu X, Kuang HC, Zhao SH. Simultaneous determination of free ergosterol and ergosteryl esters in Cordyceps sinensis by HPLC. Food Chem. 2007;105:1755–1759.

– Yue D, Feng X, Liu H, Bao TT. Cordyceps sinensis. Advanced study for traditional Chinese herbal medicine. Beijing Medical University and Peking Union Medical University Press, 1995:91–11.

– Yue, G., Lau, B., Fung, K., Leung, P. and Ko, W. 2008. Effects of Cordyceps sinensis, Cordyceps miltaras and their isolated compounds onion transport in Calu-3 human airway epithelial cells. Journal of Ethnopharmacology, 117(1):92-101.

– Yue K, Ye M, Zhou Z, Sun W, Lin X. The genus Cordyceps: a chemical and pharmacological review. J Pharm Pharmacol. 2012.

– Yun Y, Han S, Lee S, Ko S, Lee C, Ha N, Kim K. Anti-diabetic effects of CCCA, CMESS, and cordycepin from Cordyceps militaris and the immune responses in streptozotocin- induced diabetic mice. Nat Prod Sci. 2003;9:291–298.

– Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67:453–468.

– Zhang G, Huang Y, Bian Y, Wong JH, Ng TB, Wang H. Hypoglycemic activity of the fungi Cordyceps militarisCordyceps sinensisTriccholoma mongolicum, and Omphalia lapidescens in streptozotocin-induced diabetic rats. Appl Microbiol Biotechnol. 2006;72:1152–1156.

– Zhang Q, Wu J, Hu Z, Zhang D. Induction of HL-60 apoptosis by ethyl acetate extract of Cordyceps sinensis fungal mycelium. Life Sci. 2004;75:2911–2919.

– Zhang XL, Cheng LB, Assaf SA, Phillips GO, Phillips AO. Cordyceps sinensis decreases TGF-b1 dependent epithelial to mesenchymal transdifferentiation and attenuates renal fibrosis. Food Hydrocolloids. 2012;28:200–212.

– Zhang Y, Liu X, Wang M. Cloning, expression, and characterization of two novel cuticle-degrading serine proteases from the entomopathogenic fungus Cordyceps sinensis. Res Microbiol. 2008;159:462–471.

– Zhao, C.S., Yin, W.T., Wang, J.Y., Zhang, Y., Yu, H., Cooper, R., Smidt, C. and Zhu, J.S. 2002. Cordyceps Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J. Altern. Complement. Med., 8(4):403-405.

– Zhao, X. 1993.Cordyceps sinensis in protection of the kidney from cyclosporine A nephrotoxicity, Chung Hua I Hsueh Tsa Chih. 73:410-441.

– Zhen, F.1992. Mechanisms and therapeutic effect of Cordyceps sinensis (CS) on aminoglycoside induced acute renal failure (ARF) in rats.Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 12:288-329.

– Zhen, Y.Z., Chuan, L.S., Yue, R.Z., Chang, M.Z, Jia, P.Z., An, J.L. and Yong, M.Z. 2011. The purification and antioxidative activities in D-galactose-induced aging mice of a water-soluble polysaccharide from Cordyceps gunnii (berk. ) Berk. Mycelium. Journal of Food Biochemistry, 35(1):303-322.

– Zhong, X., Peng, Q.Y., Qi, L.L., Lei, W. and Liu, X. 2010. rDNA-targeted PCR primers and FISH probe in the detection of Ophiocordyceps sinensis hyphae and conidia. Journal of Microbiological Methods, 83(2): 188-193.

– Zhou, L.1990. Short term curative effect of cultured Cordyceps sinensis (Berk) Sacc. Mycelia in Chronic Hepatitis B. Chang Kuo Chung Yao Tsa Chih.(Chinese Journal)19:53- 55.

– Zhu JS, Halpern GM, Jones K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis. Part I. Journal of Alternative and Complementary Medicine 1998;4:289–303.

– Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis. Part II. J Altern Complement Med 1998;4:429–457.

– Zhu, J.S., Halpern, G.M. and Jones, K. 1998b. The Scientific Rediscovery of an Ancient Chinese Herbal Medicine: Cordyceps sinensis Part 11. Journal of Alternative and Complementary Medicine, 4(4):429-457.

– Zhu JS, Rippe JM. CordyMax enhances aerobic capability, endurance performance, and exercise metabolism in healthy, mid-age to elderly sedentary humans. FASEB Journal. 2004;18(4):A931.

– Zhou X, Gong Z, Su Y, Lin J, Tang K. Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmcol. 2009;61:279–291.

– Zhou X, Luo L, Dressel W, Shadier G, Krumbiegel D, Schmidtke P, Zepp F, Meyer CU. Cordycepin is an immunoregulatory active ingredient of Cordyceps sinensis. Am J Chin Med. 2008;36:967–980.

– Zur mkhar ba mnyam nyid rdo rje. Man ngag bye ba ring bsrel. Beijing: Mi rigs dpe khrung khang, 2005. [Zurkhar Namnyi Dorje. Ten Millions of Instructions: a Relic. Beijing: Nationalities Languages Press; 2005.]

References for Trametes Coriolus versicolor

– AB Miller, B Hoogstraten, M Staquet A. Reporting results of cancer treatment Cancer, 47 (1981), pp. 207-214.

– A Kauppila, V Raunio, PJ Taskinen Immunosuppressive effect of radiotherapy on patients with lung cancer Ann Clin Res, 8 (1976), pp. 98-103.

– A Keys, F Fidanza, MJ Karvonen Indices of relative weight and obesity J Chron Dis, 25 (1972), pp. 329-343.

– Andersen BL, Farrar WB, Golden-Kreutz D, et al. Stress and immune responses after surgical treatment for regional breast cancer. Journal of the National Cancer Institute. 1998;90(1):30–36.

– Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncologica2007;46(4):417-32.

– B Lam, WK Lam, CL Lam Adenocarcinoma of the lung in Chinese patients: a re-visit and some perspectives from the literature Postgrad Med J, 77 (2001), pp. 708-712.

– Barkholt L, Alici E, Conrad R, et al. Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study. Immunotherapy. 2009;1(5):753–764.

– Bryant J, Day R, Whiteside TL, Herbermann RB. Calculation of lytic units for the expression of cell-mediated cytotoxicity. Journal of Immunological Methods. 1992;146(1):91–103.

– C Nunez, D Gallagher, M Visser Heymsfield. Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact foot-pad electrodes Med, 29 (1997), p. Sci Sports Exerc 4th ser.

– CF Mountain Revisions in the international system for staging lung cancer Chest, 111 (1997), pp. 1710-1717.

– Chan SL, Yeung JH. Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells. Food and Chemical Toxicology 2006;44(5):689-94.

– Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: Chemical Industry Press, 2005.

– Chu KKW, Ho SSS, Chow AHL. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. Journal of Clinical Pharmacology. 2002;42(9):976–984.

– Cooley S, Weisdorf DS. Natural killer cells and tumor control. Current Opinion in Hematology. 2010;17(6):514–521.

– Cunningham-Rundles S, Filippa DA, Braun DW. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. Journal of the National Cancer Institute. 1981;67(3):585–590.

– DH Johnson Evolution of cisplatin-based chemotherapy in non-small cell lung cancer. A historical perspective and the Eastern Cooperative Oncology Group experience Chest, 117 (2000), pp. 133S-137S.

1- Eliza WL, Fai CK, Chung LP. Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Patents on Inflammation and Allergy Drug Discovery 2012;6(1):78-87.

– Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Research. 2002;22(3):1737–1754.

– Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58:579-88.

– Garcia-Lora A, Martinez M, Pedrinaci S, Garrido F. Different regulation of PKC isoenzymes and MAPK by Krestin (PSK)™ and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunol Immunother. 2003;52:59–64.

– Garcia-Lora A, Pedrinaci S, Garrido F. Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunol Immunother. 2001;50:191–198.

– GD Yu, QZ Yin, YM Hu. Effects of Coriolus versicolor polysaccharides peptides on electric activity of mediobasal hypothalamus and on immune function in rats Zhongguo Yao Li Xue Bao, 17 (1996), pp. 271-274.

– Go P, Chung CH. Adjuvant Krestin (PSK)™ immunotherapy in patients with carcinoma of the nasopharynx. J Int Med Res. 1989;17:141–149.

– Gray NM, Hall SJ, Browne S, Macleod U, Mitchell E, Lee AJ, et al. Modifiable and fixed factors predicting quality of life in people with colorectal cancer. British Journal of Cancer2011;104(11):1697-703.

– Group Non-small Cell Lung Cancer Collaborative Chemotherapy in non-small cell lung cancer: meta-analysis using updated data in individual patients from 52 randomized clinical trials BMJ, 311 (1995), pp. 899-909.

– H Nakazato, A Koike, S Saji. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer Lancet, 343 (1994), pp. 1122-1126.

– Habelhah H, Okada F, Nakai K, et al. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K. Cancer Immunol Immunother. 1998;46:338–344.

– Harada M, Matsunaga K, Oguchi Y, et al. Oral administration of Krestin (PSK)™ can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Int J Cancer. 1997;70:362–372.

– Hayakawa K, Mitsuhashi N, Saito Y, et al. Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. Anticancer Res. 1993;13:1815–1820.

– Hayashida Y, Kurimoto S, Yamamoto N. Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: enhancement of the activity by a polysaccharide preparation, Krestin. Biochem Biophys Res Commun. 1991;174:107–114.

– Higgins JPT, Green S (editors). Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011.

– Hirono M, Yoshinaka K, Matsuki K, et al. Surgical treatment of Borrmann type 4 (diffuse) gastric cancer. Gan No Rinsho. 1984;30:717–723.

– Hirose K, Zachariae CO, Oppenheim JJ, Matsushima K. Induction of gene expression and production of immunomodulating cytokines by Krestin (PSK)™ in human peripheral blood mono-nuclear cells. Lymphokine Res. 1990;9:475–483.

– Hobbs C. Medicinal value of turkey tail fungus Trametes versicolor (L.:Fr.) Pilat (aphyllophoromycetideae) Int J Med Mushrooms. 2004;6:195–218.

– Hong F, Hansen RD, Yan J, et al. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 2003;63:9023–9031.

– IH Lin, DM Hau, YH Chang. Restorative effect of Coriolus versicolor polysaccharides against gamma-irradiation-induced spleen injury in mice Zhongguo, 17 (1996), pp. Yao Li Xue Bao-104.

– Iino Y, Yokoe T, Maemura M, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res. 1995;15:2907–2911.

– Ikuzawa M, Matsunaga K, Nishiyama S, Nakajima S, Kobayashi Y, Andoh T, et al. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). International Journal of Immunopharmacology 1988;10(4):415-23.

– Imaizumi M, Kondo T, Kamei H, Ichihashi H. Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo’s group) Gan To Kagaku Ryoho. 1990;17:2397–2403.

– International Agency for Research on Cancer and Cancer Research UK. World Cancer Factsheet. London: Cancer Research UK 2012.

– Ito K, Nakazato H, Koike A, et al. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis. 2004;19:157–164.

– J Liu, J Zhou Phase II clinical trial for PSP capsules Q Yang, C Kwok (Eds.), PSP International Symposium, Fudan University Press, Hong Kong (1993), pp. 1208-1993.

– JH Schiller, D Harrington, CP Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med, 346 (2002), pp. 92-98.

– Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews 2012, Issue 6.

– K Hayakawa, N Mitsuhashi, Y Saito Effect of Krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer Anticancer Res, 13 (1993), pp. 1815-1820.

– K Ogoshi, H Satou, K Isono Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study Cancer Invest, 13 (1995), pp. 363-369.

– Kanabe S, Tamakuma S, Mimura K, et al. Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma. Gan No Rinsho. 1985;31:1805–1809.

– Kanazawa M, Yoshihara K, Abe H, et al. Effects of Krestin (PSK)™ on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res. 2005;25:443–449.

– Kariya Y, Inoue N, Kihara T, et al. Activation of human natural killer cells by the protein-bound polysaccharide Krestin (PSK)™ independently of interferon and interleukin 2. Immunol Lett. 1992;31:241–245.

– Kato M, Hirose K, Hakozaki M, et al. Induction of gene expression for immunomodulating cytokines in peripheral blood mono-nuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother. 1995;40:152–156.

– Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review 2000;5(1):4-27.

– Kobayashi H, Matsunaga K, Oguchi Y. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiology Biomarkers and Prevention. 1995;4(3):275–281.

– Koda K, Miyazaki M, Sarashina H, et al. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. Int J Oncol. 2003;23:165–172.

– Kondo T, Sakamoto J, Nakazato H. Alternating immunochem-otherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and Krestin (PSK)™ to carbazilquinone in patients with curative gastric resection. Biotherapy. 1991;3:287–295.

– Lindequist U, Niedermeyer TH, Julich WD. The pharmacological potential of mushrooms. Evidence Based Complementary and Alternative Medicine 2005;2(3):285-99.

– Liu F, Fung MC, Ooi VE, Chang ST. Induction in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. Life Sci. 1996;58:1795–1803.

– Lu H, Yang Y, Gad E, et al. Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clinical Cancer Research. 2011;17(1):67–76.

– M Torisu, Y Hayashi, T Ishimitsu. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer Cancer Immunol Immunother, 31 (1990), pp. 261-268.

– Maehara Y, Moriguchi S, Sakaguchi Y, et al. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection. J Surg Oncol. 1990;45:169–172.

– Maehara Y, Sugimachi K, Akagi M, et al. Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer. Br J Cancer. 1992;65:413–416.

– Maehara Y, Tsujitani S, Saeki H, Oki E, Yoshinaga K, Emi Y, et al. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives. Surgery Today 2012;42(1):8-28.

– Matsui T, Omura K, Kawakami K, et al. Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer. Oncol Rep. 2006;16:1111–1115.

– ME Trudeau Docetaxel: a review of its pharmacology and clinical activity Can J, 6 (1996), pp. Oncol-457 MC Bissery Preclinical pharmacology of docetaxel Eur J Cancer, 31A (1995), pp. S1-6.

– Melief CJM. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Advances in Cancer Research. 1992;58:143–175.

– Mitomi T, Tsuchiya S, Iijima N, et al. Randomized controlled study on adjuvant immunochemotherapy with Krestin (PSK)™ in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum. Gan To Kagaku Ryoho. 1989;16:2241–2249.

– Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant immunochemotherapy with Krestin (PSK)™ in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa) Dis Colon Rectum. 1992;35:123–130.

– Mizutani Y, Yoshida O. Activation by the protein-bound polysaccharide Krestin (PSK)™ (Krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer. J Urol. 1991;145:1082–1087.

– MM Yang, Z Chen, JS Kwok. The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV) Am J Chin Med, 20 (1992), pp. 221-232.

– Modak S, Koehne G, Vickers A, et al. Rituximab therapy of lymphoma is enhanced by orally administered (1–>3),(1–>4)-D-beta-glucan. Leuk Res. 2005;29:679–683.

– Morimoto T, Ogawa M, Orita K, et al. Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for vreast cancer (ACETBC) of Japan. European Journal of Cancer. 1996;32(2):235–242.

– Motzer SA, Tsuji J, Hertig V, Johnston SK, Scanlan J. Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry. Biological Research for Nursing. 2003;5(2):142–152.

– Munemoto Y, Iida Y, Abe J, et al. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: association between host or tumor factors and survival. Int J Oncol. 2002;20:403–411.

– Nakajima T, Inokuchi K, Hattori T, et al. Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer—five-year survival rate. Gan To Kagaku Ryoho. 1989;16:799–806.

– Nakazato H, Ichihashi H, Kondo T. Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group. Gan To Kagaku Ryoho. 1986;13:308–318.

– Nakazato H, Koike A, Ichihashi H, et al. An effect of adjuvant immunochemotherapy using Krestin and 5-FU on gastric cancer patients with radical surgery (first report)—a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with Krestin (PSK)™ for Gastric Cancer. Gan To Kagaku Ryoho. 1989;16:2563–2576.

– Nakazato H, Koike A, Saji S, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with Krestin (PSK)™ for Gastric Cancer. Lancet. 1994;343:1122–1126.

– National Institute for Health and Clinical Excellence. Colorectal cancer: The diagnosis and management of colorectal cancer. CG131 . London: National Institute for Health and Clinical Excellence 2011.

– Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). General Pharmacology1998;30(1):1-4.

– Niimoto M, Hattori T, Tamada R, et al. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and Krestin (PSK)™ for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg. 1988;18:681–686.

– Nio Y, Shiraishi T, Tsubono M, et al. In vitro immunomodulating effect of protein-bound polysaccharide, Krestin (PSK)™ on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer. Cancer Immunol Immunother. 1991;32:335–341.

– Nio Y, Tsubono M, Tseng CC, et al. Immunomodulation by orally administered protein-bound polysaccharide Krestin (PSK)™ in patients with gastrointestinal cancer. Biotherapy. 1992;4:117–128.

– Ogoshi K. Evaluation of immunotherapy with Krestin (PSK)™ in esophageal cancer. Gan To Kagaku Ryoho. 1988;15:3143–3151.

– Ogoshi K, Satou H, Isono K, et al. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. American Journal of Clinical Oncology. 1995;18(3):216–222.

– Ogoshi K, Satou H, Isono K, et al. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. Cancer Invest. 1995;13:363–369.

– Ogoshi K, Tajima T, Mitomi T, et al. HLA-A2 antigen status-predicts metastasis and response to immunotherapy in gastric cancer. Cancer Immunol Immunother. 1997;45:53–59.

– Ohmura Y, Matsunaga K, Motokawa I, et al. Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-alpha induction. Int Immunopharmacol. 2001;1:1797–1811.

– Ohwada S, Ikeya T, Yokomori T et al. Adjuvant immunochemotherapy with oral tegafur/uracil plus Krestin (PSK)™ in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer. 2004;90:1003–1010.

– Ohwada S, Kawate S, Ikeya T, et al. Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial. Dis Colon Rectum. 2003;46:1060–1068.

88- Ohwada S, Ogawa T, Makita F, et al. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters. Oncol Rep. 2006;15:861–868.

– Okuzawa M, Shinohara H, Kobayashi T, et al. PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro. Int J Oncol. 2002;20:1189–1195.

– Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000;7:715–729.

– Osawa S, Shiroto H, Kondo Y, et al. Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer. Gan To Kagaku Ryoho. 1996;23:327–331.

– PA Bunn, K Kelly. New combinations in the treatment of lung cancer. A time for optimism Chest, 117 (2000), pp. 138S-143S.

– Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technology Assessment 2006; Vol. 10, issue 41:1-185.

– PM Kidd. The use of mushroom glucans and proteoglycans in cancer treatment Altern Med Rev, 5 (2000), pp. 4-27.

– Price LA. Medicinal mushroom-induced activation of macro-phages and splenocytes is mediated by the toll 4 receptor. North American Conference on Complementary and Alternative Medicine.2007.

– Qian ZM, Xu MF, Tang PL. Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. Am J Chin Med. 1997;25:27–35.

– Rowan N, Sullivan R. Immunomodulatory activities of mushroom glucans and polysaccharide–Protein complexes in animals and humans (a review). International Journal of Medicinal Mushrooms 2003;5:95-110.

– Saji S, Sakamoto J, Teramukai S, et al. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with Krestin (PSK)™ for Gastric Cancer. Surg Today. 1999;29:504–510.

– Sakamoto J, Koike A, Saji S, et al. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK. Surg Today. 1992;22:530–536.

– Sakamoto J, Morita S, Oba K, et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother. 2006;55:404–411.

– Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, et al. Meta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunology, Immunotherapy: CII 2006;55(4):404-11.

– Schmidt C. Immune system’s Toll-like receptors have good opportunity for cancer treatment. J Natl Cancer Inst. 2006;98:574–575.

– Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J, et al. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. Journal of Clinical Oncology 2007;25(1):102-9.

– Shibata M, Nezu T, Kanou H, et al. Immunomodulatory effects of low dose cis-diaminedichloroplatinum (cisplatin) combined with UFT and Krestin (PSK)™ in patients with advanced colorectal cancer. Cancer Invest. 2002;20:166–173.

– Smith JE, Rowan NJ, Sullivan R. Medicinal Mushrooms and Cancer: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments. London: Cancer Research UK, 2000.

– Standish LJ, Alschuler LN, Ready AB, et al. Botanical medicine in integrative oncology. In: Abrams DI, Weil AT, editors. Integrat ed Oncology. New York, NY, USA: Oxford University Press; 2009. pp. 104–146.

– Standish LJ, Torkelson C, Hamill FA, et al. Immune defects in breast cancer patients after radiotherapy. Journal of the Society for Integrative Oncology. 2008;6(3):110–121.

– Standish LJ, Wenner CA, Sweet ES, Bridge C, Nelson A, Martzen M, et al. Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society of Integrative Oncology2008;6(3):122-8.

– Suck G, Koh MBC. Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectors. Hematology. 2010;3(3):135–142.

– Sugimachi K, Inokuchi K, Matsuura H et al. Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival. Jpn J Surg. 1984;14:217–221.

– Sugimachi K, Maehara Y, Ogawa M, et al. Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer. Cancer Chemother Pharmacol. 1997;40:233–238.

– Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspectives in Biology and Medicine 2006;49(2):159-70.

– Takashima S, Kinami Y, Miyazaki I. Clinical effect of post-operative adjuvant immunochemotherapy with the FT-207 suppository and Krestin (PSK)™ in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku. Gan To Kagaku Ryoho. 1988;15:2229–2236.

– Takahashi Y, Mai M, Nakazato H. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using Krestin (PSK)™ and 5-FU. Anticancer Res. 2005;25:1377–1384.

– Tamada R, Inokuchi K, Hattori T, et al. A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II) Gan To Kagaku Ryoho. 1987;14:716–722.

– TC Hsieh, JM Wu. Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells Int J Oncol, 18 (2001), pp. 81-88.

– The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

– Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000;92(3):205-16.

– Tichatschek E, Zielinski CC, Muller C, et al. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunology Immunotherapy. 1988;27(3):278–282.

– Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep. 2000;7:1157–1161.

– Toi M, Hattori T, Akagi M, et al. Randomized adjuvant trial to evaluate the addition of tamoxifen and Krestin (PSK)™ to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization. Cancer. 1992;70:2475–2483.

– Torisu M, Hayashi Y, Ishimitsu T, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother. 1990;31:261–268.

– Tsang KW, Lam CL, Yan C, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med. 2003;97:618–624.

– Ueda Y, Fujimura T, Kinami S, et al. A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus Krestin (PSK)™ for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC) Jpn J Clin Oncol. 2006;36:519–522.

– Wada T, Iijima H, Sekine F, et al. Effect of Krestin (PSK)™ on Th1/Th2 balance in tumor-bearing mice. Gan To Kagaku Ryoho. 2003;30:1798–1801.

– WK Lam, KW Tsang, MS Ip. Chemotherapy for advanced (stage III B and stage IV) non-small cell lung cancer: the Hong Kong perspective Respirology, 3 (1998), pp. 145-149.

– XW Mao, JO Archambeau, DS Gridley. Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor Cancer Biother, 11 (1996), pp. Radiopharm-403.

– XW Mao, LM Green, DS Gridley. Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation Oncology, 61 (2001), pp. 243-253.

– XY Li, JF Wang, PP Zhu. Immune enhancement of a polysaccharides peptides isolated from Coriolus versicolor Zhongguo Yao Li Xue Bao, 11 (1990), pp. 542-545.

– Y Dong, CY Kwan, ZN Chen. Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies Res Commun Mol Pathol Pharmacol, 92 (1996), pp. 140-148.

– Yagita A, Maruyama S, Wakasugi S, Sukegawa Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo. 2002;16:49–54.

– Yamashita K, Ougolkov AV, Nakazato H, et al. Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic beta-catenin activation. Dis Colon Rectum. 2007;50:1169–1181.

– Yamazaki H, Yoshioka Y, Inoue T, et al. Changes in natural killer cell activity by external radiotherapy and/or brachytherapy. Oncology Reports. 2002;9(2):359–363.

– Yang QY. Yun Zhi polysaccharopeptide (PSP) and the general aspects of its research. Fung Sci. 1997;12:1–8.

– Yefenof E, Gafanovitch I, Oron E, et al. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunol Immunother. 1995;41:389–396.

– Yeung JH, Or PM. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes. Phytomedicine 2012;19(5):457-63.

– Yokoe T, Iino Y, Takei H, et al. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Anticancer Res. 1997;17:2815–2818.

– Yoshino S, Oka M, Hazama S, Suzuki T. Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis. Gan To Kagaku Ryoho. 1990;17:1588–1591.

– Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Applied Microbiology and Biotechnology. 2005;67(4):453–468.

– ZM Qian, MF Xu, PL Tang. Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats Am J Chin Med, 25 (1997), pp. 27-35.

References for Pleurotus Ostreatus

– AACC (2000). Approved methods of analysis. American Association of Cereal Chemists. St. Paul Minnesota.

– Ahmad, I., 1986. Some studies on oyster mushroom (Pleurotus spp.) on waste material of corn industry. M.Sc. thesis. Department of Plant Pathology, Faisalabad, p. 50.

– Aishah, M., & Wan Rosli, W. (2013). Effect of different drying techniques on the nutritional values of oyster mushroom (Pleurotus sajor-caju). Sains Malaysiana, 42, 937–941.

– Akbarirad, H., Kazemeini, S. M., & Shariaty, M. A. (2013). Deterioration and some of applied preservation techniques for common mushrooms (Agaricus bisporus, followed by Lentinus edodes, Pleurotus spp.). The Journal of Microbiology, Biotechnology and Food Sciences, 2, 2398.

– Akyuz, M., Kirbag, S. Nutritive values of wild edible and cultivated mushrooms. Turk. J. Biol.2010;34:97–102.

– Akyuz, M., Yildiz, A., 2008. Evaluation of cellulosic wastes for the cultivation of Pleurotus eryngii (DC. ex pr) Quel. Afr. J. Biotechnol., 7: 1494-1499.

– Alam, N., A. Khan, M.S. Hossain, S.M.R. Amin and L.A. Khan, 2007. Nutritional Analysis of Dietary mushroom – Pleurotus florida 148 Eger and Pleurotus sajor-caju (Fr.) Singer. Bangladesh J. Mushroom, 1 (2): 1-7.

– Alam, N., R. Amin, A. Khan, I. Ara, M.J. Shim, M.W. Lee and T.S. Lee, 2008. Nutritional analysis of cultivated mushrooms in Bangladesh – Pleurotus ostreatus, Pleurotus sajor-caju, Pleurotus florida and Calocybe indica. Mycobiology, 36 (4): 228-232.

– Andersen CL, Jensen JL, Orntoft TF. 2004. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250. doi:10.1158/0008-5472.CAN-04-0496.

– Anderson, N., 2008. Cultivation of Pleurotus sajor-caju on unsterilized coconut husk pith. Plant Archives, 8 (1): 415-416.

– Antihyperlipidemic effect of Pleurotus ostreatus in HIV: results of a pilot proof-of-principle clinical trial. Abrams D.I, Couey P, Shade S.B, Kelly M.E, Kamanu-Elias N, Stamets P.E. Int J Med Mushr. 2007;9(3):204.

– AOAC (Association of Official Analytical Chemists) International, (1995). Official methods of analysis of the Association of Official Analytical Chemists (16th ed.). Arlington, VA, USA. Association of Analytical communities.

– Apati, G. P., Furlan, S. A., & Laurindo, J. B. (2010). Drying and rehydration of oyster mushroom. Brazilian Archives of Biology and Technology, 53, 945–952.

– Argyropoulos, D., Heindl, A., & Muller, J. (2008). Evaluation of processing parameters for hot-air drying to obtain high quality dried mushrooms in the Mediterranean region. Paper presented at the Conference on International Research on Food Security, Natural Resource Management and Rural Development, University of Hohenheim, Stuttgart, Germany.

– Arumuganathan, T., Manikantan, M., Indurani, C., Rai, R., & Kamal, S. (2010). Texture and quality parameters of oyster mushroom as influenced by drying methods. International Agrophysics, 24, 339–342.

– Awad, W.A., Ghareeb, K., Abdel-Raheem, S., Böhm, J. Effects of dietary inclusion of probiotic and synbiotic on growth performance, organ weights, and intestinal histomorphology of broiler chickens. J. Poult. Sci. 2009;88:49–55.

– Baars, J.J.P., P.M. Hendrick and A.S.M. Sonnenberg, 2004. Prototype of sporeless oyster mushroom. Mushcoom Sci., 16: 139-147.

– Bano, Z., K.S. Srinivasan, H.C. Srivastava, 1963. Amino acid composition of the protein from a mushroom (Pleurotus flabellatus). Appl. Miicrobiol., 11: 184-187.

– Bano, Z. and S. Rajarathnam, 1982. Pleurotus mushrooms as a nutritious food. In: Tropical mushrooms – Biological Nature and cultivation methods (Chang S.T. Quimio, TH, eds.). The Chinese University Press, Hong Kong, pp. 363-382.

– Bano, Z. and S. Rajarathnam, 1988. Pleurotus mushroom Part II. Chemical composition, nutritional value, post-harvest physiology, preservation and role as human food. Crit. Rev. Food Sci. Nutr., 27: 87-158.

– Baysal, E, H. Peker, M.K. Yalinkilic, A. Temis, 2003. Cultivation of oyster mushroom on waste paper with some added supplementary materials. Biores. Technol., 89: 95-97.

– Bernardi, E., E. Minotto, J.S. Nascimento, 2008. Aproveitamento de residuo de curtume como suplemento no cultivo de Pleurotus ostreatus. Arq. Inst. Biol., 72: 243-246.

– Bishayee, A., Mandal, A. Trianthema portulacastrum Linn., exerts chemoprevention of 7,12-dimethybenz(a)anthracene-induced mammary tumorigenesis in rats. Mutat. Res. 2014;768:107–118.

– Björkem, I, Lewenhaupt, A. Preferential utilization of newly synthesized cholesterol as substrate for bile acid biosynthesis. J Biol Chem. 1979;254:5252–5256.

– Bobek, P, Chorváthová, V, Ginter, E. Hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rat with streptozotocine diabetes. Biologia. 1991;46:1025–1030.

– Bobek, P., Galbavý, Š. Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung. 1999;43:339–342.

– Bobek, P., & Ginter, E. (1993). Effect of the oyster fungus on glycemia and cholesterolemia in rats with insulin-dependent diabetes. Physiological Research, 42, 175–179.

– Bobek, P, Ginter, E, Jurčovičová, M, Kuniak, Ĺ. Cholesterol-lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann Nutr Metab. 1991;35:191–195.

– Bobek, P, Ginter, E, Jurčovičová, M, Ozdín, Ĺ, Mekiňová, D. Effect of oyster fungus (Pleurotus ostreatus) on serum and liver lipids of syrian hamsters with a chronic alcohol intake. Physiol Res. 1991;40:327–332.

– Bobek, P, Ginter, E, Kuniak, Ĺ, Babala, J, Jurčovičová, M, Ozdín, Ĺ, Červeň, J. Effect of mushroom Pleurotus ostreatus and isolated fungal polysaccharide on serum and liver in syrian hamsters with hyperlipoproteinemia. Nutrition. 1991;7:105–108.

– Bobek, P, Ginter, E, Ozdin, L. Oyster mushroom (Pleurrotus ostreatus) accelerates the plasma clearance of low-density and high-density lipoproteins in rats. Nutr Res. 1993;13:885–890.

– Bobek P, Hromadová M, Ozdin L. Oyster mushroom (Pleurotus ostreatus) reduces the activity of 3-hydroxy-3-methylglutaryl CoA reductase in rat liver microsomes. Experientia (accepted).

– Bobek, P, Kuniak, Ĺ, Ozdín, Ĺ. The mushroom Pleurotus ostreatus reduces secretion and accelerates the fractional turnover rate of very-low-density lipoproteins in rat. Ann Nutr Metab. 1993;37:142–145.

– Bobek, P, Ozdin, L, Kuniak, L. Influence of water and ethanol extracts of the oyster mushroom (Pleurotus ostreatus) on serum and liver lipids of the syrian hamsters. Die Nahrung. 1993;6:571–575.

– Bobek, P, Ozdin, L, Kuniak, L. Mechanism o hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats: reduction of cholesterol absorption and increase of plasma cholesterol removal. Ztschr Ernährungswiss. 1994;33:45–50.

– Bohle K, Jungebloud A, Gocke Y, Dalpiaz A, Cordes C, Horn H, Hempel DC. 2007. Selection of reference genes for normalisation of specific gene quantification data of Aspergillus niger. J Biotechnol 132:353–358. doi:10.1016/j.jbiotec.2007.08.005.

– Bonatti, M., P. Karnopp, H.M. Soares, A.S. Furlan, 2003. Estudo da composicao de cogumelos das species Pleurotus ostreatus e Pleurotus sajor-caju, cultivados em palha de bananeira. Rev. Saude Amb., 4: 31-35.

– Bonatti, M., P. Karnopp, H.M. Soares and S.A. Furlan, 2004. Evaluation of Pleurotus ostreatus and Pleurotus sajor-caju nutritional characteristics when cultivated in different lignocellulosic wastes. Food Chem., 88 (3): 425-428.

– Bradford, MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem. 1976;72:248–254.

– Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622. doi:10.1373/clinchem.2008.112797.

– Caglairmak, Necla, 2007. The nutrients of exotic mushrooms (Lentinula edodes and Pleurotus species) and an estimated approach to the volatile compounds. Food Chemistry, 105 (3): 1188-1194.

– Campos, C.S., Da Eira, A.F., Minhoni, M.T.D. and De Anbdrade, M.C.N., 2009. Mineral composition of raw material, substrate and fruiting bodies of Pleurotus ostreatus in culture. Interciencia, Vol. 34: 6.

– Campos, Eira, A.F., Mohini, M.T.A. and Andrade, M.C.N., 2009. Mineral composition of raw material, substrate and fruiting bodies of Pleurotus ostreatus in Culture, 34: 432-436.

– Cao, W., Nishiyama, Y., & Koide, S. (2003). Thin-layer drying of Maitake mushroom analysed with a simplified model. Biosystems Engineering, 85, 331–337.

– Carlberg, I., Mannervik, B. Glutathione reductase. in: A. Meister (Ed.) Methods in Enzymology. Volume 113. Academic Press, New York; 1985:484–490.

– Castanera R, Omarini A, Santoyo F, Perez G, Pisabarro AG, Ramirez L. 2013. Non-additive transcriptional profiles underlie dikaryotic superiority in Pleurotus ostreatus laccase activity. PLoS One 8:e73282. doi:10.1371/journal.pone.0073282.

– Castanera R, Perez G, Omarini A, Alfaro M, Pisabarro AG, Faraco V, Amore A, Ramirez L. 2012. Transcriptional and enzymatic profiling of Pleurotus ostreatus laccase genes in submerged and solid-state fermentation cultures. Appl Environ Microbiol 78:4037–4045. doi:10.1128/AEM.07880-11.

– Cazzaniga, M., Bonanni, B. Breast cancer chemoprevention: old and new approaches. J. Biomed. Biotechnol. 2012;2012:985620.

– Ceriotti G. Determination of nucleic acids in animal tissues. J Biol Chem. 1955 May;214(1):59–70.

– Chang, R. (1996). Functional properties of edible mushrooms. Nutrition Reviews, 54, S91.

– Chang, S.-T., & Miles, P. G. (1989). Edible mushrooms and their cultivation. 345 p. Florida: CRC Press, Inc.

– Chang, S., & Buswell, J. (1996). Mushroom nutriceuticals. World Journal of Microbiology and Biotechnology, 12, 473–476.

– Cheng DF, Zhang ZL, He XF, Liang GW. 2013. Validation of reference genes in Solenopsis invicta in different developmental stages, castes and tissues. PLoS One 8:e57718. doi:10.1371/journal.pone.0057718.

– Chervoneva I, Li YY, Schulz S, Croker S, Wilson C, Waldman SA, Hyslop T. 2010. Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics11:253. doi:10.1186/1471-2105-11-253.

– Collins PJ, Dobson ADW. 1997. Regulation of laccase gene transcription in Trametes versicolor. Appl Environ Microbiol63:3444–3450.

– Couto SR, Herrera JLT. 2006. Industrial and biotechnological applications of laccases: a review. Biotechnol Adv 24:500–513. doi:10.1016/j.biotechadv.2006.04.003.

– Das, N. and M. Mukherjee, 2007. Cultivation of Pleurotus ostreatus on weed plants. BioResource Technology 98: 2723-2726. www.science direct.com retrieved on 07.08.2007.

– Dasgupta, T., Rao, A.R., Yadava, P.K. Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolizing phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in miceMol. Cell Biochem. 2003;245:11–22.

– Davies, G., Martin, L.A., Sacks, N., Dowsett, M. Cycloxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann. Oncol.2002;13:669–678.

– Davis, RA, Sinensky, M, Junker, LH. Regulation of cholesterol synthesis and potential for its pharmacologic manipulation. Pharmac Ther. 1989;43:221–236.

– Dawit, A (2008). Mushroom Cultivation in Ethiopia: status and opportunities. Paper presented at Addis Ababa University, 15 May 2008, Science Faculty, Addis Ababa.

– De Souza CGM, Tychanowicz GK, De Souza DF, Peralta RM. 2004. Production of laccase isoforms by Pleurotus pulmonarius in response to presence of phenolic and aromatic compounds. J Basic Microbiol 44:129–136. doi:10.1002/jobm.200310365.

– Deepalakshmi, K., Mirunalini, S. Modulatory effect of Ganoderma lucidum on expression of xenobiotic enzymes, oxidant-antioxidant and hormonal status on 7,12-dimethylbenz(a)anthracene induced mammary carcinoma rats. Pharmacogn. Mag. 2013;9:167–175.

– Deepalakshmi, K., Mirunalini, S. Toxicological assessments of Pleurotus ostreatus in Sprague-Dawley rats. Int. J. Nutr. Pharmacol. Neurol. Dis. 2014;4:139–145.

– Dunkwal, V., Jood, S., & Singh, S. (2007). Physico-chemical properties and sensory evaluation of Pleurotus sajor caju powder as influenced by pre-treatments and drying methods. British Food Journal, 109, 749–759.

– Effect of oyster mushroom on glycemia, lipid profile and quality of life in type 2 diabetic patients Australian Journal of Medical Herbalism 2010 22(2).

– Endo, A., Monacolin, K. a new hypocholesterolemic agent produced by a Monascus specis. J Antibiotic. 1979;32:852–854.

– Ernster, L. DT-diaphorase. Methods Enzymol. 1967;10:309–317.

– Escrich, E., Moral, R., Garca, G., Costal, I., Sanchez, J.A., Solanas, M. Identification of novel differentially expressed genes by the effect of a high-fat-n-6 diet in experimental breast cancer. Mol. Carcinog. 2004;40:73–78.

–  Fan CJ, Ma JM, Guo QR, Li XT, Wang H, Lu MZ. 2013.Selection of reference genes for quantitative real-time PCR in bamboo (Phyllostachys edulis). PLoS One 8:e56573. doi:10.1371/journal.pone.0056573.

– Fernandez-Fueyo E, Castanera R, Ruiz-Duenas FJ, Lopez-Lucendo MF, Ramirez L, Pisabarro AG, Martinez AT. 2014.Ligninolytic peroxidase gene expression by Pleurotus ostreatus: differential regulation in lignocellulose medium and effect of temperature and pH. Fungal Genet Biol 72:150–161. doi:10.1016/j.fgb.2014.02.003.

– Florezak, J. and W. Lasota, 1995. Cadmium uptake and binding by artificially cultivated (Pleurotus ostreatus). Bromatol. Chem. Toksykol., 28: 17-23.

– Folch, J, Lees, M, Sloane-Stanley, GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509.

– Fukushima, M., Nakano, M. The effect of a probiotic on faecal and liver lipid classes in rats. Br. J. Nutr. 1995;73:701–710.

– Giri, S., & Prasad, S. (2013). Quality characteristics of microwave-vacuum dried button mushrooms (Agaricus bisporus). Octa Journal of Biosciences, 1, 24–31.

-Gonenc, A., Erten, D., Aslan, S., Akinci, M., Simsek, B., Torun, M. Lipid peroxidation and antioxidant status in blood and tissues of malignant breast tumor and benign breast diseases. Cell Biol. Int.2006;30:376–380.

– Goodling, A.C., Cerniglia, G.J., Herbert, J.A. Production performance of white leghorn layers fedLactobacillus fermentation products. Poult. Sci. 1987;66:480–486.

– Gunde-Cimerman, A, Benički, N. Screening fungi for the production of an inhibitor of HMG CoA reductase: Production of mavinolin by the fungi of the genus Pleurotus. FEMS Microbiol Lett. 1993;111:203–206.

– Guo, F.C., Kwakkel, R.P., Williams, B.A., Li, W.K., Li, H.S., Luo, J.Y., Li, X.P., Wei, Y.X., Yan, Z.T., Verstegen, M.W.A. Effects of mushroom and herb polysaccharides, as alternatives for an antibiotic, on growth performance of broilers. Br. Poult. Sci. 2004;45:684–689.

– Guo, F.C., Savelkoulz, H.F.J., Kwakkel, R.P., Williams, B.A., Verstegen, M.W.A. Immunoactive, medicinal properties of mushroom and herb polysaccharides and their potential use in chicken diets. World’s Poult. Sci. J. 2003;59:427–440.

– Habig, W.H., Pabst, M.J., Jakoby, W.B. Glutathione S-transferase the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974;249:7130–7139.

– Hadder, Y., Z. Kerem and B. Gorodecki, 1993. Biodegradation of lignocellulosic agricultural wastes by Pleurotus ostreatus. Journal of Biotechnology, 30: 133-139.

– Haller F, Kulle B, Schwager S, Gunawan B, von Heydebreck A, Sultmann H, Fuzesi L. 2004. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal Biochem 335:1–9. doi:10.1016/j.ab.2004.08.024.

– Hassan, F., & Medany, G. M. (2014). Effect of pretreatments and drying temperatures on the quality of dried pleurotus mushroom SPP. Egypt. Journal of Agriculture Research, 92, 1009–1023.

– Havel, RJ, Eder, HA, Bragdon, JH. The distribution of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–1355.

– Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19. doi:10.1186/gb-2007-8-2-r19.

– Hernandez, D., E.J. Sanches, K. Yamasaki, 2003. A simple procedure for preparing substrate for Pleurotus ostreatus cultivation. Biores. Technol., 90: 145-150.

– Higuchi R, Fockler C, Dollinger G, Watson R. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 11:1026–1030. doi:10.1038/nbt0993-1026.

– Hoeg, JM, Brown, HB. 3-hydroxy-3-methylglutaryl-Coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. JAMA. 1987;258:3532–3536.

– Ibekwe, V.I., P.I. Azubuike, E.U. Ezeji, E.C. Chinakwe, 2008. Effects of Nutrient sources and Environmental factors on the cultivation and yield of Oyster Mushroom (Pleutorus ostreatus). Pak. J. Nutr., 7: 349-351.

– Iqbal, M., A. Rauf and M.I. Sheikh, 2005. Yield performance of oyster mushroom on different substrates. Int. J. Agi. Biol. J., 7 (6): 900-903.

– Islam, M., & Flink, J. (1982). Dehydration of potato. International Journal of Food Science & Technology, 17, 387–403.

– Jain M, Nijhawan A, Tyagi AK, Khurana JP. 2006. Validation of housekeeping genes as internal control for studying gene expression in rice by quantitative real-time PCR. Biochem Biophys Res Commun 345:646–651. doi:10.1016/j.bbrc.2006.04.140.

– Janusz G, Rogalski J, Szczodrak J. 2007. Increased production of laccase by Cerrena unicolor in submerged liquid cultures. World J Microbiol Biotechnol 23:1459–1464. doi:10.1007/s11274-007-9390-y.

– Jayakumar, T., Thomas, P.A., Geraldine, P. In-vitro antioxidant activities of an ethanolic extract of the oyster mushroom, Pleurotus ostreatus. Innov. Food Sci. Emerg. Technol. 2009;10:228–234.

– Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D. Global cancer statistics. CA: Cancer J. Clin. 2011;61:69–90.

– Jian B, Liu B, Bi YR, Hou WS, Wu CX, Han TF. 2008.Validation of internal control for gene expression study in soybean by quantitative real-time PCR. BMC Mol Biol 9:59. doi:10.1186/1471-2199-9-59.

– Jin, L.Z., Ho, Y.W., Abdullah, N., Jalaludin, S. Growth performance, intestinal michrobial populations and serum cholesterol of broilers fed diets containing Lactobacillus cultures. Poult. Sci.1998;77:1259–1265.

– Job, D., 2004. Use of coffee spent industry residues for production of Pleurotus ostreatus (Jacq.: Fr.) Kummer in solid state fermentation. Rev. Iberoam. Micol., 21: 195-197.

– Jose, N., & Janardhanan, K. (2001). Antioxidant and antitumour activity of Pleurotus florida.

– Kalavathy, R., Abdullah, N., Jalaludin, S., Ho, Y.W. Effects of Lactobacillus cultures on growth performance, abdominal fat deposition, serum lipids and weight of organs of broiler chickens. Br. Poult. Sci. 2003;44:139–144.

– Kalmis, E., Azbar, N., Yildiz, H., Kalyoncu, F. Feasibility of using olive mill effluent (OME) as a wetting agent during the cultivation of oyster mushroom, Pleurotus ostreatus on wheat straw. Bioresour. Technol. 2008;99:164–169.

– Khan MA, Tania M. 2012. Nutritional and medicinal importance of Pleurotus mushrooms: an overview. Food Rev Int 28:313–329. doi:10.1080/87559129.2011.637267.

– Klopfenstein, CF, Hoseney, RC. Cholesterol-lowering effect of β-glucan-enriched bread. Nutr Rep Internat. 1987;36:1091–1098.

– Kobori, M., Yoshida, M., Ohnishi-Kameyama, M., Shinmoto, H. Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW 264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br. J. Pharmacol. 2009;150:209–219.

– Kochu Babu, M. and K.R. Nair, 1991. Mushroom cultivation on oil palm factory wastes and performance of six species of Pleurotus (Oyster mushroom). Indian Mushrooms. Proceedings of National Symposium on Mushroom, Thiruvananthapuram, pp. 84-86.

– Krishnamoorthy, D., Sankaran, M. Modulatory effect of Pleurotus ostreatus on oxidant / antioxidant status in 7,12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats-a dose-response study. J. Cancer Res. Ther. 2016;12:386–394.

– Krokida, M., Karathanos, V., & Maroulis, Z. (2000). Effect of osmotic dehydration on color and sorption characteristics of apple and banana. Drying Technology, 18, 937–950.

– Krokida, M. K., Karathanos, V., Maroulis, Z., & Marinos-Kouris, D. (2003). Drying kinetics of some vegetables. Journal of Food Engineering, 59, 391–403.

– Krokida, M., & Marinos-Kouris, D. (2003). Rehydration kinetics of dehydrated products. Journal of Food Engineering, 57, 1–7.

– Kudryavtsev, I.A., Golenko, O.D., Gudkova, M.V., Myasishcheva, N.V. Arachidonic acid metabolism in growth control of A549 human lung adenocarcinoma cells. Biochemistry. 2002;67:1021–1026.

– Kudryavtsev, I.A., Golenko, O.D., Gudkova, M.V., Myasishcheva, N.V. Arachidonic acid metabolism in growth control of A549 human lung adenocarcinoma cells. Biochemistry. 2002;67:1021–1026.

– Kurozawa, L. E., Azoubel, P. M., Murr, F. E. X., & Park, K. J. & (2012). Drying kinetic of fresh and osmotically dehydrated mushroom (Agaricus blazei). Journal of Food Process Engineering, 35, 295–313.

– Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.

– Lakshmi, A., Subramanian, S. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7,12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. Biochimie. 2014;99:96–109.

– Larraya L, Penas MM, Perez G, Santos C, Ritter E, Pisabarro AG, Ramirez L. 1999. Identification of incompatibility alleles and characterisation of molecular markers genetically linked to the A incompatibility locus in the white rot fungus Pleurotus ostreatus. Curr Genet 34:486–493. doi:10.1007/s002940050424.

– Larraya LM, Alfonso M, Pisabarro AG, Ramirez L. 2003.Mapping of genomic regions (quantitative trait loci) controlling production and quality in industrial cultures of the edible basidiomycete Pleurotus ostreatus. Appl Environ Microbiol69:3617–3625. doi:10.1128/AEM.69.6.3617-3625.2003.

– Larraya LM, Perez G, Penas MM, Baars JJP, Mikosch TSP, Pisabarro AG, Ramirez L. 1999. Molecular karyotype of the white rot fungus Pleurotus ostreatus. Appl Environ Microbiol 65:3413–3417.

– Lerici, C., Pinnavaia, G., Rosa M. D., & Bartolucci L. (1985). Osmotic dehydration of fruit: Influence of osmotic agents on drying behavior and product quality. Journal of Food science, 50, 1217–1219.

– Lewicki, P. P., & Jakubczyk, E. (2004). Effect of hot air temperature on mechanical properties of dried apples. Journal of Food Engineering, 64, 307–314.

– Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408. doi:10.1006/meth.2001.1262.

– Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.Y. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 1951;193:265–275.

– Maiolino, R., Fioretti, A., Menna, L.F., Meo, C. Research on the efficiency of probiotics in diets for broiler chickens. Nutr. Abstr. Rev. 1992;B62:482–486.

– Maltzman, T.H., Christou, M., Gould, M.N., Jefcoate, C.R. Effects of monoterpenoids on in vivoDMBA-DNA adducts formation and on phase I hepatic metabolizing enzymes. Carcinogenesis. 1991;12:2081–2087.

– Manpreet, K., Soni, G., & Khanna, P. (2004). In vitro and in vivo antioxidant potential of Pleurotus florida in experimental animals. Mushroom Research, 13(1).

– Manzi, P., Gambelli, L., Marconi, S., Vivanti, V., & Pizzoferrato, L. (1999). Nutrients in edible mushrooms: An inter-species comparative study. Food Chemistry, 65, 477–482.

– Martin AM, Bailey VI. Growth of Agaricus campestris NRRL 2334 in the Form of Pellets. Appl Environ Microbiol. 1985 Jun;49(6):1502–1506.

– Martine, B., Gaëlle, L., & Ronan, G. (2000). Post-harvest treatment with citric acid or hydrogen peroxide to extend the shelf life of fresh sliced mushrooms. Lebensmittel-Wissenschaft und-Technologie, 33, 285–289.

– Mathivadhani, P., Shanthi, P., Sachdanandam, P. Effect of Semecarpus anacardium Linn. Nut extract on mammary and hepatic expression of xenobiotic enzymes in DMBA-induced mammary carcinoma. Environ. Toxicol. Pharmacol. 2007;23:328–334.

– Mau, J. L., Beelman, R. B., & Ziegler, G. R. (1993). Factors Affecting I-Octen-3-01 in Mushrooms at Harvest and During Postharvest Storage.

– Mau, J. L., Lin, H. C., & Chen, C. C. (2002). Antioxidant properties of several medicinal mushrooms. Journal of Agricultural and Food Chemistry, 50, 6072–6077.

– McNeill RE, Miller N, Kerin MJ. 2007. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol 8:107. doi:10.1186/1471-2199-8-107.

– Michael, H. W., Bultosa, G., & Pant, L. M. (2011). Nutritional contents of three edible oyster mushrooms grown on two substrates at Haramaya, Ethiopia, and sensory properties of boiled mushroom and mushroom sauce. International Journal of Food Science & Technology, 46, 732–738.

– Michael, H. W., Bultosa, G., & Pant, L. M. (2010). Nutrient composition and sensory characteristics of selected edible oyster mushrooms grown on two substrates at Haramaya, Ethiopia. M.Sc. Thesis Presented to the School of Graduate Studies of Haramaya University. Haramaya.

– Mitropoulos, KA, Balasurbramaniam. Cholesterol 7α-hydroxylase in rats liver microsomal preparations. Biochem J. 1972;128:1–9.

– Mountzouris, K.C., Tsitrsikos, P., Palamidi, I., Arvaniti, A., Mohnl, M., Schatzmayr, G., Fegeros, K. Effects of probiotic inclusion levels in broiler nutrition on growth performance, nutrient digestibility, plasma immunoglobulins, and cecal microflora composition. Poult. Sci. 2010;89:58–67.

– Moustafa AM. Nutrition and the development of mushroom flavor in Agaricus campestris mycelium. Appl Microbiol. 1960 Jan;8:63–67.

– Muyanja, C., Kyambadde, D., & Namugumya, B. (2014). Effect of pretreatments and drying methods on chemical composition and sensory evaluation of oyster mushroom (Pluerotus oestreatus) powder and soup. Journal of Food Processing and Preservation, 38, 457–465.

– Myant, NB, Mitropoulos, KA. Cholesterol 7 alfa — hydroxylase. J Lipid Res. 1977;19:135–153.

– National Research Council. Nutrient Requirements of Poultry. 9th ed. National Academy Press,Washington, DC, USA; 1994 (revised).

– Nuhu Alam, M., Hossain, S., Khair, A., Amin, S. R., & Khan, A. (2007). Comparative effects of oyster mushrooms on plasma lipid profile of hypercholesterolaemic rats. Bangladesh Mushroom, 1, 15–22.

– Obodai, M., Cleland-Okine, J., & Vowotor, K. (2003). Comparative study on the growth and yield of pleurotus ostreatus mushroom on different lignocellulosic by-products. Journal of Industrial Microbiology and Biotechnology, 30, 146–149.

– Obodai, M., J. Cleland-Okine and K.A. Vowotor, 2003. Comparative study on the growth and yield of Pleurotus ostreatus mushcooms on 171 different lignocellulosic by-products. Journal of Industrial Microbiology and Biotechnology, 30 (3): 146-149.

– Olivotto, I.A., Truong, P.T., Speers, C.H., Bernstein, V., Allan, S.J., Kelly, S.J. et al, Time to stop progesterone receptor testing in breast cancer management. J. Clin. Oncol. 2004;22:1769–1770.

– Omura, T., Sato, R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 1964;239:2370–2378.

– Owings, W.J. Nutritive effects of a direct-fed microbial preparation on growing turkey toms. Poult. Sci. 1992;71:932–935.

– Padmashini, L., Arulnandhy, V. and Wijeratnam, R.S.W., 2008. Cultivation of oyster mushroom (Pleurotus ostreatus) on sawdust. Cey. J. Sci. (Bio-Sci.) 37 (2): 177-182.

– Padmavathi, R., Senthilnathan, P., Sakthisekaran, D. Therapeutic effect of propolis and paclitaxel on hepatic phases I and II enzymes and marker enzymes in dimethlybenz(a)anthracene induced breast cancer in female rats. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2006;143:349–354.

– Pandi, M., Manikandan, R., Muthumary, J. Anticancer activity of fungal taxol derived fromBotryodiplodia theobromae Pat., an endophytic fungus, against 7,12-dimethylbenz(a)antheracene (DMBA) induced mammary gland carcinogenesis in Sprague-Dawley rats. Biomed. Pharmacol.2010;64:48–53.

– Paolacci AR, Tanzarella OA, Porceddu E, Ciaffi M. 2009.Identification and validation of reference genes for quantitative RT-PCR normalization in wheat. BMC Mol Biol 10:11. doi:10.1186/1471-2199-10-11.

– Parenti A, Muguerza E, Iroz AR, Omarini A, Conde E, Alfaro M, Castanera R, Santoyo F, Ramirez L, Pisabarro AG. 2013.Induction of laccase activity in the white rot fungus Pleurotus ostreatus using water polluted with wheat straw extracts. Bioresour Technol 133:142–149. doi:10.1016/j.biortech.2013.01.072.

– Park, Y.N., S.J. Go. and D.S. Kim, 1975. Studies on cultivation of oyster mushroom (P. ostreatus) using rice straw as substrate. Research report of the office of Rural Development, Soil Science, Fertilizer, Plant Protection and Mycology, 17: 103-107.

– Patel, Y., Naraian, R., & Singh, V. (2012). Medicinal properties of Pleurotus species (oyster mushroom): A review. World Journal of Fungal and Plant Biology, 3, 1–12.

– Patil, S. S., Ahmed, S. A., Telang, S. M., & Baig, M. M. V. (2010). The nutritional value of Pleurotus ostreatus (Jacq.: Fr.) kumm cultivated on different lignocellulosic agro-wastes. Innovative Romanian Food biotechnology, 7, 66.

– Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. doi:10.1093/nar/29.9.e45.

– Pfaffl MW. 2004. Quantification strategies in real-time PCR, p 87–112. In Bustin SA, editor. (ed), A-Z of quantitative PCR. International University Line, La Jolla, CA.

– Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e96. doi:10.1093/nar/gnf095.

– Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. 2004.Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26:509–515. doi:10.1023/B:BILE.0000019559.84305.47.

– Pinto F, Pacheco CC, Ferreira D, Moradas-Ferreira P, Tamagnini P. 2012. Selection of suitable reference genes for RT-qPCR analyses in cyanobacteria. PLoS One 7:e34983. doi:10.1371/journal.pone.0034983.

– Pool-zobel, B., Veeriah, S., Bohmer, F.D. Modulation of xenobiotic metabolizing enzymes by anticarcinogens focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 2005;591:74–92.

– Quimio, T.H., 1978. Indoor cultivation of Pleurotus ostreatus. Philippines Agriculturist, 61: 253-263.

– Rama, V., & John, P. J. (2000). Effects of methods of drying and pretreatments on quality of dehydrated mushroom. Indian Food Packer, 54, 59–64.

– Ramakers C, Ruijter JM, Deprez RHL, Moorman AFM. 2003.Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62–66. doi:10.1016/S0304-3940(02)01423-4.

– Raoult-Wack, A. L. (1994). Recent advances in the osmotic dehydration of foods. Trends in Food Science & Technology, 5, 255–260.

– Rapaport F, Khanin R, Liang Y, Pirun M, Krek A, Zumbo P, Mason CE, Socci ND, Betel D. 2013. Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol 14:R95. doi:10.1186/gb-2013-14-9-r95.

– Rashad, M. M., Abdou, H. M., Mahmoud, A. E., & Nooman, M. U. (2009). Nutritional analysis and enzyme activities of Pleurotus ostreatus cultivated on Citrus limonium and Carica papaya wastes. Australian Journal of Basic and Applied Sciences, 3, 3352–3360.

– Reguła, J., & Siwulski, M. (2007). Dried shiitake (Lentinulla edodes) and oyster (Pleurotus ostreatus) mushrooms as a good source of nutrient. Acta Scientiarum Polonorum Technologia Alimentaria, 6, 135–142.

– Riley R, Salamov AA, Brown DW, Nagy LG, Floudas D, Held BW, Levasseur A, Lombard V, Morin E, Otillar R, Lindquist EA, Sun H, LaButti KM, Schmutz J, Jabbour D, Luo H, Baker SE, Pisabarro AG, Walton JD, Blanchette RA, Henrissat B, Martin F, Cullen D, Hibbett DS, Grigoriev IV. 2014. Extensive sampling of basidiomycete genomes demonstrates inadequacy of the white-rot/brown-rot paradigm for wood decay fungi. Proc Natl Acad Sci U S A 111:9923–9928. doi:10.1073/pnas.1400592111.

– Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, Moorman AFM. 2009. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37:e45. doi:10.1093/nar/gkp045.

– Russell, DW. Cholesterol biosynthesis and metabolism. Cardiovasc Drug Ther. 1992;6:103–110.

– Sadler, M. (2003). Nutritional properties of edible fungi. Nutrition Bulletin, 28, 305–308.

– Sainos, E., G. Diaz-Godinez, O. Loera, A.M. Montiel-Gonzales, C. Sanches, 2006. Growth of Pleurotus ostreatus on wheat straw and wheatgrain based madia: biochemical aspects and preparation of mushroom inoculum. Appl. Microbiol. Biotechnol., 72: 812-815.

– Salame TM, Knop D, Levinson D, Yarden O, Hadar Y. 2013.Redundancy among manganese peroxidases in Pleurotus ostreatus. Appl Environ Microbiol 79:2405–2415. doi:10.1128/AEM.03849-12.

– Sales-Campos, C., 2008. Aproveitamento de residuo madeireiro e da agroindustria regional para o cultivo de Pleurotus ostreatus de ocorrencia na Amazonia. In Simposio International Sobre Congumelos no Brasil. Resumos. Caxias do Sul. Brazil, p. 105.

– Salvachua D, Prieto A, Lopez-Abelairas M, Lu-Chau T, Martinez AT, Martinez MJ. 2011. Fungal pretreatment: an alternative in second-generation ethanol from wheat straw. Bioresour Technol 102:7500–7506. doi:10.1016/j.biortech.2011.05.027.

– Samy, R.P., Gopalakrishnakone, P., Ignacimuthu, S. Anti-tumor promoting potential of luteolin against 7,12-dimethybenz(a)anthracene-induced mammary tumours in rats. Chem. Biol. Interact. 2006;164:1–14.

– Sarangi, I., Ghosh, D., Bhutia, S.K., Mallick, S.K., Maiti, T.K. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int. Immunopharmacol. 2006;6:1287–1297.

– Schneitz, C., Kiskinen, T., Toivonen, V., Nasi, M. Effect of BROILAC on the physiochemical conditions and nutrient digestibility in the gastrointestinal tract of broilers. Poult. Sci. 1998;77:426–432.

– Schwartz, CC, Berman, M, Vlahcevic, ZR, Halloran, IG, Gregory, DH, Swell, I. Multicompartmental analysis of cholesterol metabolism in man. I. Characterization of the hepatic bile acid and biliary cholesterol precursor sites. J clin Invest. 1978;61:408–423.

– Sedmak JJ, Grossberg SE. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal Biochem. 1977 May 1;79(1-2):544–552.

– Shan, Z.A., M. Ashraf, and Ch.M. Ishtiaq, 2004. Comparative study on cultivation and field performance of Oyster Mushroom 178 (Pleurotus ostreatus) on different substrates. Pakistan Journal of Nutrition 3 (3): 158-160.

– Shivhare, U., Arora, S., Ahmed, J., & Raghavan, G. (2004). Moisture adsorption isotherms for mushroom. LWT-Food Science and Technology, 37, 133–137.

– Singh, S., Kumar, C. G., & Singh, S. (1995). Production, processing and consumption patterns of mushrooms. Indian Food Industry, 14, 38–47.

– Spiess AN, Feig C, Ritz C. 2008. Highly accurate sigmoidal fitting of real-time PCR data by introducing a parameter for asymmetry. BMC Bioinformatics 9:221. doi:10.1186/1471-2105-9-221.

– Stajic M, Persky L, Friesem D, Hadar Y, Wasser SP, Nevo E, Vukojevic J. 2006. Effect of different carbon and nitrogen sources on laccase and peroxidases production by selected Pleurotus species. Enzyme Microb Technol 38:65–73. doi:10.1016/j.enzmictec.2005.03.026.

– Stajic M, Persky L, Hadar Y, Friesem D, Duletic-Lausevic S, Wasser SP, Nevo E. 2006. Effect of copper and manganese ions on activities of laccase and peroxidases in three Pleurotus species grown on agricultural wastes. Appl Biochem Biotechnol 128:87–96. doi:10.1385/ABAB:128:1:087.

– Stamler, J, Welthwoth, D, Neaton, JD. Is there a relationship between serum cholesterol and risk of premature death from coronary heart disease and grade?. J Am Med Assoc. 1986;256:2823–2829.

– Steiger MG, Mach RL, Mach-Aigner AR. 2010. An accurate normalization strategy for RT-qPCR in Hypocrea jecorina (Trichoderma reesei). J Biotechnol 145:30–37. doi:10.1016/j.jbiotec.2009.10.012.

– Strmiskova, G., F. Strmiska and J. Dubravicky, 1992. Mineral composition of oyster mushrooms. Nabrung, 36: 210-212.

– Strmiskova, G., Strmiska, F. and Dubravicky, J. 1993. Mineral composition of oyster mushrooms. Nabrung, 36: 210-212.

– Subbiah, MTR, Yunker, RL. Evidence for the presence of non-lipoprotein factors in diabetic serum capable of stimulating rat hepatic cholesterol-7α-hydroxylase in vitro. Biochem Biophys Res Commun. 1984;121:734–748.

– Sugano, M, Yamada, Y, Yoshima, K, Hasimoto, Y, Kymoto, M. The hypocholesterolemic action of the undigested fraction of soybean protein in rats. Atherosclerosis. 1988;72:115–122.

– Synytsya, A., Mícková, K., Synytsya, A., Jablonsky, I., Spevácek, J., Erban, V., Kováríková, E., Copíková, J. Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: structure and potential prebiotic activity. Carbohydr. Polym. 2009;76:548–556.

– Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard PS. 2004. Statistical modeling for selecting housekeeper genes. Genome Biol 5:R59. doi:10.1186/gb-2004-5-8-r59.

– Talebi, A., Amirzadeh, B., Mokhtari, B., Gahri, H. Effects of a multi-strain probiotic (PrimaLac) on performance and antibody responses to Newcastle disease virus and infectious bursal disease virus vaccination in broiler chickens. Avian Pathol. 2008;37:509–512.

– Tann, K.K., 1981. Cotton waste is good substrate for the cultivation of P. ostreatus the oyster mushroom. Mush. Sci., 11; 705-710.

– Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A, Heinen E. 1999. Housekeeping genes as internal standards: use and limits. J Biotechnol 75:291–295. doi:10.1016/S0168-1656(99)00163-7.

– Tichopad A, Dilger M, Schwarz G, Pfaffl MW. 2003.Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res 31:e122. doi:10.1093/nar/gng122.

– Torringa, E., Esveld, E., Scheewe, I., van den Berg, R., & Bartels, P. (2001). Osmotic dehydration as a pre-treatment before combined microwave-hot-air drying of mushrooms. Journal of Food Engineering, 49, 185–191.

– Tulek, Y. (2011). Drying kinetics of oyster mushroom (Pleurotus ostreatus) in a convective hot air dryer. Journal of Agricultural Science and Technology, 13, 655–664.

– Uchida, K, Nomura, Y, Kadowaki, M, Takeuchi, N, Yamamura, Y. Effect of dietary cholesterol on cholesterol and bile acid metabolism in rat. Japan J Pharmacol. 1977;27:193–204.

– Vahouny, GV, Tombes, R, Cassidy, MM, Kritchevsky, D, Gallo, LL. Dietary fibers. V. Binding of bile salts, phospholipids and cholesterol from mixed micelles by bile acid sequestrans and dietary fibers. Lipids. 1980;15:1012–1018.

– Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034. doi:10.1186/gb-2002-3-7-research0034.

– Vetayasuporn, S., 2007. Lignocellulosic materials as possible substrate for Pleurotus ostreatus (Fr.) Kummer cultivation. J. Agron., 6: 167- 170.

– Vetter, J., 1994. Mineral elements in the important cultivated mushrooms Agaricus bisporus and Pleurotus ostreatus. Food Chem., 50: 277-279.

– Walde, S., Velu, V., Jyothirmayi, T., & Math, R. (2006). Effects of pretreatments and drying methods on dehydration of mushroom. Journal of Food Engineering, 74, 108–115.

– Wang, D., A. Sakoda and M. Suzuki, 2001. Biological efficiency and nutritional value of Pleurotus ostreatus cultivated on spent beet grain. Bioresource Technol., 78: 293-300.

– Wang, H., Ooi, V., Ng, T., Chiu, K., & Chang, S. (1996). Hypotensive and vasorelaxing activities of a lectin from the edible mushroom Tricholoma mongolicum. Basic & Clinical Pharmacology & Toxicology, 79, 318–323.

– Wang Q, Ishikawa T, Michiue T, Zhu BL, Guan DW, Maeda H. 2012. Stability of endogenous reference genes in postmortem human brains for normalization of quantitative real-time PCR data: comprehensive evaluation using geNorm, NormFinder, and BestKeeper. Int J Legal Med 126:943–952. doi:10.1007/s00414-012-0774-7.

– Wang, S.Z., C. Bai, J. Fan, Y. Gao, J.F. Yang and Y.J. Yang, 2003. A study on the RAPD analysis of Ganoderma lucidum and Pleurotus astreatus protoplast Fusant Genome. Acta. Edulis Fungi, 10:1-5.

– Weigand-Heller, A. J., Kris-Etherton, P. M., & Beelman44, R. B. (2012). The bioavailability of ergothioneine from mushrooms (Agaricus bisporus) and the acute effects on antioxidant capacity and biomarkers of inflammation. Preventive Medicine, 54, S75–S78.

– Willis, W.L., Isikhuemhen, O.S., Ibrahim, S.A. Performance assessment of broiler chickens given mushroom extract alone or in combination with probiotics. Poult. Sci. 2007;86:1856–1860.

– Wang, R.J., Li, D.F., Bourne, S. Can 2000 years of herbal medicine history help us solve probelms in the year 2000?. in: Biotechnology in the Feed Industry. Proc. Alltech’s 14th Annu. Symp. Univ. Press. ; 1998:273–291.

– Yamashita, S, Yamashita, K, Yasuda, H. High-fiber diet in the control of diabetes in rats. Endocrinol Jap. 1980;27:169–173.

– Yang, J.-H., Lin, H. C., & Mau, J. L. (2001). Non-volatile taste components of several commercial mushrooms. Food Chemistry, 72, 465–471.

– Yoshioka, Y., T. Ikekawa, M. Nida and F. Fukuoka, 1975. Studies on antitumor activity of some fractions from basidiomycetes 1. An Antitumor acidic polysaccharide fraction of Pleurotus ostreatus (Fr.). Quel. Chem. Pharm. Bull., 20: 1175-1180.

– Yoshioka, Y., Tabeta, R., Saitô, H., Uehara, N., & Fukuoka, F. (1985). Antitumor polysaccharides from P. ostreatus (Fr.) Quél.: Isolation and structure of a β-glucan. Carbohydrate Research, 140, 93–100.

– Yuan, Y.L., Fang, B.T., Zhang, Y.X. Efficacy of polysaccharides as an adjuvant against AvianPasteurellosis in chickens. J. Trad. Chin. Vet. Med. 1993;3:6–10.

– Zadrazil, F., 1974. The Ecology and Industrial Production of Pleurotus ostreatus, Pleurotus florida, Pleurotus cornucopiae and Pleurotus eryngii. Mushroom Science, 9 (1): 621-652.

– Zakia, S.A., M.H. El-Kattan, W.A. Hussein and A.M. Khaleed, 1993. Chemical composition and processing potential of oyster mushroom, Pleurotus ostreatus. Egypt J Agric. Res., 71: 621- 631.

– Zlatkis, A, Zak, B, Boyle, AJ. New method for direct determination of serum cholesterol. J Lab Clin Med. 1953;41:486–492.

– Zulkifli, I., Abdullah, N., Mohad Azrin, N., Ho, Y.W. Growth performance and immune response of two commercial broiler strains fed diets containing Lactobacillus cultures and oxytetracyclin under heat stress conditions. Br. Poult. Sci. 2000;41:593–597.

References for Agaricus Blazei

– A. A. Soares, A. L. De Oliveira, A. B. Sá-Nakanishi et al., “Effects of an Agaricus blazei aqueous extract pretreatment on paracetamol-induced brain and liver injury in rats,” BioMed Research International, vol. 2013, Article ID 469180, 12 pages, 2013.

– A. B. D. Sá-Nakanishi, A. A. Soares, A. L. De Oliveira, J. Fernando Comar, R. M. Peralta, and A. Bracht, “Effects of treating old rats with an aqueous Agaricus blazei extract on oxidative and functional parameters of the brain tissue and brain mitochondria,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 563179, 13 pages, 2014.

– A. Čabarkapa, L. Živković, D. Žukovec et al., “Protective effect of dry olive leaf extract in adrenaline induced DNA damage evaluated using in vitro comet assay with human peripheral leukocytes,” Toxicology in Vitro, vol. 28, no. 3, pp. 451–456, 2014.

– A. E. S. S. Carvajal, E. A. Koehnlein, A. A. Soares et al., “Antitumor-active heteroglycans from niohshimeji mushroom, Tricholoma giganteum,” Bioscience Biotechnology and Biochemistry, vol. 59, no. 4, pp. 568–571, 1995.

– A. F. Da Silva, D. Sartori, F. C. MacEdo Jr., L. R. Ribeiro, M. H. P. Fungaro, and M. S. Mantovani, “Effects of β-glucan extracted from Agaricus blazei on the expression of ERCC5, CASP9, and CYP1A1 genes and metabolic profile in HepG2 cells,” Human and Experimental Toxicology, vol. 32, no. 6, pp. 647–654, 2013.

– Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1→3)-beta-d-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 1994;17:1554–60.

– Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology. 2007;148(1):32–46.

– Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. International Journal of Gynecological Cancer. 2004;14(4):589–594.

– Amino M, Noguchi R, Yata J et al. Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients. Gan To Kagaku Ryoho 1983;10:2000–6.

– Babineau TJ, Hackford A, Kenler A et al. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg1994;129:1204–10.

– Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clinical Pharmacology and Therapeutics. 2010;87(4):401–406.

– Bellini MF, Giacomini NL, Eira AF, Ribeiro LR, Mantovani MS. Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO-k1 cells, studying different developmental phases of the mushroom. Toxicol In Vitro2003;17:465–9.

– Benko S, Magyarics Z, Szabó A, Rajnavölgyi E. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors. Biological Chemistry. 2008;389(5):469–485.

– Bernardshaw S, Hetland G, Ellertsen LK, Aaland Tryggestad AM, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation. 2005;29:147–153.

– Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AMA, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation. 2005;29(4–6):147–153.

– Bernardshaw S, Hetland G, Grinde B, Johnson E. An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model of fecal peritonitis. Shock. 2006;25(4):420–425.

– Bernardshaw S, Johnson E, Hetland G. An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice. Scandinavian Journal of Immunology. 2005;62(4):393–398.

– Bernardshaw S, Lyberg T, Hetland G, Johnson E. Effect of an extract of the mushroom Agaricus blazeiMurill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo . Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2007;115(6):719–725.

– Berven L, Karppinen P, Hetland G, Samuelsen AB. The polar high molecular weight fraction of the Agaricus blazei Murill extract, AndoSan™, reduces the activity of the tumor-associated protease, legumain, in RAW 264.7 cells. J Med Food. 2015 Apr;18(4):429–38.

– Bøgwald J, Johnson E, Seljelid R. The cytotoxic effect of mouse macrophages stimulated in vitro by a beta-glucan from yeast cell walls. Scand J Immunol 1982;15:297–304.

– Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006;6:33–43.

– Castro M, Ralston NV, Morgenthaler TI, Rohrbach MS, Limper AH. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun 1994;62:3138–45.

– Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41–9.

– Chan CB, Abe M, Hashimoto N, Hao C, Williams IR, et al. Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome. Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):468–73. Epub 2008 Dec 23.

– Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. Journal of Hematology & Oncology. 2009;2:p. 25.

– Chan Y, Chang T, Chan CH, Yeh YC, Chen CW, Shieh B, Li C. Immunomodulatory effect of Agaricus blazei Murill in Balb/cByJ mice. J Microbiol Immunol Infect. 2007;40:201–208.

– Chen L, Shao H. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease. Veterinary Immunology and Immunopathology. 2006;109(1-2):177–182.

– Chen L, Shao HJ, Su YB. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses. International Immunopharmacology. 2004;4(3):403–409.

– Chihara G. Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev Biol Stand 1992;77:191–7.

– Czop JK, Valiante NM, Janusz MJ. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors. Progress in Clinical and Biological Research. 1989;297:287–296.

– D. Anderson, T.-W. Yu, B. J. Phillips, and P. Schmezer, “The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 307, no. 1, pp. 261–271, 1994.

– D. W. Fairbairn, P. L. Olive, and K. L. O’Neill, “The comet assay: a comprehensive review,” Mutation Research/Reviews in Genetic Toxicology, vol. 339, no. 1, pp. 37–59, 1995.

– De Jesus M, Ostroff GR, Levitz SM, Bartling TR, Mantis NJ. A population of Langerin-positive dendritic cells in murine Peyer’s patches involved in sampling β-glucan microparticles. PLoS One. 2014 Mar 14;9(3):e91002. eCollection 2014.

– Ebina T, Fujimiya Y. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 1998;11:259–65.

– Ellertsen LK, Hetland G. An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clinical and Molecular Allergy. 2009;7, article no. 6.

– Ellertsen LK, Hetland G, Johnson E, Grinde B. Effect of a medicinal extract from Agaricus blazei Murill on gene expression in a human monocyte cell line as examined by microarrays and immuno assays. Int Immunopharmacol. 2006;6:133–143.

– Ellertsen LK, Wiker HG, Egeberg NT, Hetland G. Allergic sensitisation in tuberculosis and leprosy patients. International Archives of Allergy and Immunology. 2005;138(3):217–224.

– Endo M, Beppu H, Akiyama H, et al. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochimica et Biophysica Acta. 2010;1800(7):669–673.

– F. Firenzuoli and L. Gori, “Herbal medicine today: clinical and research issues,” Evidence-based Complementary and Alternative Medicine, vol. 4, no. 1, pp. 37–40, 2007.

– F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008.

– Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001;10(7):721–33.

– Fitzner N, Clauberg S, Essmann F, Liebmann J, Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clinical and Vaccine Immunology. 2008;15(1):138–146.

– Fodde R. The APC gene in colorectal cancer. Eur J Cancer. 2002;38(7):867–71.

– Fodde R, Smits R. Disease model: familial adenomatous polyposis. Trends Mol Med. 2001;7(8):369–73.

– Førland DT, Johnson E, Sætre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease. Scandinavian Journal of Immunology. 2011;73(1):66–75.

– Førland DT, Johnson E, Tryggestad AMA, Lyberg T, Hetland G. An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine. 2010;49(3):245–250.

– Fujimiya Y, Suzuki Y, Oshiman KI, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunology Immunotherapy. 1998;46(3):147–159.

– G. Aviello, J. M. Canadanovic-Brunet, N. Milic et al., “Potent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusa,” PLOS ONE, vol. 6, no. 5, Article ID e19628, 2011.

– G. Hetland, E. Johnson, T. Lyberg, S. Bernardshaw, A. M. A. Tryggestad, and B. Grinde, “Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer,” Scandinavian Journal of Immunology, vol. 68, no. 4, pp. 363–370, 2008.

– G. M. Benhusein, E. Mutch, S. Aburawi, and F. M. Williams, “Genotoxic effect induced by hydrogen peroxide in human hepatoma cells using comet assay,” Libyan Journal of Medicine, vol. 5, no. 1, pp. 1–6, 2010.

– Gao L, Sun Y, Chen C, Xi Y, Wang J, Wang Z. Primary mechanism of apoptosis induction in a leukemia cell line by fraction FA-2-b-ss prepared from the mushroom Agaricus blazei Murill. Braz J Med Biol Res. 2007 Nov;40(11):1545–55.

– Garay RP, Viens P, Bauer J et al. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. Eur J Pharmacol 2007;563:1–17.

– Gatner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin- 1 and Toll-like receptor 2. J Experimental Med. 2003; May 5;197(9):1107–1117.

– Gawenda J, Traub F, Luck HJ, Kreipe H, von Wasielewski R. Legumain expression as a prognostic factor in breast cancer patients. Breast Cancer Res Treat. 2007;102:1–6.

– Geddes K, Magalhães JG, Girardin SE. Unleashing the therapeutic potential of NOD-like receptors. Nature Reviews Drug Discovery. 2009;8(6):465–479.

– Goodridge HS, Wolf AJ, Underhill DM. β-glucan recognition by the innate immune system. Immunological Reviews. 2009;230(1):38–50.

– Gravesen S, Nielsen PA, Iversen R, Nielsen KF. Microfungal contamination of damp buildings – examples of risk constructions and risk materials. Environ Health Perspect 1999;107 (Suppl.):505–8.

– Grinde B, Hetland G, Johnson E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. Int Immunopharmacol. 2006;6:1311–1314.

– Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009;4.

– Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T et al. High expression of the cysteine proteinase legumain in colorectal cancer—implications for therapeutic targeting. Eur J Cancer. 2015 Jan;51(1):9–17.

– Hetland G. Applicant/Inventor: Use of the mushroom Agaricus blazei Murill for the production of medicaments suitable for treating infections and allergies. WO 2005/065063 (Priority; Jan 2004)

– Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AMA, Grinde B. Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer. Scandinavian Journal of Immunology. 2008;68(4):363–370.

– Hetland G, Johnson E, Lyberg T, Kvalheim G. The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation. Adv Pharmacol Sci. 2011: 157015.

– Hetland G, Løvik M, Wiker HG. Protective effect of β-glucan against Mycobacterium bovis, BCG infection in BALB/c mice. Scandinavian Journal of Immunology. 1998;47(6):548–553.

– Hetland G, Ohno N, Aaberge IS, Løvik M. Protective effect of β-glucan against systemic Streptococcus pneumoniae infection in mice. FEMS Immunology and Medical Microbiology. 2000;27:111–116.

– Hetland G, Sandven P. β-1,3-glucan reduces growth of Mycobacterium bovis in macrophage cultures. FEMS Immunol Med Microbiol 2002;33:41–5.

– Holson RR, Freshwater L, Maurissen JP, Moser VC, Phang W. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol. 2008;30(4):326–48.

– Hopkins MH, Flanders WD, Bostick RM. Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients. Biomark Insights. 2012;7:143–50.

– Hsu CH, Hwang KC, Chiang YH, Chou P. The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. Journal of Alternative and Complementary Medicine. 2008;14(3):299–301.

– Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine. 2007;13(1):97–102.

– Huang N. Brazilian mushroom (Gee Song Rong) In: Huang, editor. Cultivation of eight rare and precious gourmet mushrooms. Chinese Agriculture University Press; 1997. pp. 95–101.

– Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. International Journal of Cancer. 2007;121(11):2373–2380.

– Iino Y, Yokoe T, Maemura M et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995;15:2907–11.

– Ikuzawa M, Matsunaga K, Nishiyama S, Nakajima S, Kobayashi Y, Andoh T, et al. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). Int J Immunopharmacol. 1988;10(4):415–23.

– Instanes C, Ormstad H, Rydjord B, Wiker HG, Hetland G. Mould extracts increase the allergic response to ovalbumin in mice. Clin Exp Allergy. 2004;34:1634–1641.

– Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1→6)-β-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill (’Himematsutake’) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Japanese Journal of Pharmacology. 1994;66(2):265–271.

– Izawa S, Inoue Y. A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill. Appl Microbiol Biotechnol 2004;64:537–42.

– J. Limón-Pacheco and M. E. Gonsebatt, “The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress,” Mutation Research, vol. 674, no. 1-2, pp. 137–147, 2009.

– J. Vasiljevic, L. P. Zivkovic, A. Cabarkapa, V. P. Bajic, N. J. Djelic, and B. M. Spremo-Potparevic, “Cordyceps sinensis: genotoxic potential in human peripheral blood cells and antigenotoxic properties against hydrogen peroxide by comet assay,” Alternative Therapies in Health and Medicine, vol. 22, supplement 2, pp. 24–31, 2016.

– Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. International Journal of Oncology. 2010;37(6):1529–1536.

– Johnson E, Førland DT, Sætre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol. 2009;69:242–250.

– K. Shimada, K. Fujikawa, K. Yahara, and T. Nakamura, “Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion,” Journal of Agricultural and Food Chemistry, vol. 40, no. 6, pp. 945–948, 1992.

– Kasai H, He LM, Kawamura M, Yang PT, Deng XW, Munkanta M, Yamashita A, Terunuma H, Hirama M, Horiuchi I, Natori T, Koga T, Amano Y, Yamaguchi N, Ito M. IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR) Evid Based Complement Alternat Med. 2004;1:259–267.

– Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186(2):267–73.

– Kerrigan RW. Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia. 2005;97:12–24.

– Kim GY, Lee MY, Lee HJ et al. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol 2005;5:1523–32.

– Kim SP, Nam SH, Friedman M. Hericium erinaceus (Lion’s Mane) Mushroom Extracts Inhibit Metastasis of Cancer Cells to the Lung in CT-26 Colon Cancer-Tansplanted Mice. J Agric Food Chem. 2013;61(20):, 4898–4904.

– Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Science. 2004;95(9):758–764.

– Kisich KO, Higgins M, Diamond G, Heifets L. Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect Immun 2002;70:4591–9.

– Kobayashi H, Matsunaga K, Oguchi Y. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev 1995;4:275–81.

– Kobayashi H, Yoshida R, Kanada Y, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology. 2005;131(8):527–538.

– Kubo N, Myojin Y, Shimamoto F et al. Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei murill against X-irradiation in B6C3F1 mice: increased small intestinal crypt survival and prolongation of average time to animal death. Int J Mol Med2005;15:401–6.

– Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. Journal of Allergy and Clinical Immunology. 2010;125(5):985–992.

– Kuo YC, Huang YL, Chen CC, Lin YS, Chuang KA, Tsai WJ. Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei. J Lab Clin Med. 2002;140:176–187.

– Kvifte B. Reddet av japansk soppekstrakt. Mat & Helse 2003;10:34–5.

– L. Henderson, A. Wolfreys, J. Fedyk, C. Bourner, and S. Windebank, “The ability of the Comet assay to discriminate between genotoxins and cytotoxins,” Mutagenesis, vol. 13, no. 1, pp. 89–94, 1998.

– Lee IP, Kang BH, Roh JK, Kim JR. Lack of carcinogenicity of lyophilized Agaricus blazei Murill in a F344 rat two year bioassay. Food and Chemical Toxicology. 2008;46(1):87–95.

– Lin H, Cheung SWY, Nesin M, Cassileth B, Cunningham-Rundles S. Enhancement of umbilical cord blood cell hematopoiesis by Maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 2007;14:21–7.

– Lin Hm Yu-Hing S, Cassileth B, Sirotnak F, Cunningham Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 2004;4:91–9.

– Lin Y, Wei C, Liu Y, Qiu Y, Liu C, Guo F. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer Sci. 2013 Sep;104(9):1217–25.

– Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. European Journal of Immunology. 2002;32(6):1605–1613.

– Liu C, Sun C, Huang H, Janda K, Edgington T. Overexpressionof legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 2003;63:2957–2964.

– Liu Y, Bajjuri K M, Liu C, Sinha SC. Targeting Cell Surface Alpha(v)beta(3) Integrins Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug. Mol Pharm. 2012 Jan 1; 9(1): 168–175.

– Løvik M, Hogseth AK, Gaarder PI, Hagemann R, Eide I. Diesel exhaust particles and carbon black have adjuvant activity on the local lymph node response and systemic IgE production to ovalbumin. Toxicology. 1997;121:165–178.

– Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006 Aug;116(8):2132–2141.

– M. A. Hussein, “A convenient mechanism for the free radical scavenging activity of resveratrol,” International Journal of Phytomedicine, vol. 3, no. 4, pp. 459–469, 2011.

– M. F. Bellini, N. L. Giacomini, A. F. Eira, L. R. Ribeiro, and M. S. Mantovani, “Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO-k1 cells, studying different developmental phases of the mushroom,” Toxicology in Vitro, vol. 17, no. 4, pp. 465–469, 2003.

– M. Kozarski, A. Klaus, D. Jakovljevic et al., “Antioxidants of edible mushrooms,” Molecules, vol. 20, no. 10, pp. 19489–19525, 2015.

– M. Kozarski, A. Klaus, M. Niksic, D. Jakovljevic, J. P. F. G. Helsper, and L. J. L. D. Van Griensven, “Antioxidative and immunomodulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus,” Food Chemistry, vol. 129, no. 4, pp. 1667–1675, 2011.

– M. Oyaizu, “Studies on products of browning reaction prepared from glucose amine,” Japanese Journal of Nutrition, vol. 44, pp. 307–315, 1986.

– M. Radaković, N. Đelić, J. Stevanović et al., “Evaluation of the antigenotoxic effects of the royal sun mushroom, Agaricus brasiliensis (Higher basidiomycetes) in human lymphocytes treated with thymol in the comet assay,” International Journal of Medicinal Mushrooms, vol. 17, no. 4, pp. 321–330, 2015.

– Maes MF, van Baar HM, van Ginkel CJ. Occupational allergic contact dermatitis from the mushroom White Pom Pom (Hericeum erinaceum) Contact Derm. 1999;40:289–290.

– Martins de Oliveira J, Jordão BQ, Ribeiro LR, Ferreira da Eira A, Mantovani MS. Anti-genotoxic effect of aqueous extracts of sun mushroom (Agaricus blazei Murill lineage 99/26) in mammalian cells in vitro. Food Chem Toxicol2002;40:1775–80.

– Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Int J Cancer. 2013 Jul;133(1):108–19.

– Metzler-Zebeli BU, Zijlstra RT, Mosenthin R., and Gänzle MG. Dietary calciumphosphate content and oat β-glucan influence gastrointestinal microbiota, butyrate-producing bacteria and butyrate fermentation in weaned pigs. FEMS Microbiol Ecol. 2011;75:402–413.

– Miller G, Matthews SP, Reinheckel T, Fleming S, Watts C. Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J. 2011;25:1606–1617.

– Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 1987;80:535–44.

– Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 2007;7:701–24.

– Morikawa K, Takeda R, Yamazaki M, Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-d-glucan and other immunomodulators in murine cells. Cancer Res1985;45:1496–501.

– Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, et al. Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett. 2007;581:1417–1424.

– Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol. 2006;36:808–810.

– Murakawa K, Fukunaga K, Tanouchi M, Hosokawa M, Hossain Z, Takahashi K. Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Murill as an immune respond activator. Journal of Oleo Science. 2007;56(4):179–188.

– Murthy RV, Arbman G, Gao J, Roodman GD, Sun XF. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Clin Cancer Res. 2005;11:2293–2299.

– N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–191, 1988.

– N. V. Savina, N. V. Nikitchenko, T. D. Kuzhir, A. I. Rolevich, S. A. Krasny, and R. I. Goncharova, “The cellular response to oxidatively induced DNA damage and polymorphism of some DNA repair genes associated with clinicopathological features of bladder cancer,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 5710403, 13 pages, 2016.

– Nakajima A, Ishida T, Koga M, Takeuchi T, Mazda O, Takeuchi M. Effect of hot water extract from Agaricus blazei Murill on antibody-producing cells in mice. Int Immunopharmacol 2002;2:1205–11.

– Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994;343:1122–6.

– Nielsen KF. Mycotoxin production by indoor moulds. Fungal Genet Biol 2003;39:103–17.

– Niu YC, Liu JC, Zhao XM, Wu XX. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo. Oncology Reports. 2009;21(1):145–152.

– Oh TW, Kim YA, Jang WJ, et al. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry. 2010;58(7):4113–4119.

– Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol Pharm Bull 1996;19:608–12.

– Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei . Biological and Pharmaceutical Bulletin. 2001;24(7):820–828.

– Okazaki M, Chiba N, Adachi Y, Ohno N, Yadomae T. Signal transduction pathway on beta-glucans-triggered hydrogen peroxide production by murine peritoneal macrophages in vitro. Biol Pharm Bull 1996;19:18–23.

– Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7:715–29.

– Ormstad H, Groeng EC, Løvik M, Hetland G. The fungal cell wall component β-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice. J Toxicol Environ Health Part A. 2000;61:55–67.

– Oshiman K, Fujimiya Y, Ebina T, Suzuki I, Noji M. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Planta Med 2002;68:610–4.

– P. H. Gameiro, J. S. Nascimento, B. H. G. Rocha, C. F. B. Piana, R. A. Santos, and C. S. Takahashi, “Antimutagenic effect of aqueous extract from agaricus brasiliensis on culture of human lymphocytes,” Journal of Medicinal Food, vol. 16, no. 2, pp. 180–183, 2013.

– Paulsen JE. Modulation by dietary factors in murine FAP models. Toxicology Letters. 2000;112:403–9.

– Paulsen JE, Elvsaas IK, Steffensen IL, Alexander J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis. 1997 Oct;18(10):1905–10.

– Pelligrini P, Berghella AM, Del Beato T, et al. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progession. Cancer Research. 1998;42:1–8.

– Pinheiro F, Faria RR, de Camargo JL, Spinardi-Barbisan AL, da Eira AF, Barbisan LF. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food Chem Toxicol. 2003 Nov;41(11):1543–50.

– R. C. Luiz, B. Q. Jordão, A. F. Da Eira, L. R. Ribeiro, and M. S. Mantovani, “Non-mutagenic or genotoxic effects of medicinal aqueous extracts from the Agaricus blazei mushroom in V79 cells,” Cytologia, vol. 68, no. 1, pp. 1–6, 2003.

– R. C. R. N. Menoli, M. S. Mantovani, L. R. Ribeiro, G. Speit, and B. Q. Jordão, “Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on V79 cells,” Mutation Research – Genetic Toxicology and Environmental Mutagenesis, vol. 496, no. 1-2, pp. 5–13, 2001.

– R. D. Delmanto, P. L. A. De Lima, M. M. Sugui et al., “Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide,” Mutation Research, vol. 496, no. 1-2, pp. 15–21, 2001.

– R. W. Kerrigan, “Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms,” Mycologia, vol. 97, no. 1, pp. 12–24, 2005.

– Rainard P, Riollet C, Poutrel B, Paape MJ. Phagocytosis and killing of Staphylococcus aureus by bovine neutrophils after priming by tumor necrosis factor-alpha and the des-arginine derivative of C5a. Am J Vet Res2000;61:951–9.

– Reynolds JA, Kastello MD, Harrington DG, Crabbs CL, Peters CJ, Jemski JV, Scott GH, Di Luzio NR. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect Immun. 1980;30:51–57.

– Riggi S, Di Luzio NR. Identification of a RE stimulating agent in zymosan. Am J Physiol 1961;200:297–300.

– Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity. Medical Mycology. 2004;42(6):485–498.

– Romagnani S. The Th1/Th2 paradigm. Immunology Today. 1997;18:263–266.

– Ross GD, Vetvicka V, Yan J, Xia Y, Vetvicková J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999;42:61–74.

– S. I. R. Franke, D. Prá, B. Erdtmann, J. A. P. Henriques, and J. Da Silva, “Influence of orange juice over the genotoxicity induced by alkylating agents: an in vivo analysis,” Mutagenesis, vol. 20, no. 4, pp. 279–283, 2005.

– S. J. Huang and J.-L. Mau, “Antioxidant properties of methanolic extracts from Agaricus blazei with various doses of γ-irradiation,” LWT – Food Science and Technology, vol. 39, no. 7, pp. 707–716, 2006.

– S. K. Chung, T. Osawa, and S. Kawakishi, “Hydroxyl radical-scavenging effects of spices and scavengers from brown mustard (Brassica nigra),” Bioscience, Biotechnology and Biochemistry, vol. 61, no. 1, pp. 118–123, 1997.

– S. Wasser, “Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides,” Applied Microbiology and Biotechnology, vol. 60, no. 3, pp. 258–274, 2002.

– S. Y. Tsai, H.-L. Tsai, and J.-L. Mau, “Antioxidant properties of Agaricus blazei, Agrocybe cylindracea, and Boletus edulis,” LWT—Food Science and Technology, vol. 40, no. 8, pp. 1392–1402, 2007.

– Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2009;31(1):37–49. Article ID bgp272.

– Seljelid R. A water-soluble aminated beta-1-3D-glucan derivative causes regression of solid tumores in mice. Biosci Rep. 1986;6:845–851.

– Seljelid R, Rasmussen LT, Larm O, Hoffman J. The protective effect of beta 1-3d-glucan-derivatized plastic beads against Escherichia coli infection in mice. Scand J Immunol 1987;25:55–60.

– Shimizu S, Kitada H, Yokota H et al. Activation of the alternative complement pathway by Agaricus blazeiMurill. Phytomedicine 2002;9:536–45.

– Sodring M, Gunnes G, Paulsen JE. Spontaneous initiation, promotion, and progression of colorectal cancer in the novel A/J Min/+ mouse. Int J Cancer. 2016 Apr 15;138(8):1936–46.

– Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Structure and Function. 2001;26(2):103–108.

– Sorimachi K, Akimoto K, Koge T. Inhibitory Effect of Agaricus blazei Murill Components on Abnormal Collagen Fiber Formation in Human Hepatocarcinoma Cells. Biosci Biotechnol Biochem 2008;72:621–3.

– Sorimachi K, Ikehara Y, Maezato G et al. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci Biotechnol Biochem2001;65:1645–7.

– Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, et al. Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the Apc Gene. Science. 1992;256(5057):668–70.

– Suehiro M, Kishimoto S. Cheilitis due to Agaricus blazei Murill mushroom extract. Contact Derm. 2007;56:293–294.

– Suzuki I, Itani T, Ohno N, Oikawa S, Sato K, et al. Antitumor activity of a polysaccharide fraction extracted from cultured fruiting bodies of Grifola frondosa. J Pharmacobiodyn. 1984 Jul;7(7):492–500.

– Suzuki T, Ohno N, Saito K, Yadomae T. Activation of the complement system by (1→3)-β-D-glucans having different degrees of branching and different ultrastructures. Journal of Pharmacobio-Dynamics. 1992;15(6):277–285.

– T. Mizuno, T. Kinoshita, C. Zhuang, H. Ito, and Y. Mayuzumi, “Antitumor-active heteroglycans from niohshimeji mushroom, tricholoma giganteum,” Bioscience, Biotechnology and Biochemistry, vol. 59, no. 4, pp. 568–571, 1995.

– T. Savić, A. Patenković, M. Soković, J. Glamočlija, M. Andjelković, and L. J. L. D. van Griensven, “The Effect of Royal Sun Agaricus, Agaricus brasiliensis S. Wasser et al., extract on methyl methanesulfonate caused genotoxicity in Drosophila melanogaster,” International Journal of Medicinal Mushrooms, vol. 13, no. 4, pp. 377–385, 2011.

– Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Ogawa N. Clinical efficacy of lentinan on neoplastic diseases. Adv Exp Med Biol 1983;166:181–7.

– Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. Journal of Nutrition. 2001;131(5):1409–1413.

– Takimoto H, Kato H, Kaneko M, Kumazawa Y. Amelioration of skewed Th1/Th2 balance in tumor-bearing and asthma-induced mice by oral administration of Agaricus blazei extracts. Immunopharmacol Immunotoxicol. 2008;30:747–760.

– Tanaka H, Tsunematsu K, Makamura N, Suzuki K, Tanaka N, Takeya I, Saikai T, Abe S. Successful treatment of hyper-sensitivity pneumonitis caused by Grifola frondosa (Maitake) mushroom using a HFA-BDP extra-fine aerosol. Intern Med. 2004;43:737–740.

– Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM et al. Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study. Biomed Res Int. 2015;2015:718539.

– Tangen J-M, Tryggestad AMA and Hetland G. Stimulation of human monocytic cells by the medicinal mushroom Agaricus blazei Murill induces expression of cell surface markers associated with activation and antigen presentation. Applied Scientific Reports. 2014; 1(1): 1.

– Tapper H, Sundler R. Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages. Biochem J 1995;306:829–35.

– Tian X, Lun Z, Wang J, Ito H, Simura K. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill. J Lanzhou Med College 1994;20:169–71.

– Toi M, Hattori T, Akagi M et al. Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization. Cancer 1992;70:2475–83.

– Torisu M, Hayashi Y, Ishimitsu T et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990;31:261–8.

– Tryggestad AMA, Espevik T, Førland DT, Ryan L, Hetland G. The Medical Mushroom Agaricus blazei Murill Activates NF-κB via TLR2. 13th International Congress of Immunology, Rio de Janeiro, 2007: P2.23 INI-02 Signalling pathways of innate immune receptors; P1193.

– van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res. 2001;264(1):126–34.

– Vetvicka V, Thornton BP, Ross GD. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest. 1996;98:50–61.

– Viola A. Improving cancer immunotherapy by preventing chemokine nitration. European Journal of Cancer Supplment. 2010;8:p. 89.

– Volman JJ, Helsper JPFG, Wei S, et al. Effects of mushroom-derived β-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-κb transactivation in Caco-2 reporter cells: can effects be explained by structure? Molecular Nutrition and Food Research. 2010;54(2):268–276.

– Wan GH, Li CS, Guo SP, Rylander R, Lin RH. An airborne mold-derived product, beta-1,3-D-glucan potentiates airway allergic responses. Eur J Immunol. 1999;29:2491–2497.

– Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Critical Reviews in Immunology. 1999;19(1):65–96.

– Xiaohui T, Lun Z, Wang J, et al. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill. Journal of Lanzhou Medical College. 1994;20:169–171.

– Y. Shi, A. E. James, I. F. F. Benzie, and J. A. Buswell, “Genoprotective activity of edible and medicinal mushroom components,” International Journal of Medicinal Mushrooms, vol. 6, pp. 1–14, 2004.

– Yazawa Y, Yokota M, Sugiyama K. Antitumor promoting effect of an active component of polyporus, ergosterol and related compounds on rat urinary bladder carcinogenesis in a short-term test with concanavalin A. Biological and Pharmaceutical Bulletin. 2000;23(11):1298–1302.

– Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and future perspectives on metabolic disorders. Nutrients. 2016 Mar 18;8(3). Pii: E173.

– Yoshimura K, Kamoto T, Ogawa O, et al. Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label study. International Journal of Urology. 2010;17(6):548–554.

– Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms of Agaricus blazeiMurill on the growth of prostate cancer in vitro and in vivo. Journal of Nutritional Biochemistry. 2009;20(10):753–764.

– Yuminamochi E, Koike T, Takeda K, Horiuchi I, Okumura K. Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill. Immunology. 2007;121:197–206.

– Z. da Rosa Guterres, M. S. Mantovani, A. F. da Eira, L. R. Ribeiro, and B. Q. Jordão, “Genotoxic and antigenotoxic effects of organic extracts of mushroom Agaricus blazei Murrill on V79 cells,” Genetics and Molecular Biology, vol. 28, no. 3, pp. 458–463, 2005.

– Z. R. Guterrez, M. S. Mantovani, A. F. Eira, L. R. Ribeiro, and B. Q. Jordão, “Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murrill in vitro,” Toxicology in Vitro, vol. 18, no. 3, pp. 301–309, 2004.

– Ziliotto L, Pinheiro F, Barbisan LF, Rodrigues MAM. Screening for in vitro and in vivo antitumor activities of the mushroom Agaricus blazei. Nutrition and Cancer, 2009;61(2), 245–250.

– Zittermann A. Effects of vitamin K on calcium and bone metabolism. Current Opinion in Clinical Nutrition and Metabolic Care. 2001;4(6):483–487.

0
$0.00
Mini Cart
  • Empty cart

    No products in the cart.

Hekma Center
0